Performance of Functions; Claims for Compensation Under the Energy Employees Occupational Illness Compensation Program Act of 2000, as Amended, 78520-78568 [E6-21839]
Download as PDF
78520
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
DEPARTMENT OF LABOR
Office of Workers’ Compensation
Programs
20 CFR Parts 1 and 30
RIN 1215–AB51
Performance of Functions; Claims for
Compensation Under the Energy
Employees Occupational Illness
Compensation Program Act of 2000, as
Amended
Office of Workers’
Compensation Programs, Employment
Standards Administration, Labor.
ACTION: Final rule.
pwalker on PROD1PC60 with RULES2
AGENCY:
SUMMARY: On June 8, 2005, the
Department of Labor (DOL) published
interim final regulations that govern its
responsibilities under the Energy
Employees Occupational Illness
Compensation Program Act of 2000, as
amended (EEOICPA or Act). Part B of
the Act provides lump-sum payments of
$150,000 and medical benefits to
covered employees and, where
applicable, to survivors of such
employees, of the Department of Energy
(DOE), its predecessor agencies and
certain of its vendors, contractors and
subcontractors. Part B also provides
lump-sum payments of $50,000 and
medical benefits to individuals found
eligible by the Department of Justice
(DOJ) for $100,000 under section 5 of
the Radiation Exposure Compensation
Act (RECA) and, where applicable, to
their survivors. Part E of the Act
provides variable lump-sum payments
(based on a worker’s permanent
impairment and/or calendar years of
qualifying wage-loss) and medical
benefits for covered DOE contractor
employees and, where applicable,
provides variable lump-sum payments
to survivors of such employees (based
on a worker’s death due to a covered
illness and any calendar years of
qualifying wage-loss). Part E also
provides these same payments and
benefits to uranium miners, millers and
ore transporters covered by section 5 of
RECA and, where applicable, to
survivors of such employees.
At the same time the Department
published the interim final regulations,
it also invited written comments and
advice from interested parties regarding
possible changes to those regulations.
This document amends the interim final
regulations based on comments that the
Department received.
DATES: Effective Date: This rule will be
effective on February 27, 2007, and will
apply to all claims filed on or after that
date. This rule will also apply to any
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
claims that are pending on February 27,
2007.
FOR FURTHER INFORMATION CONTACT:
Shelby Hallmark, Director, Office of
Workers’ Compensation Programs,
Employment Standards Administration,
U.S. Department of Labor, Room S–
3524, 200 Constitution Avenue, NW.,
Washington, DC 20210, Telephone:
202–693–0031 (this is not a toll-free
number).
SUPPLEMENTARY INFORMATION: The
Department of Labor’s interim final
regulations implementing its
responsibilities under the Energy
Employees Occupational Illness
Compensation Program Act of 2000, as
amended (42 U.S.C. 7384 et seq.), were
published in the Federal Register on
June 8, 2005 (70 FR 33590). They took
effect immediately and included a 60day period for comment. During the
comment period, the Department
received 533 timely comments: two
joint comments from 39 congressional
representatives; two from labor
organizations; four from attorneys; four
from advocacy groups; one from a lay
representative; one from DOE; one from
a DOE contractor; and 518 from
individuals. The Department also
received untimely comments from one
physician, one attorney, one advocacy
group, the Coconino County (Arizona)
Board of Supervisors, one labor
organization, the Navajo Nation and 23
individuals; all of the points they raised
were also raised by the timely
comments. Almost all of the timely
comments (521) addressed the issue of
eligibility for survivor benefits under
Part E of EEOICPA; 494 of the comments
addressed this issue alone. They also
addressed a number of other issues,
including the administrative claims
process used to adjudicate claims under
EEOICPA, entitlement qualifications,
and the extent of coverage provided
under Part E. The Department’s sectionby-section analysis of the timely
comments it received is set forth below
(see sections I and II).
Some minor changes have been made
to the interim final regulations that did
not result from any comments. One such
change is the addition of new language
to § 30.112(b) to recognize that pursuant
to § 30.106, entities other than DOE may
be verifying alleged periods of
employment that claimants have
reported to OWCP. A second change is
the addition of language to § 30.301(c)
clarifying that OWCP will also not issue
a subpoena for the testimony of
employees of the National Institute for
Occupational Safety and Health
(NIOSH) or contractors of either OWCP
or NIOSH acting in their official
PO 00000
Frm 00002
Fmt 4701
Sfmt 4700
capacities with respect to the EEOICPA
claims adjudication process. In
addition, the existing language of
§ 30.316(c) has been modified so that a
recommended decision on a claim that
is pending for more than one year after
the date it was reopened for issuance of
a new final decision will be considered
a final decision on that claim as of that
date, and § 30.400(a) has been modified
to reflect the current practice of OWCP
to pay for medically necessary treatment
of a primary cancer in claims where the
accepted occupational illness or covered
illness is a secondary cancer.
When publishing a final rule
following a comment period, it is
customary to publish only the changes
that have been made to the rule;
however, in order to be more userfriendly, the Department is publishing
the entire rule, including the parts that
have not been changed. By doing so,
only one document containing all of the
regulations and commentary needs to be
consulted rather than multiple
documents.
I. Comments on the Interim Final
Regulations
The section numbers used in the
headings of the following analysis are
those that were used in the interim final
regulations. Unless otherwise stated, the
section numbers in the text of the
analysis refer to the numbering used for
the final regulations. No comments were
received with respect to part 1.
Section 30.5
One individual suggested that the
definition for the statutory term
‘‘Department of Energy facility’’ be
modified to more clearly identify the
‘‘list of facilities established by the
Department of Energy’’ referred to in the
interim final regulation. To eliminate
any confusion with respect to this list,
and as suggested by the comment,
§ 30.5(x) has been amended in this final
rule to specify which list of facilities the
Department has adopted. Another
individual believed that the five-year
latency period requirement for specified
cancers listed in § 30.5(ff)(5) was ‘‘in
error’’ and suggested that it be deleted.
However, the latency period
requirement is contained within section
7384l(17)(A) of the Act and cannot be
modified in these regulations.
Therefore, the suggested change was not
made. A third individual suggested that
§ 30.5(gg) be modified to more clearly
describe the requirements for eligibility
of survivors under Part E. Section
30.5(gg) is only intended to inform
readers that survivors must be alive to
receive a payment. Because complete
descriptions of the requirements for
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
pwalker on PROD1PC60 with RULES2
eligibility of survivors under Part B and
Part E of EEOICPA already appear at
§ 30.500, the suggested change is
unnecessary and was not made.
Sections 30.100, 30.101, 30.102 and
30.103
One attorney pointed out that while
employees and survivors can use Forms
EE–1 and EE–2 to file their initial claims
with OWCP, there was no form
provided for filing a claim for an alleged
consequential illness or injury. The
absence of a specific form for claiming
an alleged consequential illness or
injury is intentional since in those
situations, OWCP would already have
all of the necessary factual information
that could be requested by a form.
Claimants need only submit written
‘‘words of claim’’ to OWCP, together
with the type of supporting medical
evidence described in §§ 30.207(d),
30.215, 30.222(b), 30.226 or 30.232(c), to
file a claim for a consequential illness
or injury. Therefore, no new form has
been designed and the suggested
changes to §§ 30.100 and 30.101 were
not made.
Two individuals disputed the
provision in § 30.101(c) that a survivor
must be alive to receive a payment
under the Act and noted that if all of the
eligible survivors die before payment
can be made, no payment can be made
to any other individual as the heir of a
deceased eligible survivor. However,
this result is required under both Parts
B and E of EEOICPA pursuant to
sections 7384s(e)(1) and 7385s–3(c),
which require that survivors under both
Part B and Part E must be alive at the
time of payment, and cannot be altered
by regulation. Therefore, the requested
change to § 30.101(c) was not made.
Three advocacy groups suggested that
the provision in § 30.102 that OWCP
will only adjudicate a claim for an
increased impairment rating if it is filed
at least two years from the date of the
last award of impairment benefits is
unreasonable and proposed that the
waiting period to be reduced to either
one year or six months. The claim
development process that OWCP uses
when it determines a covered Part E
employee’s minimum impairment rating
is necessarily complex and usually takes
a considerable amount of time to
complete. For example, the medical
evidence submitted in support of an
alleged rating may not contain all of the
information that OWCP will need to
determine an impairment rating. OWCP
would then have to seek that
information from another source, or
obtain an impairment evaluation by
another physician before it would be
able to determine the extent of the
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
alleged permanent impairment based on
the evidence in the case record. If
claimants were permitted to apply for
an increased impairment rating sooner
than two years after their prior award
for impairment benefits, the claims
processing system would inevitably
become less efficient and claimants who
have not had their initial impairment
claims adjudicated and who have not
received benefits for their compensable
permanent impairments would
necessarily have to wait even longer to
receive a decision from OWCP.
Therefore, in order to maintain an
efficient system of adjudication for all
claimants and to best use its limited
resources, OWCP concludes that the
two-year waiting period should remain
in place and none of the suggested
changes to this section have been
adopted.
One of these same advocacy groups
also noted that while § 30.103 requires
claimants to use approved forms when
filing claims under Part E of EEOICPA,
‘‘the present forms do not allow for
claiming diseases other than cancer,
berylliosis or silicosis.’’ On June 20,
2005, the Office of Management and
Budget approved new versions of Forms
EE–1 and EE–2 that allow claimants to
file for all illnesses potentially
compensable under Part E. As noted in
§ 30.103(b), these forms are available on
the Internet at https://www.dol.gov/esa/
regs/compliance/owcp/eeoicp/
main.htm. Therefore, the suggested
change to § 30.103 is unnecessary and
has not been made.
Section 30.106
One individual questioned whether
DOE was in possession of sufficient
employment data to enable it to verify
alleged periods of employment for
‘‘most’’ claims. OWCP does not dispute
that there are a number of facilities for
which DOE does not have access to any
employment data. However, OWCP has
developed a number of alternative
methods to be used for verifying alleged
employment at those facilities. In
acknowledgement of this situation,
§ 30.106 describes the various
alternative methods by which OWCP
may seek to verify alleged periods of
employment at those facilities for which
DOE has no employment data, and no
change to this section was made in the
final rule.
Sections 30.111, 30.113 and 30.114
One individual and two labor
organizations questioned the
description of the general burden of
proof that all claimants must meet in
order to establish their entitlement to
any compensation under either Parts B
PO 00000
Frm 00003
Fmt 4701
Sfmt 4700
78521
or E of EEOICPA. Section 30.111(a)
describes the general burden of proof
that claimants must meet, ‘‘[e]xcept
where otherwise provided in the Act
and these regulations,’’ with respect to
all of the required elements involved in
a claim. As one of these labor
organizations noted, there are differing
burdens of proof between Parts B and E,
as well as between different claimed
illnesses within a single Part of the Act.
This fact, however, does not mean that
the description of the general burden of
proof in § 30.111(a) is incorrect. OWCP
is committed to helping claimants meet
their burden of proof and is aware that
some claimants may have difficulty
proving both the presence of and their
exposure to a toxic substance at a
particular facility under Part E. In an
effort to remedy this situation, OWCP is
currently developing exposure matrices
that will compile information provided
by a variety of sources, including DOE,
former worker medical survey programs,
and epidemiological studies. For all of
the DOE facilities, extensive
documentation exists covering
thousands of toxic materials. The
matrices now being developed will be
posted on our Web site and will be
available to claimants and their
representatives. While it is not possible
to define precisely in a regulation how
these complex matrices will be used in
each case, OWCP’s procedural guidance
documents will provide additional
clarity in this regard, and those
documents will also be available to the
public on our Web site. Nevertheless, it
would not be appropriate to relieve
claimants of their ultimate obligation to
prove their claims, which is a standard
requirement of all state and federal
workers’ compensation programs. Since
Part E was intended to substitute for the
state workers’ compensation benefits
that claimants could have sought DOE’s
assistance in obtaining under former
Part D of EEOICPA, OWCP’s application
of standard workers’ compensation
principles is appropriate and no
changes were made to § 30.111(a).
Another individual suggested that
OWCP amend § 30.111(c) to state that an
affidavit submitted by a claimant is not,
in and of itself, sufficient to establish a
period of alleged employment. Section
30.111(c) currently states that such
affidavits ‘‘may be relied on in
determining whether a claim meets the
requirements of the Act. * * *’’
However, since § 30.112(b)(3) already
makes clear that OWCP may reject a
claim when the only evidence of
covered employment is a ‘‘self-serving
affidavit,’’ the suggested change is
unnecessary and was not adopted in the
E:\FR\FM\29DER2.SGM
29DER2
78522
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
pwalker on PROD1PC60 with RULES2
final rule. A third individual suggested
that language be added to § 30.111
stating that when OWCP requests a
second opinion from a medical
specialist, it will only provide such
specialist with copies of the ‘‘medical’’
evidence in the case file to review
instead of all ‘‘relevant’’ evidence in the
file. This suggestion ignores the fact that
factual evidence from a case file may be
highly relevant (e.g., evidence of
exposure levels, environmental
assessments, etc.) to the probative value
of the specialist’s medical opinion and
as a result, the requested change was not
made.
A third individual requested that
§ 30.113(a) be changed to indicate that
OWCP will accept various types of
‘‘electronic’’ submissions in support of
claims for compensation under
EEOICPA, while an advocacy group
suggested that § 30.113(c) be changed
due to its belief that all statements
regarding the substance of lost or
destroyed factual or medical evidence
would be ‘‘self-serving’’ and therefore
not acceptable. Both of these provisions
have been in effect since the issuance of
the first final rule on December 26,
2002, and have not proved problematic
in practice. Therefore, the requested
changes were not made in this final
rule.
A fourth individual disagreed with
the general requirement in § 30.114 that
claims for compensation under
EEOICPA be supported with medical
evidence that establishes the existence
of the alleged occupational illness under
Part B or covered illness under Part E.
However, these medical requirements
are derived from the statutory
requirements in the Act itself and
cannot be altered through the
rulemaking process. Therefore, the
requested change to § 30.114 was not
made.
Section 30.115
Two individuals asserted that
application of the dose reconstruction
process discussed in § 30.115 of the
interim final regulations to Part E cancer
claims would be neither just nor fair,
and one advocacy group asked how
OWCP planned to adjudicate the claims
of employees with non-specified
cancers (those not listed at § 30.5(ff)) at
newly designated Special Exposure
Cohort worksites. With respect to the
first of these two concerns, the
discussion of § 30.213 in the preamble
to the interim final rule described the
scientific and administrative reasons
why OWCP decided to use the existing
dose reconstruction process from Part B
to adjudicate certain radiogenic cancer
claims filed under Part E, and the two
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
commenters have not presented any
arguments challenging the underlying
bases for that decision. As for the
comment regarding OWCP’s
adjudication of non-specified cancer
claims following an administrative
addition of a class of employees to the
Special Exposure Cohort, this question
involves the manner in which the
Department of Health and Human
Services (HHS) defines the new class of
employees and the unique factual basis
for its addition to the Special Exposure
Cohort. However, since neither of these
matters are within the jurisdiction of
OWCP, they cannot be addressed in the
context of this rulemaking (see
§ 30.2(b)). For the above reasons, no
changes were made to § 30.115 in the
final rule based on these three
comments.
Section 30.213
OWCP received 19 comments
regarding the operation of § 30.213 with
respect to the 50 percent compensable
level of probability of causation (PoC) it
will use to adjudicate claims for
radiogenic cancer under Part E of
EEOICPA (three comments were
received from advocacy groups, 11 from
individuals, two from congressional
representatives, one from a lay
representative, and two from a single
labor organization). These comments
requested that OWCP lower the
compensability level below the 50
percent level that is used for Part B
claims, but gave no scientific or other
rationale for setting the compensability
level at any particular point below 50
percent. Rather, the commenters base
their arguments on the fact that the
statutory causation standard for Part E
uses language that differs from the
language used for Part B. For the reasons
set forth below, OWCP has determined
that it is more consistent with
congressional intent and current science
to continue to use HHS’s regulations in
making the determination required by
section 7385s–4(c)(1)(A) of the Act
because those regulations provide the
only reasonable factual basis upon
which OWCP can determine if it is ‘‘at
least as likely as not’’ that exposure to
radiation at a DOE facility or RECA
section 5 facility was a ‘‘significant
factor in aggravating, contributing to, or
causing’’ radiogenic cancer for which
compensation is claimed under Part E.
It is clear from the scientific literature
that it is not possible to definitively
attribute any individual’s cancer to any
particular cause, and no commenter
identified a method of attribution. As
noted in Science Panel Report No. 6,
Use of Probability of Causation by the
Veterans Administration in the
PO 00000
Frm 00004
Fmt 4701
Sfmt 4700
Adjudication of Claims of Injury Due to
Ionizing Radiation, issued by the
Committee on Interagency Radiation
Research and Policy Coordination of the
Office of Science and Technology
Policy, Executive Office of the President
(August 1988), ‘‘[a]nalysis of medical
findings cannot separate the ‘radiogenic
cases’ from those unrelated to radiation
exposure; no ‘biological markers’ have
yet been identified that can
unequivocally point to radiogenic
cancers as distinct from non-radiogenic
cancers. An excess incidence of cancer
is identifiable in a statistical sense
only.’’
It is, thus, not surprising that
Congress required the use of statistical
probability in the determination
whether to compensate an individual
with a claimed cancer under Part B.
Under Part B, an individual will be
determined to have sustained ‘‘cancer in
the performance of duty for purposes of
the compensation program if, and only
if, the cancer [at issue] was at least as
likely as not related to employment at
the facility’’ (emphasis added),
determined pursuant to guidelines
based upon radiation dose and ‘‘the
upper 99 percent confidence interval of
the probability of causation in the
radioepidemiological tables published
under section 7(b) of the Orphan Drug
Act (42 U.S.C. 241 note),’’ as well as a
number of other factors. The technical
documentation prepared by HHS to
explain the computer program used to
make this calculation similarly notes
that ‘‘it is not possible to determine, for
a given individual, whether his or her
cancer resulted from workplace
exposure to ionizing radiation.’’
(NIOSH—Interactive
RadioEpidemiological Program (IREP)
Technical Documentation, June 18,
2002). Part B, thus, requires that a
claimed cancer be determined to be
‘‘related to’’ employment at a covered
facility if the radiation dose and other
factors combined indicate that there is
a statistical probability that the cancer
would not have occurred in the absence
of work-related exposure to radiation. In
other words, the PoC determination
made for purposes of Part B is actually
a determination that there is a 50
percent or better chance that radiation
was a factor, however slight, ‘‘in
aggravating, contributing to, or causing’’
a claimed cancer because, in the
absence of work-related exposure to
radiation, the cancer would not have
occurred at all.
Because it is impossible to determine
the extent to which any individual
factor contributed to the development of
cancer, OWCP has concluded that the
only way to comply with the statutory
E:\FR\FM\29DER2.SGM
29DER2
pwalker on PROD1PC60 with RULES2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
mandate in Part E is, in effect, to
interpret ‘‘a significant factor’’ as
including any factor. Accordingly, the
determination made pursuant to HHS
regulations issued under Part B whether
there is a 50 percent probability that
radiation was a factor in the
development of cancer (i.e., that in the
absence of work-related exposure to
radiation, the cancer would not have
occurred at all) will be deemed
sufficient to establish that radiation was
not only a factor, but was also a
significant factor ‘‘in aggravating,
contributing to, or causing’’ the cancer
in question.
The position taken by the commenters
appears to be based on a
misunderstanding of the test used by
Congress in Part B of EEOICPA for
determining coverage for cancer due to
exposure to radiation. The standard
used is whether a cancer suffered by a
worker is ‘‘related to’’ his or her
employment at a covered facility. The
commenters suggest that Part B awards
benefits only for cancers caused by
exposure to radiation, while Part E was
intended to award benefits where the
cancer was either caused by or
contributed to by exposure to radiation.
This misunderstanding may well stem
from use of the term ‘‘probability of
causation’’ to describe the results of the
statistical determination made by the
radioepidemiological tables used in the
process. By using the term ‘‘related to’’
in Part B, however, Congress
encompassed all cancers for which there
is a statistical probability that exposure
to radiation was a factor in the
development of the cancer. Despite the
use of the word ‘‘causation’’ in the term
‘‘probability of causation,’’ the
determination reached is not an
individual determination of the
mechanism of cause and effect leading
to a particular cancer, which as
explained above is not scientifically
possible, but a statistical prediction of
the probability that the cancer would
not have occurred in the absence of
exposure to radiation. Thus, the HHS
technical documentation describes PoC
as ‘‘the likelihood that an existing
cancer resulted from that [workplace
radiation] exposure.’’ (NIOSH–IREP
Technical Documentation, June 18,
2002). Scientific analysis does not
distinguish between cancers that are
caused or contributed to by radiation.
Since the actual mechanisms of cause
(or contribution) for a given cancer are
not known, only probabilistic assertions
can be made, and they address only
whether the cancer is more or less likely
not to have occurred absent the
exposure. The IREP approach identifies
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
all conceivable cancers that might have
resulted from the radiation exposure.
This probabilistic approach is the only
generally accepted scientific means of
assigning responsibility for cancers in
relation to radiation exposure. The
Department of Veterans Affairs and the
Defense Department also utilize
essentially the same statistical
probability test to adjudicate benefits for
potentially radiogenic cancer cases
incurred by veterans exposed to
radiation.
Further, it should be noted that the
epidemiological method utilized in this
determination is actually far more
favorable towards claimants than merely
requiring a determination that radiation
exposure was ‘‘at least as likely as not’’
a significant factor. The method
specified by Congress for Part B and
adopted by OWCP for Part E requires
that OWCP use the upper 99 percent
confidence interval to determine
whether cancers of employees are to be
compensable. In essence, a confidence
interval indicates the likelihood that a
statistical sample will reflect actual
results and is often demonstrated in
terms of a margin of error (e.g., ±5
percentage points in a poll). The precise
statistical definition of the 99 percent
confidence interval is that if a study or
poll were conducted 100 times, the
results would be within the sample’s
margin of error 99 times and one time
the results would be either higher or
lower. For purposes of the calculations
performed under Parts B and/or E of
EEOICPA, an upper 99 percent
confidence interval establishes a
significant margin of error in favor of
claimants for whether the exposures
that appeared at least as likely as not to
cause cancer actually did. That is, use
of this confidence interval means that
there is only a one percent chance that
the exposure level has been
underestimated and a 99 percent chance
that it has been overestimated. Because
of this extremely claimant-favorable
margin of error, we believe that it is
reasonable to conclude that the use of
this method for adjudicating radiogenic
cancer claims under Part E will provide
compensation in any case in which it is
at least as likely as not that an employee
would not have suffered cancer absent
his or her employment-related exposure
to radiation.
This conclusion finds further support
in the Report of the NCI–CDC Working
Group to Revise the 1985 NIH
Radioepidemiological Tables
(September 2003), which found that the
PoC model was a viable method to
adjudicate claims for radiation-related
instances of cancer that appropriately
summarized ‘‘the likelihood that prior
PO 00000
Frm 00005
Fmt 4701
Sfmt 4700
78523
radiation exposure might be causally
related to cancer occurrence.’’ The
report described the Department of
Veterans Affairs’ use of PoC calculated
at the 99 percent credibility limit (the
term used in that report for confidence
interval) as ‘‘highly unlikely to exclude
persons with meritorious claims.
However it is likely to award many
persons whose true [PoC’s] are very
much less than 50 percent.’’ For
example, as noted in that report,
because of the substantial margin for
error established by use of the 99
percent confidence level, a cancer that
is actually nine percent likely to have
been caused by the alleged exposure,
but for which data is limited, could
yield a PoC of 82 percent under the HHS
PoC guidelines.
OWCP also believes that utilizing the
50 percent PoC process for Part E is
more likely to result in a scientifically
valid and consistent determination
process than attempting to reach a
determination based on medical
opinions from physicians that inevitably
contain a significant speculative
component. Use of the PoC guidelines
for claims under both Part B and Part E
allows OWCP to adjudicate the
entitlement of radiogenic cancers that
are potentially compensable under both
Part B and Part E in a uniform manner.
Any process for determining coverage of
claims for radiogenic cancers that would
yield inconsistent results as to whether
that cancer is compensable under Parts
B and E is unlikely to be understood or
accepted by claimants and other
stakeholders.
The commenters’ argument that
eligibility for a radiogenic cancer under
Part E should be based on a lower than
50 percent PoC level apparently is based
on their interpretation of the language of
section 7385s–4(c)(1)(A), which requires
a determination that it is ‘‘at least as
likely as not that exposure to a toxic
substance at a Department of Energy
facility was a significant factor in
aggravating, contributing to, or causing’’
the claimed cancer. While Congress
utilized different terminology to
establish the test for compensation in
Part E and Part B, the differences reflect
the fact that Part B was intended to
establish narrowly drawn tests for
specific medical conditions, such as
radiogenic cancer or chronic beryllium
disease. Part E, on the other hand, sets
forth a broad test that must be used to
determine the compensability of a
virtually unlimited array of illnesses
potentially caused by exposure to the
tens of thousands of toxic substances
present at Department of Energy
facilities. While there is no way to
distinguish between causation and
E:\FR\FM\29DER2.SGM
29DER2
78524
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
pwalker on PROD1PC60 with RULES2
contribution in regard to cancer related
to exposure to radiation (because it is
only possible to determine the statistical
probability that, absent work-related
exposure to radiation, the employee in
question would not have incurred the
cancer or cancers from which he or she
suffered), Part E applies to other types
of illnesses for which the concept of
‘‘contribution’’ may be highly relevant.
Indeed, unlike the case of radiogenic
cancer, it is possible to determine that
toxic exposure contributed to a number
of other illnesses or that other preexisting illnesses were aggravated by
toxic exposure. Therefore, the difference
in the statutory language between the
standard in Part B and the standard in
Part E does not indicate that Part E was
intended to establish a more lenient test,
but can be explained by the fact that it
was designed to cover a wide variety of
situations and circumstances, as
opposed to the more narrowly drawn
Part B radiogenic cancer standard,
where no difference existed between
causation and contribution.
It should also be noted that the
regulation specifies that the PoC model
will be determinative under Part E only
with respect to claims where the sole
alleged condition is radiogenic cancer.
When a claim for cancer under Part E
cannot be accepted based on exposure
to radiation alone because the PoC was
determined to be less than 50 percent,
the claimant is provided the
opportunity to establish that the cancer
was caused by a combination of
exposure to radiation and exposure to
one or more other toxic substances.
OWCP will adjudicate those claims for
cancer allegedly due to exposure to
radiation combined with exposure to
one or more other toxic substances
using the eligibility criteria for other
covered illnesses in §§ 30.230 through
30.232. As a result, no changes were
made to § 30.213(c) in the final rule.
Sections 30.230, 30.231 and 30.232
One labor organization suggested that
the statutory terms ‘‘aggravated,’’
‘‘contributed to’’ and ‘‘caused’’ from one
portion of the Part E causation standard
appearing in section 7385s–4(c)(1)(A) of
EEOICPA be defined in § 30.230 of the
final rule so it will be ‘‘possible to
determine how DOL will adjudicate
claims.’’ However, these statutory terms
have a long and settled history in
workers’ compensation law, and OWCP
believes any attempt to further define
those terms (which involve matters of
administrative discretion and
professional medical opinion) would
only lead to increased confusion. As a
result, § 30.230 has not been amended
in the final rule.
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
Two comments from congressional
representatives, three from advocacy
groups and one from an individual
asserted that it would be extremely
difficult for claimants to satisfy their
burden of proof under § 30.231 to
establish both the presence of a toxic
substance and the employee’s exposure
to the substance without the
development of site exposure
assessments of toxic substances. OWCP
shares this concern and is committed to
studying all of the available information
pertaining to these sites and making
publicly available a listing of the toxic
substances present at such sites. The
information compiled from these
studies will be accepted as probative
evidence in determining the eligibility
of claimants, barring extraordinary and
unusual circumstances, and § 30.231(b)
has been modified to clarify OWCP’s
policies regarding this matter. However,
the remainder of the suggested changes
to the burden of proof described in
§ 30.231 have not been adopted.
One advocacy group objected to the
requirement in § 30.232(a)(2) that each
claimant under Part E provide a signed
medical release authorizing the release
of any diagnosis, medical opinion or
medical records documenting the
employee’s alleged covered illness and
that it resulted from exposure to a toxic
substance. The advocacy group is
concerned that in some cases such
documents may no longer exist. OWCP
is aware of this problem and has
established procedures in § 30.113 by
which a claimant can nevertheless meet
this requirement through the
submission of affidavits attesting to
medical evidence that was contained in
documents that no longer exist.
However, a signed medical release is
needed in all Part E claims so OWCP
may thoroughly investigate the claim.
Thus, the suggestion to drop this
requirement was not adopted. The same
advocacy group and another advocacy
group suggested that the requirement
contained in § 30.232(c) that a claimant
establish that a covered Part E employee
suffered an injury, illness, impairment
or disease as a consequence of a covered
illness be deleted. These commenters
feel that OWCP claims examiners
should have enough documentation and
medical evidence in the case file to
made these determinations without
requiring the submission of additional
medical evidence. However, the nature
of these consequential conditions is that
they only arise subsequent to the
development of an underlying
condition, thus necessitating the
submission of more recent medical
evidence establishing their causal
PO 00000
Frm 00006
Fmt 4701
Sfmt 4700
relationship to an existing covered
illness. Accordingly, the suggestion was
not adopted in the final rule.
Section 30.300
Two comments from individuals, two
from congressional representatives and
one from an advocacy group suggested
that OWCP use Physicians Panels to
make determinations when there is a
dispute with regard to issues of
causation or the degree of impairment.
After considering the use of Physicians
Panels in the adjudication of Part E
claims, OWCP decided in the interim
final rule to base the formal
adjudicatory and review structure for
those claims on the same successful and
streamlined structure that has been used
for Part B claims since 2001. The use of
Physicians Panels as deciding bodies for
claims submitted to DOE under former
Part D of EEOICPA proved to be both
inefficient and extremely timeconsuming. Nevertheless, OWCP will
use a full range of qualified medical
specialists to assist in the development
of claims, especially the kind of
complex cases these comments discuss.
When a claim involves extreme
complexity and multiple medical
disciplines, OWCP may refer the
claimant to a panel of physicians for a
medical evaluation. Once a report is
received, OWCP’s adjudicatory staff will
then consider it when they make a
decision on the claim. OWCP continues
to believe that this type of claims
adjudication process provides for a
more efficient and expeditious handling
of medical disputes and the application
of more uniform criteria to resolve such
disputes. Thus, the suggested changes
have not been adopted.
The same advocacy group suggested
that OWCP state in the regulations the
processes it will follow with respect to
classified information that may be
pertinent to a claim under EEOICPA,
and urged that in situations where the
claimant or his or her representative
lacked the requisite security clearances,
OWCP should ask the Ombudsman to
provide a properly cleared lawyer or
qualified technical expert to evaluate
the factual evidence and advocate on
behalf of the claimant during the claims
adjudication process. OWCP is also
concerned about the impact of using
classified information to adjudicate
claims under the Act. However, since it
is not the classifying agency with
respect to such information, it cannot
allow greater access to the information
than is currently permitted. As for the
suggestion that OWCP should ask the
Ombudsman to nominate or otherwise
provide a person with the requisite
security clearance to advocate for
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
pwalker on PROD1PC60 with RULES2
claimants, the Ombudsman is not
authorized to perform that function by
either the statute or Secretary’s Order
1–2005 (70 FR 33328), which
established the Office of the
Ombudsman within the Department.
The Ombudsman does not have any role
in the claims adjudication process
administered by OWCP. Thus, the
suggestions were not adopted in the
final rule.
Another advocacy group suggested
that the claims adjudication processes
described in § 30.300 be altered to
include a review by an ‘‘independent
entity’’ like an administrative law judge.
This same suggestion was made by
several commenters with respect to this
section as it appeared in the first interim
final rule governing its administration of
the Act that OWCP published on May
25, 2001 (66 FR 28948). As it noted
when it subsequently published the first
final rule governing its administration of
EEOICPA on December 26, 2002 (67 FR
78874), OWCP believed that utilizing
administrative law judges or another
type of independent review body would
unnecessarily complicate and delay the
claims adjudication process to the
detriment of claimants. The commenter
did not present any new reason not
previously considered by OWCP when
it originally decided to retain the
adjudicatory structure described in
§ 30.300, or any evidence of problems
with it since its inception in 2001.
Therefore, the suggested change to this
section of the regulations was not
adopted.
Sections 30.301 and 30.302
One advocacy group suggested that
OWCP extend the ability to request
issuance of a subpoena to include Part
E claims as well as Part B claims, and
that this ability should be extended to
all stages of the claims adjudication
process. Section 30.301 indicates that a
claimant may request that a Final
Adjudication Branch (FAB) reviewer
issue a subpoena in connection with a
claim under Part B of EEOICPA. The
statutory authority underlying this
section is derived from section 7384w,
which only applies to claims filed under
Part B; Part E does not contain a similar
provision. Therefore, OWCP does not
have authority to extend the ability to
request a subpoena to claimants under
Part E. Further, OWCP has found it to
be more efficient to limit the use of
subpoenas by claimants to the portion of
the claims adjudication process that
includes the right to request an oral
hearing, i.e., the portion before the FAB.
OWCP claims examiners regularly assist
claimants in obtaining relevant
documents and information in the early
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
78525
development of claims under EEOICPA,
and adding subpoena requests to this
assistance would not appear to be either
efficient or productive. Therefore, the
suggested changes to § 30.301 have not
been adopted.
One attorney suggested that § 30.302
be modified so that claimants will be
relieved of their obligation to pay the
costs associated with subpoenas they
have requested when the subpoenaed
witness submits evidence into the case
record that is relevant to the claimant’s
case and where the witness failed before
the hearing to provide written evidence
after being requested to provide such
evidence by the claimant. OWCP
believes that the suggested modification
erroneously presumes that there will
likely be situations where a witness will
refuse to provide requested evidence
without issuance of a subpoena by a
FAB reviewer. This has not been the
experience of OWCP in other benefit
programs it administers, and OWCP
does not contemplate that it will occur
in its future administration of Part B. Up
to the present time, OWCP has not
encountered significant difficulty
obtaining the factual or medical
evidence necessary for it to adjudicate
these claims, and there is no reason to
think that these sorts of difficulties will
occur in the future. Therefore, the
suggestion to modify § 30.302 was not
adopted in the final rule.
sections currently provide that the
recommended decision and final
decision be sent to the claimant, unless
he or she has a representative. In such
a case, the recommended decision and
final decision are to be sent only to the
representative. OWCP believes that
these suggestions have merit, and also
notes that this has been the
administrative practice of the program
for some time. Thus, §§ 30.307(a) and
30.316(e) have been amended in the
final rule to provide that OWCP will
send a copy of the recommended
decision and the final decision on a
claim to both the claimant and the
claimant’s representative, if any.
Section 30.303
DOE commented that the 60-day
period within which it was required to
respond to a request from OWCP for
information or documents relevant to a
claim under Part E of the Act in § 30.303
was unreasonable, and noted that it
would not be able to respond to such a
request in a timely manner if the
evidence needed to be reviewed for
declassification purposes. As an
alternative, DOE proposed that the
standard for compliance with such a
request be ‘‘as soon as possible.’’ While
it does not dispute the validity of this
concern, OWCP believes that the
suggested proposal would effectively
remove the time period for response
from § 30.303. However, in order to
accommodate DOE’s belief that it
requires additional time to comply with
these necessary requests, OWCP has
amended § 30.303(a) to provide DOE
with 90 days within which to respond.
Section 30.320
One attorney suggested that
§ 30.320(b) be amended to require the
reopening of a final adverse decision on
a claim if the claimant submits new
evidence of a medical condition or
discovers additional medical reports.
The section currently requires the
Director for Energy Employees
Occupational Illness Compensation to a
reopen a final decision on a claim if he
concludes that the claimant has
submitted new and material evidence
with regard to either covered
employment or exposure to a toxic
substance, or identifies either a material
change in the PoC guidelines, a material
change in the dose reconstruction
methods or a material addition of a class
of employees to the Special Exposure
Cohort. The experience of OWCP with
respect to the processing and
adjudicating of claims based on
occupational or covered illnesses is that
new medical evidence of a condition is
easily obtained and, upon
consideration, rarely sufficient to
warrant the reversal of an earlier
determination regarding a claimed
condition. To permit an automatic
reopening of a final decision based on
such evidence would inevitably lead to
Sections 30.307 and 30.316
One attorney suggested that
§§ 30.307(a) and 30.316(e) be amended
to provide that a copy of the
recommended decision and the final
decision be sent to both the claimant
and the claimant’s representative. These
PO 00000
Frm 00007
Fmt 4701
Sfmt 4700
Section 30.315
One attorney suggested that § 30.315
be amended to permit, at the discretion
of the FAB reviewer, a postponement of
a hearing if the claimant’s representative
provides reasonable notice that the
representative has a medical reason that
prevents his or her attendance at the
claimant’s hearing. The interim final
rule permits such a postponement
where the claimant is prevented from
attending the hearing for medical
reasons, and it is the current practice of
OWCP to permit such postponements
for representatives whose attendance is
prevented for the same reasons. Thus,
§ 30.315(b) has been amended as
suggested by the commenter.
E:\FR\FM\29DER2.SGM
29DER2
78526
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
numerous frivolous reopenings and the
attendant administrative inefficiencies
would deprive claimants with
meritorious claims of the opportunity to
have those claims adjudicated in a
timely manner. It should be noted,
however, that claims may be reopened
on the basis of new medical evidence by
the Director under § 30.320(a), which
permits the Director, at his discretion, to
reopen a final decision at any time. For
these reasons, the suggestion regarding
§ 30.320(b) has not been adopted.
pwalker on PROD1PC60 with RULES2
Sections 30.400, 30.403, 30.404 and
30.405
OWCP received three comments from
advocacy groups, one from an attorney
and two from congressional
representatives objecting to the wording
in §§ 30.400, 30.403, 30.404 and 30.405
that suggested that there was no way for
a claimant to administratively challenge
a denial of a particular medical benefit.
The wording in question was intended
to describe the process that OWCP’s
medical billing contractor uses to
inform claimants of decisions on
medical bills that are submitted for
payment. However, this wording
incorrectly suggested that there was no
administrative method by which a
claimant could challenge an adverse
medical billing determination by
OWCP’s contractor. To rectify this
situation, and as suggested by the
commenters, §§ 30.400, 30.403, 30.404
and 30.405 have been changed to
indicate that a claimant may
administratively challenge an adverse
medical billing determination by
utilizing the internal adjudicatory
processes described in subpart D of the
regulations.
Sections 30.410 and 30.411
One advocacy group asked that OWCP
clarify the provisions in §§ 30.410(b)
and 30.411(c) regarding disruptions of
directed medical examinations. The
provisions in question are intended to
remind employees and their
representatives that these medical
examinations are under the control of
medical professionals and are not,
therefore, a proper forum for disputing
aspects of individual claim
adjudications. These physicians have
been asked to conduct an examination
at the request of OWCP in order to
further clarify aspects of an employee’s
alleged medical condition, not to treat
the employee, and therefore they do not
have the type of ethical obligations
regarding the employee that would
otherwise naturally arise with a normal
‘‘doctor-patient’’ relationship. Since any
attempt to interfere with a directed
examination would disrupt the purpose
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
of the examination, § 30.410(b) and
§ 30.411(c) set out the consequences of
taking such actions, and have not been
altered in the final rule.
This same advocacy group disagreed
with § 30.411(b), which states that when
OWCP finds that a conflict in the
medical evidence exists, OWCP will
select a third physician to conduct a
referee examination that resolves such
conflict. This process has been in place
since the inception of OWCP’s
administration of Part B, and was not
altered in any way with the
promulgation of the interim final rule.
Further, this same process has been
used successfully in other benefit
programs administered by OWCP.
Accordingly, § 30.411(b) was not
modified in the final rule.
The same advocacy group and another
advocacy group criticized the absence of
any ‘‘conflict of interest’’ provisions
with respect to physicians in the interim
final rule. These comments asserted that
it was important that OWCP indicate
that physicians involved in the claims
adjudication process who submitted
medical evidence upon which OWCP
claims examiners would make
determinations on claims would be
subject to some sort of constraints
regarding such matters as prior
involvement with a claimant, former
work for a claimant’s employer, etc.
OWCP agrees with the general thrust of
these comments, and has added
provisions to §§ 30.410 and 30.411 that
indicate that physicians who perform
directed medical examinations at the
request of OWCP in connection with the
claims adjudication process will be
subject to ‘‘conflict of interest’’
standards devised by OWCP to ensure
their compliance with ethical standards
of professional conduct.
Sections 30.500 and 30.501
A total of 521 comments objecting to
the definitions of ‘‘covered’’ child and
‘‘surviving spouse’’ for the purposes of
Part E in § 30.500(a) were received from
502 individuals and one lay
representative (several individual
commenters submitted multiple
comments on this issue). While the
definition of a ‘‘surviving spouse’’ is the
same one that applies to Part B claims,
a ‘‘covered’’ child under Part E must
meet the same definition of a ‘‘child’’
used in Part B and, as of the date of the
covered Part E employee’s death, be
either under the age of 18, under the age
of 23 and a full-time student who was
continuously enrolled in one or more
educational institutions since attaining
the age of 18 years, or any age and
incapable of self-support. These
definitions merely follow, as they must,
PO 00000
Frm 00008
Fmt 4701
Sfmt 4700
the definitions for these two terms that
appear in section 7385s–3(d). Since
these terms cannot be altered through
the rulemaking process, the suggestions
were not adopted and no changes were
made to § 30.500(a).
The same lay representative and two
of the same individuals also objected to
the order of precedence for survivors
under Part E that is set out in § 30.501(b)
and argued that a surviving spouse
should not be required to share an
award with children of a deceased Part
E employee under any circumstances.
This section states that if there is a
surviving spouse and at least one
‘‘covered’’ child of a deceased covered
Part E employee who is living at the
time of payment and who is not a
recognized natural child or adopted
child of such surviving spouse, half of
the payment is made to the surviving
spouse and the other half is shared
equally among all ‘‘covered’’ children of
the employee who are living at the time
of payment. As was the case with the
survivor definitions discussed in the
preceding paragraph, the regulatory
order of precedence for survivors under
Part E of the Act merely tracks the
statutory order of precedence contained
in section 7385s–3(c)(3) of EEOICPA.
Since the order of precedence for
survivors under Part E cannot be
modified by regulation, the suggestion
was not adopted.
Section 30.505
Two advocacy groups suggested that
the unified benefit payment processes
for both Parts B and E described in
§ 30.505(a) be amended to require
OWCP to issue a ‘‘partial’’ award of
$12,500 to covered Part E employees at
the time it determines that they have
contracted a covered illness, and to
determine the balance of any
compensation due them within another
six months. Unlike Part B of EEOICPA,
which compensates individuals upon a
finding that a covered Part B employee
contracted an occupational illness, Part
E monetary compensation can only be
awarded if OWCP further determines
that a covered Part E employee’s wageloss, impairment or death was due to his
or her covered illness. Thus, this
suggestion would result in the issuance
of a monetary award to a claimant
before OWCP has determined that the
statutory entitlement criteria established
by Part E have been met, and that a
payment is due after any required
offsets have been calculated. Shortening
the monetary benefit payment processes
for Part E as suggested by these two
commenters would violate the explicit
terms of EEOICPA, and therefore the
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
suggestions to change § 30.505(a) have
not been adopted.
One labor organization suggested that
§ 30.505(d) be amended to permit a
claimant to receive up to the $250,000
maximum aggregate compensation
payable under Part E for both wage-loss
and impairment, for each of his or her
covered illnesses. As OWCP noted in
the preamble discussion of this
provision of the interim final rule, 42
U.S.C. 7385s–12 ‘‘limits the aggregate
compensation (other than medical
benefits) that OWCP may pay under Part
E to all claimants for each individual
whose illness or death serves as a basis
for compensation or benefits under Part
E to a total of $250,000. This is the only
reading of the statutory language that is
consistent with the statutory
requirement that the computation of
both impairment benefits and wage-loss
benefits under [section] 7385s–2 be
based upon impairment or wage-loss
that is ’the result of any covered illness.’
This reading is also consistent with
congressional intent, as reflected in the
Conference Report for Public Law 108–
375, which states that the ‘maximum
aggregate benefit available under [Part]
E of EEOICPA is $250,000.’ See H.R.
Conf. Rep. No. 108–767, at 894 (2004).’’
Thus, the suggested changes have not
been adopted.
pwalker on PROD1PC60 with RULES2
Section 30.509
Two advocacy groups asked why
§ 30.509(c) indicates that OWCP will
only make an impairment determination
for a deceased Part E employee if an
eligible survivor makes an election to
receive the compensation of the
employee as permitted by section
7385s–1(2)(B) of EEOICPA, when the
Conference Report states that survivors
under Part E are to receive a minimum
lump-sum payment of $125,000. These
comments are based on a
misunderstanding of the operation of
§ 30.509, which describes the very
limited universe of survivors who are
eligible to make the election described
in section 7385s–1(2)(B), and the fact
that the only survivors entitled to utilize
this election provision would not be
entitled to survivor benefits because the
election is only available to survivors of
a covered Part E employee who died
‘‘from a cause other than the covered
illness of the employee.’’ Survivors who
make this election will therefore not be
eligible to receive any other
compensation (such as the $125,000
lump-sum payment) under the terms of
section 7385s–3. Accordingly, the
provision discussed in § 30.509(c) is
correct, and no changes were made to
this section in the final rule.
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
Sections 30.513 Through 30.517
One lay representative suggested that
in § 30.517, OWCP should more
specifically describe the circumstances
under which it would decide to waive
its statutory right to recover an
overpayment pursuant to section 7385j–
2 of EEOICPA. While § 30.513 of the
interim final regulations notes the
general authority of OWCP to waive
recovery of an overpayment of EEOICPA
benefits, §§ 30.514 through 30.517
elaborate on that authority with a
substantial amount of detail. In light of
the variety of factual circumstances and
fairness considerations that may apply
in any specific case, it is not possible to
identify particular circumstances rather
than general principles concerning how
this authority is to be exercised.
Therefore, since §§ 30.513 through
30.517 in the interim final regulations
adequately identify the standards that
OWCP will use to make these
determinations without depriving
OWCP of sufficient flexibility to
administer this aspect of the program,
the suggested changes have not been
adopted.
Section 30.600
One individual suggested that
§ 30.600(b) make it clearer that a
claimant can grant a person a ‘‘power of
attorney’’ to act on his or her behalf, and
that such person can then designate a
representative to pursue the claim under
EEOICPA. OWCP believes there is merit
in this suggestion. Thus, additional
language was added to § 30.600(b) to
clarify that a person who has been
granted a power of attorney by a
claimant under EEOICPA may designate
a representative to pursue that claim
before OWCP. Also, one attorney
suggested that OWCP change
§ 30.600(c)(2) to allow an attorney or
representative to complete, but not sign,
a Form EN–20. OWCP believes that this
suggestion has merit, and § 30.600(c)(2)
has been amended as requested.
Section 30.603
One attorney suggested that the 10
percent limit for attorney fees for filing
objections to a recommended decision
should apply to the amount of the lumpsum awarded in the final decision. The
interim final rule currently applies this
limit to the amount by which the lumpsum award is increased as a result of the
objections, and is consistent with the
mandate in section 7385s–9 to limit
such fees in Part E cases in the same
manner as Part B cases. Since Part B
claimants either receive a full lump-sum
award or no award at all, successful
objections to a recommended decision
PO 00000
Frm 00009
Fmt 4701
Sfmt 4700
78527
provide a claimant with an ‘‘increased’’
lump-sum award equal to the entire
amount payable under Part B. Section
30.603(b)(2) in the interim final rule
merely applies this same principle to
Part E cases as required by the explicit
terms of the Act. Since lump-sum
awards to covered Part E employees
may vary according to their level of
impairment and the extent of their
wage-loss, there may be instances where
an objection to a recommended decision
proposing to award benefits under Part
E may result in a final decision
awarding greater benefits. In such a
case, the gain to the covered Part E
employee from the filing of the
objection will not be the entire lumpsum award; the gain will the difference
between the lump-sum payment and the
amount proposed in the recommended
decision. To be consistent with Part B,
as required by the statute, the attorney
fees under Part E have to be limited to
the difference in lump-sum amounts.
Thus, the suggested change has not been
adopted.
This attorney and two other attorneys
also objected to the provision in
§ 30.603(b)(1) that does not permit a
representative to charge a two percent
fee unless he or she was retained prior
to the initial filing of the claim. This
provision, however, is based on the
limitation contained in 42 U.S.C.
7385g(b)(1), which states that a
representative may only charge a two
percent fee ‘‘for the filing of an initial
claim for payment of lump-sum
compensation. * * *’’ OWCP believes
that it would violate the statute to
permit a representative to charge a fee
of two percent of the lump-sum award
if the representative was retained after
the claim was filed. One of these two
other attorneys also suggested that the
term ‘‘initial claim’’ be defined to
include the filing of amended claim
forms, the submission of additional
documents or data, or the reopening of
the claim following the issuance of a
final decision by the FAB; in the
alternative, he also suggested that the
limitations described in the interim
final rule not apply to claims that were
filed prior to the effective date of that
rule, i.e., June 8, 2005. OWCP believes
that an expansive definition of the term
‘‘initial claim’’ would be inconsistent
with the plain meaning of the statute,
which has not changed in this regard
since section 7385g was amended on
December 28, 2001. For this same
reason, OWCP also believes that there
would be no justification for applying
the fee limitations described in § 30.603
only to claims filed on or after June 8,
E:\FR\FM\29DER2.SGM
29DER2
78528
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
2005. Thus, none of these suggested
changes were adopted in the final rule.
Section 30.609
Two advocacy groups disagreed with
the requirement in § 30.609 that
claimants must report (for offset
purposes) any payments that they
receive due to medical malpractice
resulting from treatment of their
occupational illness or covered illness.
Such medical malpractice payments
have as their genesis exposures for
which compensation is payable under
Part B or Part E of EEOICPA. Under
section 7385 of EEOICPA, benefits
payable under Part B or Part E must be
offset to reflect these types of payments.
Thus, OWCP must be informed of these
types of payments so it can perform the
statutorily mandated offset of EEOICPA
benefits, and the suggestion to eliminate
this section has not been adopted in the
final rule.
pwalker on PROD1PC60 with RULES2
Section 30.626
One lay representative and five
individuals objected to § 30.626, which
describes the required coordination of
payments under Part E of EEOICPA with
benefits from state workers’
compensation programs for the same
covered illness or illnesses. However,
OWCP is required to coordinate Part E
benefits in this manner by section
7385s–11 of the Act. Thus, the
suggestion to eliminate this section has
not been adopted.
Sections 30.801, 30.805, 30.806 and
30.815
One individual suggested that
§ 30.801 indicate that compensation will
be provided to employees who have
suffered occasional days of lost pay due
to their covered illnesses. However, Part
E is not a program that provides
compensation for any wage-loss,
regardless of amount, that a covered Part
E employee may experience due to his
or her covered illness. Instead, Part E
only provides compensation under a
specific formula in section 7385s–
2(a)(2)(A) based on a qualifying amount
of wage-loss sustained in a given
calendar year, and this formula cannot
be altered in this final rule. Thus, the
suggestion has not been adopted.
One labor organization asserted that it
is more difficult for employees who
worked intermittently at DOE facilities
to establish their average annual wage
and their alleged calendar years of
wage-loss through reliance on wage data
received from the Social Security
Administration, and that this will result
in employees having to use the methods
of § 30.806 to convince OWCP to
determine a different average annual
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
wage and/or the extent of compensable
calendar years of wage-loss than it
determined using § 30.805. However,
the labor organization did not put
forward any discernable proposal to
address the purported problem it raised
in its comment. While it is possible that
some employees may incur difficulties
in securing the type of records described
as acceptable to OWCP in § 30.806,
these difficulties alone should not
relieve them of their burden to produce
records that show a level of wage-loss
sufficient to make them eligible for an
award. OWCP claims examiners are
instructed to accept tax returns, pay
stubs, union records and pension
records as evidence of earnings. In
addition, claims examiners can request
earning records from employers.
Therefore, no change has been made to
§ 30.806 in the final rule. However,
because of these concerns, § 30.805 has
been amended in the final rule to more
precisely define the term ‘‘wages.’’
Another labor organization asserted that
some occupations are more likely to be
affected by the business cycle than
others, and asked that the wages of
employees in these occupations be
determined by looking to the average
wages of their ‘‘peer group’’ rather than
to their own individual wages. OWCP
does not believe that adjustments for
fluctuations in demand for labor in
certain occupations can be made fairly
or efficiently, nor does it believe that it
has the authority to make this type of
change to the statutory formulae for
determining these matters by regulation.
As a result, this suggested change has
also not been adopted.
One individual suggested a stylistic
change for the wording of § 30.815(b),
which he felt was too confusing. Section
30.815(b) is merely intended to inform
readers that in most situations, OWCP
will determine the number of
compensable years of wage-loss in
accordance with the procedures
described in §§ 30.800 through 30.811.
The suggested change is not substantive
in nature and would be, in OWCP’s
opinion, more confusing than the
language that currently appears in
§ 30.815(b). Therefore, the suggested
change to this section has not been
adopted in the final rule.
Section 30.901
One labor organization questioned
OWCP’s ability to make the type of
apportionment determinations
described in § 30.901(a) of the interim
final rule and asserted that there was no
reasoned basis for allocating the cause
of a permanent impairment of an organ
or body function among both
compensable and non-compensable
PO 00000
Frm 00010
Fmt 4701
Sfmt 4700
exposures. This provision was based on
the somewhat ambiguous language of
section 7385s–2(a)(1)(A) of the Act,
which can be read in such a way as to
require the apportionment described in
§ 30.901(a) of the interim final rule.
However, after carefully considering
both the dearth of support for such
apportionments in the medical literature
and the practical difficulties that claims
examiners would be faced with if they
were required to make these particular
types of determinations, OWCP agrees
with the commenter and has decided to
interpret the statutory provision in
question as not requiring such an
apportionment. Thus, OWCP has
modified § 30.901(a) in the final rule to
remove this requirement. Conforming
changes have also been made to
§§ 30.901(d), 30.902, and 30.908(b) and
(c).
One lay representative, four
individuals and the same labor
organization also criticized the
description of the criteria for physicians
to perform impairment evaluations set
out in § 30.901(b), and suggested that
OWCP modify that description to make
the criteria less restrictive so as to
increase the potential pool of physicians
who can perform impairment
evaluations acceptable to OWCP. After
considering several different potential
criteria since the issuance of the interim
final rule, OWCP believes that it has
developed criteria that will satisfy the
commenters’ concern that there will be
few physicians who meet the criteria in
a given locality, or that claimants will
not be able to use their local physicians
to perform the testing and
measurements upon which an
impairment evaluation under Part E can
be performed by a physician who meets
the criteria. As changed, these criteria
will now provide that a physician has
to establish (to OWCP’s satisfaction) that
he or she possesses knowledge and
experience in using the American
Medical Association’s Guides to the
Evaluation of Permanent Impairment
(AMA’s Guides) and/or possesses the
requisite professional background and
work experience to conduct acceptable
impairment evaluations. Further, while
a claimant’s local physician may not be
able to satisfy all of the criteria
described in § 30.901(b) and perform the
impairment evaluation itself, the
claimant can still elect to have such a
physician perform the underlying
objective testing and other procedures
that another physician who does satisfy
the criteria could rely upon in arriving
at an evaluation of his or her
impairment. Since OWCP has changed
the policy to which the commenters
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
pwalker on PROD1PC60 with RULES2
objected, no changes were made to
§ 30.901(b) in the final rule.
Sections 30.905 and 30.906
One individual objected to the
provision in § 30.905(b)(1) that only
impairment evaluations performed by
physicians who meet the criteria
identified by OWCP will be considered
probative. The comment suggests that
impairment evaluations performed by
physicians of the Radiation Exposure
Screening and Education Program
(RESEP) that is administered by the
Health Resources and Services
Administration within HHS be
considered probative under Part E of
EEOICPA. OWCP has no objection to
claimants submitting impairment
evaluations performed by a RESEP
physician, so long as that physician
meets the qualifications set forth by
OWCP. The same would be true for
physicians who are affiliated with other
government-sponsored health clinics.
Not all physicians, however, have the
necessary training to perform
impairment evaluations (as noted above,
claimants can utilize any physician to
perform the testing and measurements
upon which an impairment evaluation
can be performed by a physician who
meets OWCP’s criteria). Thus, OWCP
must put into place certain criteria to
identify those physicians who are
qualified to perform impairment
evaluations upon which it can base its
ratings. As a result, no changes to
§ 30.905(b)(1) were made in the final
rule. Two other individuals objected to
the requirement found in § 30.905(b)(2)
that an impairment evaluation must
have been performed within one year of
its submission to OWCP for it to be
considered probative in determining the
permanent impairment of a covered Part
E employee and suggested that this
requirement be deleted. OWCP does not
find any merit to this objection because
the Act requires OWCP to determine the
minimum impairment rating of the
employee as of the time it is
adjudicating the claim for the award. In
light of this requirement, OWCP
believes that it is reasonable to insist
that the rating be based on an
impairment evaluation that is no more
than one year old. Two advocacy groups
also suggested that this same
requirement be deleted because covered
Part E employees with previous
temporary impairments from which
they have recovered would not receive
compensation. OWCP believes that the
reasoning behind these latter comments
ignores the mandate in the Act to
compensate covered Part E employees
for their permanent impairment rather
than their temporary impairment. Thus,
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
the suggestions to delete the
requirement in § 30.905(b)(2) were not
adopted.
Two attorneys suggested that § 30.906
be amended to provide that OWCP will
pay for the cost of any additional
impairment evaluation if such
impairment evaluation increases the
minimum impairment rating. In the
interim final rule, this section states that
OWCP will pay for one evaluation if it
meets the criteria set forth in
§ 30.905(b), and that it will also pay for
any additional impairment evaluations
that it directs the employee to undergo
(and reimburse the employee for
reasonable expenses, as defined in the
rule, that are associated with such an
evaluation). OWCP is not persuaded
that there is a reasonable basis for
paying for additional impairment
evaluations beyond those already
described in § 30.906, and therefore the
suggestion was not adopted in the final
rule.
Sections 30.907 and 30.908
Two advocacy groups asserted that
§ 30.907(b) did not provide a process
whereby a dispute regarding a covered
Part E employee’s impairment
evaluation could be resolved. While
§ 30.907(b) in the interim final rule
noted that the procedures for ‘‘directed
medical examinations’’ set out in
§§ 30.410 and 30.411 of the regulations
applied to these types of disputes,
OWCP acknowledges that it did not
explicitly note that such procedures
include the process by which OWCP
resolves medical disputes in general.
Therefore, in order to make this
provision more clear, § 30.907(b) has
been modified slightly in the final rule
to explicitly note that OWCP will
resolve medical disputes regarding
impairment through the ‘‘referee
examination’’ process set out in
§ 30.411.
One labor organization objected to the
provisions in § 30.908 requiring that
medical evidence of impairment
submitted to the FAB in opposition to
the impairment evaluation that was
relied upon in a recommended decision
conform to the requirements set out in
§ 30.905(b) in order to be afforded any
probative value, and noted that
claimants have the burden of proving
that the new medical evidence has
greater probative value than the
impairment evaluation relied upon in
the recommended decision.
Requirements of this sort that set out
minimum standards for new evidence
and the assumption of the burden of
proof when challenging a determination
made below are standard features of any
adjudicative system, and are necessary
PO 00000
Frm 00011
Fmt 4701
Sfmt 4700
78529
to conserve scarce administrative
resources. OWCP does not agree that
their use in this context is either unduly
burdensome on claimants or inherently
unfair in a system such as Part E.
Therefore, no changes were made to
§ 30.908 as a result of the comment.
Section 30.910
Two comments from congressional
representatives, four from advocacy
groups and two from individuals
objected to the provision in § 30.910(a)
of the interim final rule that an
impairment that cannot be assigned a
numerical percentage using the AMA’s
Guides will not be included in a covered
Part E employee’s impairment rating,
and noted that the Conference Report
for Public Law 108–375 suggests that for
those illnesses for which the AMA’s
Guides do not provide a method to
assign a numerical percentage, the
Department should devise another
method to determine the amount of an
impairment award to a covered Part E
employee. See H.R. Conf. Rep. No. 108–
767, at 893 (2004). However, as the
Department pointed out when it
promulgated § 30.910, the plain
language of section 7385s–2(b) requires
OWCP to determine the amount of an
impairment award to a covered Part E
employee in accordance with the
AMA’s Guides and does not contain the
exception referred to in the Conference
Report for ‘‘an illness for which the
[AMA’s Guides] do not provide an
impairment rating. * * *’’ It should be
noted that this suggestion appears to be
based on the assumption that the AMA’s
Guides cannot be used to determine an
impairment rating for an illness unless
they explicitly provide a method to
evaluate that particular illness.
However, because the Guides evaluate
the impairment of organs and body
functions rather than illnesses per se,
even a newly identified illness can be
evaluated using the Guides so long as its
effects on those organs and/or body
functions are known and quantifiable.
As noted above, section 7385s–2(b) of
EEOICPA requires that impairment
ratings ‘‘shall be determined in
accordance with the American Medical
Association’s Guides to the Evaluation
of Permanent Impairment.’’ The
discussion of mental impairments that
do not originate from documented
physical dysfunctions of the nervous
system in Chapter 14 (Mental and
Behavioral Disorders) of the AMA’s
Guides states that ‘‘there are no precise
measures of impairment in mental
disorders. The use of percentages
implies a certainty that does not exist.’’
Chapter 14 then explains that the
authors of the current (fifth) edition of
E:\FR\FM\29DER2.SGM
29DER2
78530
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
the AMA’s Guides are ‘‘unaware of data
that show the reliability’’ of any
percentages for these particular types of
impairments and that ‘‘the Committee
on Disability and Rehabilitation of the
American Psychiatric Association
advised Guides contributors against the
use of percentages in the chapter on
mental and behavioral disorders of the
fourth edition, and that remains the
opinion of the authors of the present
chapter.’’ In support of their decision
not to assign numerical percentages to
mental impairments that do not
originate from documented physical
dysfunctions of the nervous system, the
authors point out that ‘‘[n]o available
empirical evidence supports any
method for assigning a percentage of
impairment of the whole person’’ to
these disorders. Since the AMA’s
Guides clearly takes the position that
there is no basis to calculate numerical
percentages of mental impairment due
to mental disorders, attempting to do so
by devising a rating mechanism
independent of the AMA’s Guides
would violate EEOICPA’s requirement
that impairment ratings be determined
‘‘in accordance with’’ the AMA’s
Guides. Thus, § 30.910(b) indicates that
these types of mental impairments will
not be included in an impairment
rating; no change was made to this
section in the final rule.
pwalker on PROD1PC60 with RULES2
Section 30.911
Two comments from individuals, two
from congressional representatives, two
from advocacy groups and two from
attorneys questioned the
appropriateness of the provision in
§ 30.911(a) in light of the progressive
nature of the covered illnesses that
would be compensable under Part E of
EEOICPA. OWCP’s intent in the interim
final rule was to apply the requirement
that an individual reach ‘‘maximum
medical improvement’’ in order for an
impairment rating to be determined in
a manner that is appropriate for the
conditions covered by EEOICPA. OWCP
recognizes that many of these covered
illnesses are progressive, and that many
employees may find themselves in a
situation where their accepted condition
is not likely to improve but can be
expected to gradually deteriorate. The
intent in the interim final rule was to
allow for minimum impairment ratings
to be calculated and compensated in
such circumstances. However, since the
wording of § 30.911(a) in the interim
final rule did not convey this intent as
clearly as it could have, this provision
has been modified slightly in the final
rule by changing the word ‘‘change’’ to
‘‘improve’’ in the final rule.
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
II. Miscellaneous Comments
Several of the 533 timely comments
the Department received raised issues
that either were not addressed in the
interim final regulations or involved
extraneous matters. The Department’s
analysis of these miscellaneous
comments follows:
The Ombudsman
OWCP received one comment from an
advocacy group pointing out that the
interim final regulations did not address
the role and functions of the
Ombudsman provided for in section
7385s–15 of EEOICPA. However, this
omission was intentional and required
by the terms of section 7385s–15(d),
which requires that the Ombudsman be
independent ‘‘from other officers and
employees of the Department [of Labor]
engaged in activities relating to the
administration of the provisions of’’ Part
E of EEOICPA. Instead, the role and the
functions of the Ombudsman are set out
in Secretary’s Order 1–2005. Therefore,
the final rule also does not address
either the role or the functions of the
Ombudsman.
The Rulemaking Process
OWCP received one comment from an
attorney on a specific aspect of the
rulemaking process. Without identifying
any particular provision of the
regulations, the commenter opined that
at least some of them would not be
comprehensible to some members of the
public and should be rewritten in ‘‘plain
English.’’ OWCP acknowledges that
some of the regulations for Part E
involve complex medical matters or
complicated arithmetic calculations.
However, while these concepts can be
difficult to comprehend, OWCP went to
great lengths in an effort to ensure that
the corresponding regulations in
subparts I and J were written in a clear
and understandable manner. Since the
commenter neither identified a
particularly incomprehensible provision
of the regulations nor provided any
suggested improvements, no additional
changes were made to the regulations
based on this comment.
Coverage
One DOE contractor and four
individuals made suggestions about
which workers or survivors should be
covered by Part E of EEOICPA.
However, the Act mandates the
categories of workers and survivors
covered under Part B and Part E and the
regulations cannot be changed to either
expand or restrict these categories
unless the Act is amended. Therefore,
the suggested changes have not been
made in this final rule.
PO 00000
Frm 00012
Fmt 4701
Sfmt 4700
III. Publication in Final
The Department of Labor has
determined, pursuant to 5 U.S.C.
553(b)(B), that good cause exists for
waiving public comment on this final
rule with respect to the following
changes: (1) Corrections of
typographical errors; and (2) minor
wording changes and clarifications that
do not affect the substance of the
regulations. For these changes,
publication of a proposed rule and
solicitation of comments would be
neither necessary nor fruitful.
IV. Statutory Authority
Section 7384d of EEOICPA provides
general statutory authority, which E.O.
13179 allocates to the Secretary, to
prescribe rules and regulations
necessary for administration of Part B of
the Act. Section 7385s–10(e) also
provides the Secretary with the general
statutory authority to prescribe
regulations necessary for administration
of Part E of the Act. Sections 7384t,
7384u and 7385s–8 provide the specific
authority regarding medical treatment
and care, including authority to
determine the appropriateness of
charges. The Federal Claims Collection
Act of 1966, as amended (31 U.S.C. 3701
et seq.), authorizes imposition of
interest charges and collection of debts
by withholding funds due the debtor.
V. Paperwork Reduction Act
This final rule contains information
collection requirements subject to the
Paperwork Reduction Act of 1995
(PRA), 44 U.S.C. 3501 et seq. The
requirements set out in §§ 30.401,
30.404, 30.420, 30.421, 30.512, 30.518,
30.700, 30.701 and 30.702 of this rule
were both submitted to and approved by
OMB under the PRA in OMB Control
Nos. 1215–0054 (expires June 30, 2007),
1215–0055 (expires October 31, 2009),
1215–0137 (expires March 31, 2007),
1215–0144 (expires October 31, 2009),
1215–0176 (expires January 31, 2007),
1215–0193 (expires March 31, 2007) and
1215–0194 (expires March 31, 2007).
The requirements in §§ 30.100, 30.101,
30.102, 30.103, 30.111, 30.112, 30.113,
30.114, 30.206, 30.207, 30.212, 30.213,
30.214, 30.215, 30.221, 30.222, 30.226,
30.231, 30.232, 30.415, 30.416, 30.417,
30.505, 30.620, 30.806, 30.905 and
30.907of this rule were also both
submitted to and approved by OMB
under the PRA in OMB Control No.
1215–0197 (expires August 31, 2007).
Following publication of this final
rule, the Department plans to seek OMB
approval of two new information
collections under the PRA and will
issue 60-day Federal Register notices
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
seeking public comment on (1) a
collection that will annually request
updated information relating to state
workers’ compensation benefits
received by EEOICPA Part E
beneficiaries; and (2) a collection
annually requesting verifying
information on state workers’
compensation benefits from state
authorities. These collections will
implement the Department’s
responsibilities under section 7385s–11
of EEOICPA.
This rule is being treated as a
‘‘significant regulatory action,’’ within
the meaning of E.O. 12866, because it is
‘‘economically significant’’ as defined
by section 3(f)(1) of that Order. The
payment of the benefits provided for by
EEOICPA through the program
administered pursuant to this regulatory
action has an annual effect on the
economy of $100 million or more.
However, this rule does not adversely
affect in a material way the economy, a
sector of the economy, productivity,
jobs, the environment, public health or
pwalker on PROD1PC60 with RULES2
Admin .......................................................................................................
Benefits ....................................................................................................
The Department’s estimate of the
benefits to be paid pursuant to EEOICPA
and of the administrative costs of
providing those benefits is based on
program experience to date, data
collected from other federal agencies,
assumptions about the incidence of
cancer, covered beryllium disease,
chronic silicosis and other covered
illnesses in the claimant population, life
expectancy tables, dose reconstruction
acceptance rates, Physicians Panel
acceptances under the former Part D of
the Act, the anticipated distribution of
benefit amounts, and its experience in
estimating administrative and medical
costs of workers’ compensation
programs. The Department’s benefit
estimates are not based on any
projections regarding the number of
future additions to the Special Exposure
Cohort (SEC).
For Part B benefits, estimates for
cancer claims are based on the actual
number of claims received by OWCP,
the anticipated number of future claims,
and the historical approval rates for
both SEC and non-SEC claims. Part B
benefit estimates for beryllium exposure
are based on the actual number of such
claims received by OWCP, anticipated
future claims, and the historical
approval rate. Benefit estimates for
chronic silicosis are based on similar
factors. Benefit estimates for claims that
require receipt of an award from DOJ
under section 5 of RECA are based on
historical claim receipts and include the
amounts awarded by DOJ under RECA
but paid from the compensation fund.
Medical benefits for living employees
eligible under Part B are computed
using an average of $10,000 per year.
Part E benefit estimates for Part E
cases are based on cases received by
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
safety, or State, local, or tribal
governments or communities, as defined
by section 3(f)(1) of E.O. 12866. This
rule is also a ‘‘significant regulatory
action’’ because it meets the criterion of
section 3(f)(4) of that Order in that it
raises novel or legal policy issues
arising out of the legal mandate
established by EEOICPA.
Based on the factors and assumptions
set forth below, DOL’s estimate of the
aggregate cost of benefits and
administrative expenses of this
regulatory action implementing Part B
and Part E of EEOICPA is, in millions
of dollars:
VI. Executive Order 12866
FY2007
FY2008
$162
1,123
Frm 00013
Fmt 4701
Sfmt 4700
FY2009
$163
861
OWCP to date, future expected receipts,
and the average Part B approval rate.
The benefit amounts for Part E are
calculated based on an estimated
distribution of approved claims with
varying degrees of compensable
impairment and wage-loss, with an
average benefit amount of $135,000 and
average medical costs of $10,000 per
year for each eligible living employee.
Additional Part E benefits for
individuals who are determined to be
eligible RECA section 5 uranium
workers are computed based upon the
number of such claims received to date
and the expected number of such claims
in the future.
Administrative cost estimates were
developed based upon OWCP’s
experience to date in administering Part
B and the other workers’ compensation
programs that fall within its area of
administrative responsibility, using
calculations of the number of incoming
claims and forecasting the necessary
full-time equivalents and other
resources that are necessary to
efficiently administer the program.
No more extensive economic impact
analysis of this rule is necessary because
this regulatory action only addresses the
transfer of funds from the federal
government to individuals who qualify
under EEOICPA and to providers of
medical services in that program. This
regulatory action has no affect on the
functioning of the economy and private
markets, on the health and safety of the
general population, or on the natural
environment. In addition, because this
rule implements a statutory mandate,
there are no feasible alternatives to this
regulatory action. Finally, to the extent
that policy choices have been made in
interpreting statutory terms, those
PO 00000
78531
$147
752
FY2010
$127
656
FY2011
$111
579
choices have no significant impact on
the cost of this regulatory action. Such
policy choices may affect who will be
entitled to receive benefits (such as
covered Part E employees with
unratable impairments due to a covered
illness), but will not have a significant
impact on the number of eligible Part B
or E beneficiaries or the level of benefits
to which they are entitled.
OMB has reviewed the rule for
consistency with the President’s
priorities and the principles set forth in
E.O. 12866.
VII. Small Business Regulatory
Enforcement Fairness Act
As required by Congress under the
Small Business Regulatory Enforcement
Fairness Act of 1996 (5 U.S.C. 801 et
seq.), the Department will report to
Congress promulgation of this final rule
prior to its effective date. The report
will state that the Department has
concluded that this final rule is a ‘‘major
rule’’ because it will likely result in an
annual effect on the economy of $100
million or more.
VIII. Unfunded Mandates Reform Act
of 1995
Title II of the Unfunded Mandates
Reform Act of 1995 (2 U.S.C. 1531 et
seq.) directs agencies to assess the
effects of federal regulatory actions on
state, local, and tribal governments, and
the private sector, ‘‘other than to the
extent that such regulations incorporate
requirements specifically set forth in
law.’’ For purposes of the Unfunded
Mandates Reform Act, this final rule
does not include any federal mandate
that may result in increased annual
expenditures in excess of $100 million
by state, local or tribal governments in
the aggregate, or by the private sector.
E:\FR\FM\29DER2.SGM
29DER2
pwalker on PROD1PC60 with RULES2
78532
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
IX. Regulatory Flexibility Act
The Department believes that this rule
has ‘‘no significant economic impact
upon a substantial number of small
entities’’ within the meaning of the
Regulatory Flexibility Act (5 U.S.C. 601
et seq.). The provisions of this rule that
apply cost-control measures to
payments for medical expenses are the
only ones that could have a monetary
effect on small businesses, and have
been in effect since OWCP began
administration of Part B of EEOICPA on
July 31, 2001. The economic effect of
these cost-control measures are not
significant for a substantial number of
those businesses who participate in the
program under Parts B and E of
EEOICPA, however, because no one
business bills a significant amount to
OWCP for EEOICPA-related services,
and the monetary effect on bills that are
submitted, while a worthwhile savings
for the Government in the aggregate, are
not significant for any individual
business affected.
The cost-control provisions are: (1) A
set schedule of maximum allowable fees
for professional medical services; (2) a
set schedule for payment of pharmacy
bills; and (3) a prospective payment
system for hospital inpatient services.
The methodologies used for the first two
of these provisions were explained in
the text of the preamble to two earlier
regulatory actions that implemented
EEOICPA in 2001 (66 FR 28948) and
2002 (67 FR 78874), which essentially
adopted payment systems that are
prevalent in the industry. Their
adoption for use in connection with
OWCP’s administration of Part E of the
Act results in continued efficiencies for
the Government and providers. The
Government benefits because OWCP did
not develop new cost containment
measures for Part E claims, but rather
adopted existing and well-recognized
measures that were already in place.
The providers benefit because
submitting a bill and receiving a
payment is almost the same as
submitting it to Medicare, a program
with which they are already familiar
and have existing systems in place for
billing—they do not have to incur
unnecessary administrative costs to
learn a new process because the
EEOICPA bill process for Part E claims
is identical to the bill process that
applies to Part B claims, and is not
readily distinguishable from the
Medicare billing process. Similarly,
pharmacies are familiar with billing
through clearing houses and having
their charges subject to limits by private
insurance carriers. By adopting private
sector uniform billing requirements and
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
a familiar cost control methodology,
OWCP has not altered the billing
environment with which pharmacies are
already familiar. The methods chosen,
therefore, represent systems familiar to
the providers. The third of these three
provisions does not have an effect on a
substantial number of ‘‘small entities’’
under Small Business Administration
(SBA) standards, since most hospitals
providing services for medical
conditions covered by EEOICPA have
annual receipts that exceed the set
maximum.
The implementation of these costcontrol methods does not have a
significant effect on any single medical
professional or pharmacy since they are
already used by Medicare, CHAMPUS,
and the Departments of Labor and
Veterans Affairs, among Government
entities, and by private insurance
carriers. In actual terms, the amount by
which these provider bills are reduced
does not have a significant impact on
any one small entity since these charges
are currently being processed by other
payers applying similar cost-control
provisions. The costs to providers
whose charges are reduced also are
relatively small because EEOICPA bills
simply do not represent a large share of
any single provider’s total business.
Since the small universe of potential
claimants is spread across the United
States and this bill processing system
covers only those employees who have
sustained an occupational illness or a
covered illness and require medical
treatment on or after October 30, 2000,
the number of bills submitted by any
one small entity which may be subject
to these provisions is likely to be very
small. Therefore, the ‘‘cost’’ of this rule
to any one pharmacy or medical
professional is negligible. On the other
hand, OWCP reaps substantial aggregate
cost savings that benefit both OWCP (by
strengthening the integrity of the
program) and the taxpayers to whom the
costs of the program are eventually
charged.
The Assistant Secretary for
Employment Standards has certified to
the Chief Counsel for Advocacy of the
SBA that this rule does not have a
significant impact on a substantial
number of small entities. The factual
basis for this certification has been
provided above. Accordingly, no
regulatory impact analysis is required.
procedures that claimants under that
Part must follow in order to seek review
of decisions on their claims, Part E
specifies that claimants under that Part
have 60 days to file petitions for review
of decisions on their claims in the
United States district courts, and
mandates the use of an ‘‘arbitrary and
capricious’’ standard of review. It is
reasonably likely that some EEOICPA
claimants will seek review of adverse
decisions in United States district courts
pursuant to 28 U.S.C. 1331 (for claims
under Part B of EEOICPA) or the
EEOICPA itself (for claims under Part
E). This rule should help minimize the
burden placed on courts by litigation
seeking to challenge decisions under
EEOICPA by providing claimants with
an opportunity to seek administrative
review of adverse decisions prior to
resorting to the court system, and by
providing a clear legal standard for
affected conduct. The rule has been
reviewed carefully to eliminate drafting
errors and ambiguities.
X. Executive Order 12988 (Civil Justice
Reform)
This final rule has been drafted and
reviewed in accordance with E.O. 12988
and will not unduly burden the federal
court system. While Part B of EEOICPA
does not provide any specific
XIV. Submission to Congress and the
General Accountability Office
In accordance with the Small
Business Regulatory Enforcement
Fairness Act of 1996, the Department
will submit to each House of the
Congress and to the Comptroller General
PO 00000
Frm 00014
Fmt 4701
Sfmt 4700
XI. Executive Order 13045 (Protection
of Children From Environmental,
Health Risks and Safety Risks)
In accordance with E.O. 13045, the
Department has evaluated the
environmental health and safety effects
of this rule on children. The Department
has determined that the final rule will
have no effect on children.
XII. Executive Order 13132
(Federalism)
The Department has reviewed this
final rule in accordance with E.O. 13132
and has determined that it does not
have any ‘‘federalism implications.’’
The final rule does not ‘‘have
substantial direct effects on the States,
on the relationship between the national
government and the States, or on the
distribution of power and
responsibilities among the various
levels of government.’’
XIII. Executive Order 13211 (Actions
Concerning Regulations That
Significantly Affect Energy Supply,
Distribution, or Use)
In accordance with E.O. 13211, the
Department has evaluated the effects of
this final rule on energy supply,
distribution or use, and has determined
that this rule is not likely to have a
significant adverse effect on them.
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
a report regarding the issuance of this
final rule prior to the effective date set
forth at the outset of this notice. The
report will note that this rule constitutes
a ‘‘major rule’’ as defined by 5 U.S.C.
804(2).
XV. Catalog of Federal Domestic
Assistance Number
This program is listed in the Catalog
of Federal Domestic Assistance as No.
17.310.
List of Subjects
20 CFR Part 1
Organization and functions
(Government agencies).
20 CFR Part 30
Administrative practice and
procedure, Cancer, Claims, Kidney
diseases, Leukemia, Lung diseases,
Miners, Radioactive materials, Tort
claims, Underground mining, Uranium,
Workers’ compensation.
Text of the Rule
For the reasons set forth in the
preamble, 20 CFR Chapter 1 is amended
as follows:
I
Subchapter A—Organization and
Procedures
I
1. Part 1 is revised to read as follows:
PART 1—PERFORMANCE OF
FUNCTIONS
Sec.
1.1 Under what authority was the Office of
Workers’ Compensation Programs
established?
1.2 What functions are assigned to OWCP?
1.3 What rules are contained in this
chapter?
1.4 Where are other rules concerning OWCP
functions found?
1.5 When was the former Bureau of
Employees’ Compensation abolished?
1.6 How were many of OWCP’s current
functions administered in the past?
Authority: 5 U.S.C. 301, 8145 and 8149
(Reorganization Plan No. 6 of 1950, 15 FR
3174, 3 CFR, 1949–1953 Comp., p. 1004, 64
Stat. 1263); 42 U.S.C. 7384d and 7385s–10;
Executive Order 13179, 65 FR 77487, 3 CFR,
2000 Comp., p. 321; Secretary of Labor’s
Order No. 13–71, 36 FR 8155; Employment
Standards Order No. 2–74, 39 FR 34722.
pwalker on PROD1PC60 with RULES2
§ 1.1 Under what authority was the Office
of Workers’ Compensation Programs
established?
The Assistant Secretary of Labor for
Employment Standards, by authority
vested in him by the Secretary of Labor
in Secretary’s Order No. 13–71 (36 FR
8755), established in the Employment
Standards Administration an Office of
Workers’ Compensation Programs
(OWCP) by Employment Standards
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
Order No. 2–74 (39 FR 34722). The
Assistant Secretary subsequently
designated as the head thereof a Director
who, under the general supervision of
the Assistant Secretary, administers the
programs assigned to OWCP by the
Assistant Secretary.
§ 1.2 What functions are assigned to
OWCP?
The Assistant Secretary of Labor for
Employment Standards has delegated
authority and assigned responsibility to
the Director of OWCP for the
Department of Labor’s programs under
the following statutes:
(a) The Federal Employees’
Compensation Act, as amended and
extended (5 U.S.C. 8101 et seq.), except
5 U.S.C. 8149 as it pertains to the
Employees’ Compensation Appeals
Board.
(b) The War Hazards Compensation
Act (42 U.S.C. 1701 et seq.).
(c) The War Claims Act (50 U.S.C.
App. 2003).
(d) The Energy Employees
Occupational Illness Compensation
Program Act of 2000, as amended (42
U.S.C. 7384 et seq.), except activities,
pursuant to Executive Order 13179
(‘‘Providing Compensation to America’s
Nuclear Weapons Workers’’) of
December 7, 2000, assigned to the
Secretary of Health and Human
Services, the Secretary of Energy and
the Attorney General.
(e) The Longshore and Harbor
Workers’ Compensation Act, as
amended and extended (33 U.S.C. 901 et
seq.), except: 33 U.S.C. 919(d) with
respect to administrative law judges in
the Office of Administrative Law Judges;
33 U.S.C. 921(b) as it pertains to the
Benefits Review Board; and activities,
pursuant to 33 U.S.C. 941, assigned to
the Assistant Secretary of Labor for
Occupational Safety and Health.
(f) The Black Lung Benefits Act, as
amended (30 U.S.C. 901 et seq.).
§ 1.3 What rules are contained in this
chapter?
The rules in this chapter are those
governing the OWCP functions under
the Federal Employees’ Compensation
Act, the War Hazards Compensation
Act, the War Claims Act and the Energy
Employees Occupational Illness
Compensation Program Act of 2000.
§ 1.4 Where are other rules concerning
OWCP functions found?
(a) The rules of the OWCP governing
its functions under the Longshore and
Harbor Workers’ Compensation Act and
its extensions are set forth in subchapter
A of chapter VI of this title.
(b) The rules of the OWCP governing
its functions under the Black Lung
PO 00000
Frm 00015
Fmt 4701
Sfmt 4700
78533
Benefits Act program are set forth in
subchapter B of chapter VI of this title.
(c) The rules and regulations of the
Employees’ Compensation Appeals
Board are set forth in chapter IV of this
title.
(d) The rules and regulations of the
Benefits Review Board are set forth in
Chapter VII of this title.
§ 1.5 When was the former Bureau of
Employees’ Compensation abolished?
By Secretary of Labor’s Order issued
September 23, 1974 (39 FR 34723),
issued concurrently with Employment
Standards Order 2–74 (39 FR 34722),
the Secretary revoked the prior
Secretary’s Order No. 18–67 (32 FR
12979), which had delegated authority
and assigned responsibility for the
various workers’ compensation
programs enumerated in § 1.2, except
the Black Lung Benefits Program and
the Energy Employees Occupational
Illness Compensation Program not then
in existence, to the Director of the
former Bureau of Employees’
Compensation.
§ 1.6 How were many of OWCP’s current
functions administered in the past?
(a) Administration of the Federal
Employees’ Compensation Act and the
Longshore and Harbor Workers’
Compensation Act was initially vested
in an independent establishment known
as the U.S. Employees’ Compensation
Commission. By Reorganization Plan
No. 2 of 1946 (3 CFR, 1943–1949 Comp.,
p. 1064; 60 Stat. 1095, effective July 16,
1946), the Commission was abolished
and its functions were transferred to the
Federal Security Agency to be
performed by a newly created Bureau of
Employees’ Compensation within such
Agency. By Reorganization Plan No. 19
of 1950 (15 FR 3178, 3 CFR, 1949–1954
Comp., page 1010, 64 Stat. 1271), said
Bureau was transferred to the
Department of Labor (DOL), and the
authority formerly vested in the
Administrator, Federal Security Agency,
was vested in the Secretary of Labor. By
Reorganization Plan No. 6 of 1950 (15
FR 3174, 3 CFR, 1949–1953 Comp., page
1004, 64 Stat. 1263), the Secretary of
Labor was authorized to make from time
to time such provisions as he shall deem
appropriate, authorizing the
performance of any of his functions by
any other officer, agency, or employee of
the DOL.
(b) In 1972, two separate
organizational units were established
within the Bureau: an Office of
Workmen’s Compensation Programs (37
FR 20533) and an Office of Federal
Employees’ Compensation (37 FR
22979). In 1974, these two units were
E:\FR\FM\29DER2.SGM
29DER2
78534
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
abolished and one organizational unit,
the Office of Workers’ Compensation
Programs, was established in lieu of the
Bureau of Employees’ Compensation (39
FR 34722).
I 2. Subchapter C consisting of part 30
is revised to read as follows:
Subchapter C—Energy Employees
Occupational Illness Compensation
Program Act of 2000
PART 30—CLAIMS FOR
COMPENSATION UNDER THE
ENERGY EMPLOYEES
OCCUPATIONAL ILLNESS
COMPENSATION PROGRAM ACT OF
2000, AS AMENDED
Subpart A—General Provisions
Introduction
Sec.
30.0 What are the provisions of EEOICPA,
in general?
30.1 What rules govern the administration
of EEOICPA and this chapter?
30.2 In general, how have the tasks
associated with the administration of the
EEOICPA claims process been assigned?
30.3 What do these regulations contain?
Information in Program Records
30.10 Are all OWCP records relating to
claims filed under EEOICPA considered
confidential?
30.11 Who maintains custody and control
of claim records?
30.12 What process is used by a person who
wants to obtain copies of or amend
EEOICPA claim records?
Rights and Penalties
30.15 May EEOICPA benefits be assigned,
transferred or garnished?
30.16 What penalties may be imposed in
connection with a claim under the Act?
30.17 Is a beneficiary who defrauds the
government in connection with a claim
for EEOICPA benefits still entitled to
those benefits?
pwalker on PROD1PC60 with RULES2
Subpart B—Filing Claims; Evidence and
Burden of Proof; Special Procedures for
Certain Cancer Claims
Filing Claims for Benefits Under EEOICPA
30.100 In general, how does an employee
file an initial claim for benefits?
30.101 In general, how is a survivor’s claim
filed?
30.102 In general, how does an employee
file a claim for additional impairment or
wage-loss under Part E of EEOICPA?
30.103 How does a claimant make sure that
OWCP has the evidence necessary to
process the claim?
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
30.110 Who is entitled to compensation
under the Act?
30.111 What is the claimant’s responsibility
with respect to burden of proof,
production of documents, presumptions,
and affidavits?
30.112 What kind of evidence is needed to
establish covered employment and how
will that evidence be evaluated?
30.113 What are the requirements for
written medical documentation,
contemporaneous records, and other
records or documents?
30.114 What kind of evidence is needed to
establish a compensable medical
condition and how will that evidence be
evaluated?
Special Procedures for Certain Radiogenic
Cancer Claims
30.115 For those radiogenic cancer claims
that do not seek benefits under Part B of
the Act pursuant to the Special Exposure
Cohort provisions, what will OWCP do
once it determines that an employee
contracted cancer?
Subpart C—Eligibility Criteria
General Provisions
30.200
Definitions
30.5 What are the definitions used in this
part?
Verification of Alleged Employment
30.105 What must DOE do after an
employee or survivor files a claim?
30.106 Can OWCP request employment
verification from other sources?
Evidence and Burden of Proof
What is the scope of this subpart?
Eligibility Criteria for Claims Relating to
Covered Beryllium Illness Under Part B of
EEOICPA
30.205 What are the criteria for eligibility
for benefits relating to beryllium
illnesses covered under Part B?
30.206 How does a claimant prove that the
employee was a ‘‘covered beryllium
employee’’ exposed to beryllium dust,
particles or vapor in the performance of
duty?
30.207 How does a claimant prove a
diagnosis of a beryllium disease covered
under Part B?
Eligibility Criteria for Claims Relating to
Radiogenic Cancer Under Parts B and E of
EEOICPA
30.210 What are the criteria for eligibility
for benefits relating to radiogenic cancer?
30.211 How does a claimant establish that
the employee has or had contracted
cancer?
30.212 How does a claimant establish that
the employee contracted cancer after
beginning employment at a DOE facility,
an atomic weapons employer facility or
a RECA section 5 facility?
30.213 How does a claimant establish that
the radiogenic cancer was at least as
likely as not related to employment at
the DOE facility, the atomic weapons
employer facility, or the RECA section 5
facility?
30.214 How does a claimant establish that
the employee is a member of the Special
Exposure Cohort?
30.215 How does a claimant establish that
the employee has sustained an injury,
illness, impairment or disease as a
consequence of a diagnosed cancer?
PO 00000
Frm 00016
Fmt 4701
Sfmt 4700
Eligibility Criteria for Claims Relating to
Chronic Silicosis Under Part B of EEOICPA
30.220 What are the criteria for eligibility
for benefits relating to chronic silicosis?
30.221 How does a claimant prove exposure
to silica in the performance of duty?
30.222 How does a claimant establish that
the employee has been diagnosed with
chronic silicosis or has sustained a
consequential injury, illness, impairment
or disease?
Eligibility Criteria for Certain Uranium
Employees Under Part B of EEOICPA
30.225 What are the criteria for eligibility
for benefits under Part B of EEOICPA for
certain uranium employees?
30.226 How does a claimant establish that
a covered uranium employee has
sustained a consequential injury, illness,
impairment or disease?
Eligibility Criteria for Other Claims Under
Part E of EEOICPA
30.230 What are the criteria necessary to
establish that an employee contracted a
covered illness under Part E of
EEOICPA?
30.231 How does a claimant prove
employment-related exposure to a toxic
substance at a DOE facility or a RECA
section 5 facility?
30.232 How does a claimant establish that
the employee has been diagnosed with a
covered illness, or sustained an injury,
illness, impairment or disease as a
consequence of a covered illness?
Subpart D—Adjudicatory Process
30.300 What process will OWCP use to
decide claims for entitlement and to
provide for administrative review of
those decisions?
30.301 May subpoenas be issued for
witnesses and documents in connection
with a claim under Part B of EEOICPA?
30.302 Who pays the costs associated with
subpoenas?
30.303 What information may OWCP
request in connection with a claim under
Part E of EEOICPA?
Recommended Decisions on Claims
30.305 How does OWCP determine
entitlement to EEOICPA compensation?
30.306 What does the recommended
decision contain?
30.307 To whom is the recommended
decision sent?
Hearings and Final Decisions on Claims
30.310 What must the claimant do if he or
she objects to the recommended decision
or wants to request a hearing?
30.311 What happens if the claimant does
not object to the recommended decision
or request a hearing within 60 days?
30.312 What will the FAB do if the
claimant objects to the recommended
decision but does not request a hearing?
30.313 How is a review of the written
record conducted?
30.314 How is a hearing conducted?
30.315 May a claimant postpone a hearing?
30.316 How does the FAB issue a final
decision on a claim?
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
30.317 Can the FAB request a further
response from the claimant or return a
claim to the district office?
30.318 Can the FAB consider objections to
HHS’s reconstruction of a radiation dose
or to the guidelines OWCP uses to
determine if a claimed cancer was at
least as likely as not related to
employment?
30.319 May a claimant request
reconsideration of a final decision of the
FAB?
Reopening Claims
30.320 Can a claim be reopened after the
FAB has issued a final decision?
Subpart E—Medical and Related Benefits
Medical Treatment and Related Issues
30.400 What are the basic rules for
obtaining medical treatment?
30.401 What are the special rules for the
services of chiropractors?
30.402 What are the special rules for the
services of clinical psychologists?
30.403 Will OWCP pay for the services of
an attendant?
30.404 Will OWCP pay for transportation to
obtain medical treatment?
30.405 After selecting a treating physician,
may an employee choose to be treated by
another physician instead?
30.406 Are there any exceptions to these
procedures for obtaining medical care?
Directed Medical Examinations
30.410 Can OWCP require an employee to
be examined by another physician?
30.411 What happens if the opinion of the
physician selected by OWCP differs from
the opinion of the physician selected by
the employee?
30.412 Who pays for second opinion and
referee examinations?
Medical Reports
30.415 What are the requirements for
medical reports?
30.416 How and when should medical
reports be submitted?
30.417 What additional medical
information may OWCP require to
support continuing payment of benefits?
Medical Bills
30.420 How should medical bills and
reimbursement requests be submitted?
30.421 What are the time frames for
submitting bills and reimbursement
requests?
30.422 If an employee is only partially
reimbursed for a medical expense, must
the provider refund the balance of the
amount paid to the employee?
pwalker on PROD1PC60 with RULES2
Subpart F—Survivors; Payments and
Offsets; Overpayments
Survivors
30.500 What special statutory definitions
apply to survivors under EEOICPA?
30.501 What order of precedence will
OWCP use to determine which survivors
are entitled to receive compensation
under EEOICPA?
30.502 When is entitlement for survivors
determined for purposes of EEOICPA?
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
Payment of Claims and Offset for Certain
Payments
30.505 What procedures will OWCP follow
before it pays any compensation?
30.506 To whom and in what manner will
OWCP pay compensation?
30.507 What compensation will be
provided to covered Part B employees
who only establish beryllium sensitivity
under Part B of EEOICPA?
30.508 What is beryllium sensitivity
monitoring?
30.509 Under what circumstances may a
survivor claiming under Part E of the Act
choose to receive the benefits that would
otherwise be payable to a covered Part E
employee who is deceased?
Overpayments
30.510 How does OWCP notify an
individual of a payment made on a
claim?
30.511 What is an ‘‘overpayment’’ for
purposes of EEOICPA?
30.512 What does OWCP do when an
overpayment is identified?
30.513 Under what circumstances may
OWCP waive recovery of an
overpayment?
30.514 If OWCP finds that the recipient of
an overpayment was not at fault, what
criteria are used to decide whether to
waive recovery of it?
30.515 Is a recipient responsible for an
overpayment that resulted from an error
made by OWCP?
30.516 Under what circumstances would
recovery of an overpayment defeat the
purpose of the Act?
30.517 Under what circumstances would
recovery of an overpayment be against
equity and good conscience?
30.518 Can OWCP require the recipient of
the overpayment to submit additional
financial information?
30.519 How does OWCP communicate its
final decision concerning recovery of an
overpayment?
30.520 How are overpayments collected?
Subpart G—Special Provisions
Representation
30.600 May a claimant designate a
representative?
30.601 Who may serve as a representative?
30.602 Who is responsible for paying the
representative’s fee?
30.603 Are there any limitations on what
the representative may charge the
claimant for his or her services?
Third Party Liability
30.605 What rights does the United States
have upon payment of compensation
under EEOICPA?
30.606 Under what circumstances must a
recovery of money or other property in
connection with an illness for which
benefits are payable under EEOICPA be
reported to OWCP?
30.607 How is a structured settlement (that
is, a settlement providing for receipt of
funds over a specified period of time)
treated for purposes of reporting the
recovery?
PO 00000
Frm 00017
Fmt 4701
Sfmt 4700
78535
30.608 How does the United States
calculate the amount to which it is
subrogated?
30.609 Is a settlement or judgment received
as a result of allegations of medical
malpractice in treating an illness covered
by EEOICPA a recovery that must be
reported to OWCP?
30.610 Are payments to a covered Part B
employee, a covered Part E employee or
an eligible surviving beneficiary as a
result of an insurance policy which the
employee or eligible surviving
beneficiary has purchased a recovery
that must be reported to OWCP?
30.611 If a settlement or judgment is
received for more than one medical
condition, can the amount paid on a
single EEOICPA claim be attributed to
different conditions for purposes of
calculating the amount to which the
United States is subrogated?
Effect of Tort Suits Against Beryllium
Vendors and Atomic Weapons Employers
30.615 What type of tort suits filed against
beryllium vendors or atomic weapons
employers may disqualify certain
claimants from receiving benefits under
Part B of EEOICPA?
30.616 What happens if this type of tort suit
was filed prior to October 30, 2000?
30.617 What happens if this type of tort suit
was filed during the period from October
30, 2000 through December 28, 2001?
30.618 What happens if this type of tort suit
was filed after December 28, 2001?
30.619 Do all the parties to this type of tort
suit have to take these actions?
30.620 How will OWCP ascertain whether a
claimant filed this type of tort suit and
if he or she has been disqualified from
receiving any benefits under Part B of
EEOICPA?
Coordination of Part E Benefits With State
Workers’ Compensation Benefits
30.625 What does ‘‘coordination of
benefits’’ mean under Part E of
EEOICPA?
30.626 How will OWCP coordinate
compensation payable under Part E of
EEOICPA with benefits from state
workers’ compensation programs?
30.627 Under what circumstances will
OWCP waive the statutory requirement
to coordinate these benefits?
Subpart H—Information for Medical
Providers
Medical Records and Bills
30.700 What kind of medical records must
providers keep?
30.701 How are medical bills to be
submitted?
30.702 How should an employee prepare
and submit requests for reimbursement
for medical expenses, transportation
costs, loss of wages, and incidental
expenses?
30.703 What are the time limitations on
OWCP’s payment of bills?
Medical Fee Schedule
30.705 What services are covered by the
OWCP fee schedule?
E:\FR\FM\29DER2.SGM
29DER2
78536
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
30.706 How are the maximum fees defined?
30.707 How are payments for particular
services calculated?
30.708 Does the fee schedule apply to every
kind of procedure?
30.709 How are payments for medicinal
drugs determined?
30.710 How are payments for inpatient
medical services determined?
30.711 When and how are fees reduced?
30.712 If OWCP reduces a fee, may a
provider request reconsideration of the
reduction?
30.713 If OWCP reduces a fee, may a
provider bill the employee for the
balance?
Exclusion of Providers
30.715 What are the grounds for excluding
a provider for payment under this part?
30.716 What will cause OWCP to
automatically exclude a physician or
other provider of medical services and
supplies?
30.717 When are OWCP’s exclusion
procedures initiated?
30.718 How is a provider notified of
OWCP’s intent to exclude him or her?
30.719 What requirements must the
provider’s reply and OWCP’s decision
meet?
30.720 How can an excluded provider
request a hearing?
30.721 How are hearings assigned and
scheduled?
30.722 How are subpoenas or advisory
opinions obtained?
30.723 How will the administrative law
judge conduct the hearing and issue the
recommended decision?
30.724 How can a party request review by
OWCP of the administrative law judge’s
recommended decision?
30.725 What are the effects of nonautomatic exclusion?
30.726 How can an excluded provider be
reinstated?
Subpart I—Wage-Loss Determinations
Under Part E of EEOICPA
General Provisions
30.800 What types of wage-loss are
compensable under Part E of EEOICPA?
30.801 What special definitions does OWCP
use in connection with Part E wage-loss
determinations?
pwalker on PROD1PC60 with RULES2
Evidence of Wage-Loss
30.805 What evidence does OWCP use to
determine a covered Part E employee’s
average annual wage and whether he or
she experienced compensable wage-loss
under Part E of EEOICPA?
30.806 May a claimant submit factual
evidence in support of a different
determination of average annual wage
and/or wage-loss than that found by
OWCP?
Determinations of Average Annual Wage
and Percentages of Loss
30.810 How will OWCP calculate the
average annual wage of a covered Part E
employee?
30.811 How will OWCP calculate the
duration and extent of a covered Part E
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
employee’s initial period of compensable
wage-loss?
30.812 May a covered Part E employee
claim for subsequent periods of
compensable wage-loss?
Special Rules for Certain Survivor Claims
Under Part E of EEOICPA
30.815 Are there special rules that OWCP
will use to determine the extent of a
deceased covered Part E employee’s
compensable wage-loss?
Subpart J—Impairment Benefits Under Part
E of EEOICPA
General Provisions
30.900 Who can receive impairment
benefits under Part E?
30.901 How does OWCP determine the
extent of an employee’s impairment that
is due to a covered illness contracted
through exposure to a toxic substance at
a DOE facility or a RECA section 5
facility, as appropriate?
30.902 How will OWCP calculate the
amount of the award of impairment
benefits that is payable under Part E?
Medical Evidence of Impairment
30.905 How may an impairment evaluation
be obtained?
30.906 Who will pay for an impairment
evaluation?
30.907 Can an impairment evaluation
obtained by OWCP be challenged prior
to issuance of the recommended
decision?
30.908 How will the FAB evaluate new
medical evidence submitted to challenge
the impairment determination in the
recommended decision?
Ratable Impairments
30.910 Will an impairment that cannot be
assigned a numerical percentage using
the AMA’s Guides be included in the
impairment rating?
30.911 Does maximum medical
improvement always have to be reached
for an impairment to be included in the
impairment rating?
30.912 Can a covered Part E employee
receive benefits for additional
impairment following an award of such
benefits by OWCP?
Authority: 5 U.S.C. 301; 31 U.S.C. 3716
and 3717; 42 U.S.C. 7384d, 7384t, 7384u and
7385s–10; Executive Order 13179, 65 FR
77487, 3 CFR, 2000 Comp., p. 321; Secretary
of Labor’s Order No. 4–2001, 66 FR 29656.
Subpart A—General Provisions
Introduction
§ 30.0 What are the provisions of
EEOICPA, in general?
Part B of the Energy Employees
Occupational Illness Compensation
Program Act of 2000, as amended
(EEOICPA or Act), 42 U.S.C. 7384 et
seq., provides for the payment of
compensation benefits to covered Part B
employees and, where applicable,
survivors of such employees, of the
PO 00000
Frm 00018
Fmt 4701
Sfmt 4700
United States Department of Energy
(DOE), its predecessor agencies and
certain of its contractors and
subcontractors. Part B also provides for
the payment of supplemental
compensation benefits to other covered
Part B employees who have already
been found eligible for benefits under
section 5 of the Radiation Exposure
Compensation Act, as amended (RECA),
42 U.S.C. 2210 note, and where
applicable, survivors of such persons.
Part E of the Act provides for the
payment of compensation benefits to
covered Part E employees and, where
applicable, survivors of such employees.
The regulations in this part describe the
rules governing filing, processing, and
paying claims for benefits under both
Part B and Part E of EEOICPA.
(a) Part B of EEOICPA provides for the
payment of either lump-sum monetary
compensation for the disability of a
covered Part B employee due to an
occupational illness or for monitoring
for beryllium sensitivity, as well as for
medical and related benefits for such
illness. Part B also provides for the
payment of monetary compensation for
the disability of a covered Part B
employee to specified survivors if the
employee is deceased at the time of
payment.
(b) Part E of EEOICPA provides for the
payment of monetary compensation for
the established wage-loss and/or
impairment of a covered Part E
employee due to a covered illness, and
for medical and related benefits for such
covered illness. Part E also provides for
the payment of monetary compensation
for the death (and established wage-loss,
where applicable) of a covered Part E
employee to specified survivors if the
covered Part E employee is deceased at
the time of payment.
(c) All types of benefits and
conditions of eligibility listed in this
section are subject to the provisions of
EEOICPA and this part.
§ 30.1 What rules govern the
administration of EEOICPA and this
chapter?
In accordance with EEOICPA,
Executive Order 13179 and Secretary’s
Order No. 4–2001, the primary
responsibility for administering the Act,
except for those activities assigned to
the Secretary of Health and Human
Services (HHS), the Secretary of Energy
and the Attorney General, has been
delegated to the Assistant Secretary of
Labor for Employment Standards. The
Assistant Secretary, in turn, has
delegated the responsibility for
administering the Act to the Director of
the Office of Workers’ Compensation
Programs (OWCP). Except as otherwise
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
provided by law, the Director of OWCP
and his or her designees have the
exclusive authority to administer,
interpret and enforce the provisions of
the Act.
§ 30.2 In general, how have the tasks
associated with the administration of
EEOICPA claims process been assigned?
pwalker on PROD1PC60 with RULES2
(a) In E.O. 13179, the President
assigned the tasks associated with
administration of the EEOICPA claims
process among the Secretaries of Labor,
HHS and Energy, and the Attorney
General. In light of the fact that the
Secretary of Labor has been assigned
primary responsibility for administering
EEOICPA, almost the entire claims
process is within the exclusive control
of OWCP. This means that all claimants
file their claims with OWCP, and OWCP
is responsible for granting or denying
compensation under the Act (see
§§ 30.100 through 30.102). OWCP also
provides assistance to claimants and
potential claimants by providing
information regarding eligibility and
other program requirements, including
information on completing claim forms
and the types and availability of
medical testing and diagnostic services
related to occupational illnesses under
Part B of the Act and covered illnesses
under Part E of the Act. In addition,
OWCP provides an administrative
review process for claimants who
disagree with its recommended and
final adverse decisions on claims of
entitlement (see §§ 30.300 through
30.320).
(b) However, HHS has exclusive
control of the portion of the claims
process under which it provides
reconstructed doses for certain
radiogenic cancer claims (see § 30.115).
HHS also has exclusive control of the
process for designating classes of
employees to be added to the Special
Exposure Cohort under Part B of the
Act, and has promulgated regulations
governing that process at 42 CFR part
83. Finally, HHS has promulgated
regulations at 42 CFR part 81 that set
out guidelines that OWCP follows when
it assesses the compensability of an
employee’s radiogenic cancer (see
§ 30.213). DOE and DOJ must, among
other things, notify potential claimants
and submit evidence that OWCP deems
necessary for its adjudication of claims
under EEOICPA (see §§ 30.105, 30.112,
30.206, 30.212 and 30.221).
§ 30.3
What do these regulations contain?
This part 30 sets forth the regulations
governing administration of all claims
that are filed with OWCP, except to the
extent specified in certain provisions.
Its provisions are intended to assist
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
persons seeking benefits under
EEOICPA, as well as personnel in the
various federal agencies and DOL who
process claims filed under EEOICPA or
who perform administrative functions
with respect to EEOICPA. The various
subparts of this part contain the
following:
(a) Subpart A: The general statutory
and administrative framework for
processing claims under both Parts B
and E of EEOICPA. It contains a
statement of purpose and scope,
together with definitions of terms,
information regarding the disclosure of
OWCP records, and a description of
rights and penalties involving EEOICPA
claims, including convictions for fraud.
(b) Subpart B: The rules for filing
claims for entitlement under EEOICPA.
It also addresses general standards
regarding necessary evidence and the
burden of proof, descriptions of basic
forms and special procedures for certain
cancer claims.
(c) Subpart C: The eligibility criteria
for occupational illnesses and covered
illnesses compensable under Parts B
and E of EEOICPA, respectively.
(d) Subpart D: The rules governing the
adjudication process leading to
recommended and final decisions on
claims for entitlement filed under Parts
B and E of EEOICPA. It also describes
the hearing and reopening processes.
(e) Subpart E: The rules governing
medical care, second opinion and
referee medical examinations and
impairment evaluations directed by
OWCP as part of its adjudication of
entitlement, and medical reports and
records in general. It also addresses the
kinds of medical treatment that may be
authorized and how medical bills are
paid.
(f) Subpart F: The rules relating to the
payment of monetary compensation
available under Parts B and E of
EEOICPA. It includes provisions on
medical monitoring for beryllium
sensitivity, on the identification,
processing and recovery of
overpayments of compensation, and on
the maximum aggregate amount of
compensation payable under Part E.
(g) Subpart G: The rules concerning
the representation of claimants in
connection with the administrative
adjudication of claims before OWCP,
subrogation of the United States, the
effect of tort suits against beryllium
vendors and atomic weapons
employers, and the coordination of
benefits under Part E of EEOICPA with
state workers’ compensation benefits for
the same covered illness.
(h) Subpart H: Information for
medical providers. It includes rules for
medical reports, medical bills, and the
PO 00000
Frm 00019
Fmt 4701
Sfmt 4700
78537
OWCP medical fee schedule, as well as
the provisions for exclusion of medical
providers.
(i) Subpart I: The rules relating to the
adjudication of alleged periods of wageloss of covered Part E employees. It also
includes provisions on the use by
OWCP of Social Security
Administration earnings information
and certain medical evidence to
establish compensable wage-loss.
(j) Subpart J: The rules relating to the
adjudication of alleged permanent
impairment due to the exposure of
covered Part E employees to toxic
substances. It includes provisions
relating to the medical evaluation of
ratable impairments, the rating of
progressive conditions, and
qualifications of physicians.
Definitions
§ 30.5
part?
What are the definitions used in this
(a) Act or EEOICPA means the Energy
Employees Occupational Illness
Compensation Program Act of 2000, as
amended (42 U.S.C. 7384 et seq.).
(b) Atomic weapon means any device
utilizing atomic energy, exclusive of the
means for transporting or propelling the
device (where such means is a separable
and divisible part of the device), the
principle purpose of which is for use as,
or for development of, a weapon, a
weapon prototype, or a weapon test
device.
(c) Atomic weapons employee means:
(1) An individual employed by an
atomic weapons employer during a
period when the employer was
processing or producing, for the use by
the United States, material that emitted
radiation and was used in the
production of an atomic weapon,
excluding uranium mining and milling;
or
(2)(i) An individual employed at a
facility that the National Institute for
Occupational Safety and Health
(NIOSH) reported had a potential for
significant residual contamination
outside of the period described in
paragraph (c)(1) of this section;
(ii) By the atomic weapons employer
that owned the facility referred to in
paragraph (c)(2)(i) of this section, or a
subsequent owner or operator of such
facility; and
(iii) During a period reported by
NIOSH, in its report dated October 2003
and titled ‘‘Report on Residual
Radioactive and Beryllium
Contamination at Atomic Weapons
Employer Facilities and Beryllium
Vendor Facilities,’’ or any update to that
report, to have a potential for significant
residual radioactive contamination.
E:\FR\FM\29DER2.SGM
29DER2
pwalker on PROD1PC60 with RULES2
78538
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
(d) Atomic weapons employer means
any entity, other than the United States,
that:
(1) Processed or produced, for use by
the United States, material that emitted
radiation and was used in the
production of an atomic weapon,
excluding uranium mining and milling;
and
(2) Is designated by the Secretary of
Energy as an atomic weapons employer
for purposes of the compensation
program.
(e) Atomic weapons employer facility
means any facility, owned by an atomic
weapons employer, that:
(1) Is or was used to process or
produce, for use by the United States,
material that emitted radiation and was
used in the production of an atomic
weapon, excluding uranium mining or
milling; and
(2) Is designated as such in the list
periodically published in the Federal
Register by DOE.
(f) Attorney General means the
Attorney General of the United States or
the United States Department of Justice
(DOJ).
(g) Benefit or Compensation means
the money the Department pays to or on
behalf of either a covered Part B
employee under Part B, or a covered
Part E employee under Part E, from the
Energy Employees Occupational Illness
Compensation Fund. However, the term
‘‘compensation’’ used in section
7385f(b) of EEOICPA (restricting
entitlement to only one payment of
compensation under Part B) means only
the payments specified in section
7384s(a)(1) and in section 7384u(a).
Except as used in section 7385f(b), these
two terms also include any other
amounts paid out of the Fund for such
things as medical treatment, monitoring,
examinations, services, appliances and
supplies as well as for transportation
and expenses incident to the securing of
such medical treatment, monitoring,
examinations, services, appliances, and
supplies.
(h) Beryllium sensitization or
sensitivity means that the individual has
an abnormal beryllium lymphocyte
proliferation test (LPT) performed on
either blood or lung lavage cells.
(i) Beryllium vendor means the
specific corporations and named
predecessor corporations listed in
section 7384l(6) of the Act and any of
the facilities designated as such in the
list periodically published in the
Federal Register by DOE.
(j) Chronic silicosis means a nonmalignant lung disease if:
(1) The initial occupational exposure
to silica dust preceded the onset of
silicosis by at least 10 years; and
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
(2) A written diagnosis of silicosis is
made by a medical doctor and is
accompanied by:
(i) A chest radiograph, interpreted by
an individual certified by NIOSH as a B
reader, classifying the existence of
pneumoconioses of category 1/0 or
higher; or
(ii) Results from a computer assisted
tomograph or other imaging technique
that are consistent with silicosis; or
(iii) Lung biopsy findings consistent
with silicosis.
(k) Claim means a written assertion to
OWCP of an individual’s entitlement to
benefits under EEOICPA, submitted in a
manner authorized by this part.
(l) Claimant means the individual
who is alleged to satisfy the criteria for
compensation under the Act.
(m) Compensation fund or fund
means the fund established on the books
of the Treasury for payment of benefits
and compensation under the Act.
(n) Contemporaneous record means
any document created at or around the
time of the event that is recorded in the
document.
(o) Covered beryllium illness means
any of the following:
(1) Beryllium sensitivity as
established by an abnormal LPT
performed on either blood or lung
lavage cells.
(2) Established chronic beryllium
disease (see § 30.207(c)).
(3) Any injury, illness, impairment, or
disability sustained as a consequence of
a covered beryllium illness referred to
in paragraphs (o)(1) or (2) of this
section.
(p) Covered Part E employee means,
under Part E of the Act, a Department
of Energy contractor employee or a
RECA section 5 uranium worker who
has been determined by OWCP to have
contracted a covered illness (see
paragraph (r) of this section) through
exposure at a Department of Energy
facility or a RECA section 5 facility, as
appropriate.
(q) Covered Part B employee means,
under Part B of the Act, a covered
beryllium employee (see § 30.205), a
covered employee with cancer (see
§ 30.210(a)), a covered employee with
chronic silicosis (see § 30.220), or a
covered uranium employee (see
paragraph (s) of this section).
(r) Covered illness means, under Part
E of the Act relating to exposures at a
DOE facility or a RECA section 5
facility, an illness or death resulting
from exposure to a toxic substance.
(s) Covered uranium employee means,
under Part B of the Act, an individual
who has been determined by DOJ to be
entitled to an award under section 5 of
RECA, whether or not the individual
PO 00000
Frm 00020
Fmt 4701
Sfmt 4700
was the employee or the deceased
employee’s survivor.
(t) Current or former employee as
defined in 5 U.S.C. 8101(1) as used in
§ 30.205(a)(1) means an individual who
fits within one of the following listed
groups:
(1) A civil officer or employee in any
branch of the Government of the United
States, including an officer or employee
of an instrumentality wholly owned by
the United States;
(2) An individual rendering personal
service to the United States similar to
the service of a civil officer or employee
of the United States, without pay or for
nominal pay, when a statute authorizes
the acceptance or use of the service, or
authorizes payment of travel or other
expenses of the individual;
(3) An individual, other than an
independent contractor or individual
employed by an independent contractor,
employed on the Menominee Indian
Reservation in Wisconsin in operations
conducted under a statute relating to
tribal timber and logging operations on
that reservation;
(4) An individual appointed to a
position on the office staff of a former
President; or
(5) An individual selected and serving
as a Federal petit or grand juror.
(u) Department means the United
States Department of Labor (DOL).
(v) Department of Energy or DOE
includes the predecessor agencies of the
DOE, including the Manhattan
Engineering District.
(w) Department of Energy contractor
employee means any of the following:
(1) An individual who is or was in
residence at a DOE facility as a
researcher for one or more periods
aggregating at least 24 months.
(2) An individual who is or was
employed at a DOE facility by:
(i) An entity that contracted with the
DOE to provide management and
operating, management and integration,
or environmental remediation at the
facility; or
(ii) A contractor or subcontractor that
provided services, including
construction and maintenance, at the
facility.
(x)(1) Department of Energy facility
means, as determined by the Director of
OWCP, any building, structure, or
premise, including the grounds upon
which such building, structure, or
premise is located:
(i) In which operations are, or have
been, conducted by, or on behalf of, the
DOE (except for buildings, structures,
premises, grounds, or operations
covered by E.O. 12344, dated February
1, 1982, pertaining to the Naval Nuclear
Propulsion Program); and
E:\FR\FM\29DER2.SGM
29DER2
pwalker on PROD1PC60 with RULES2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
(ii) With regard to which the DOE has
or had:
(A) A proprietary interest; or
(B) Entered into a contract with an
entity to provide management and
operation, management and integration,
environmental remediation services,
construction, or maintenance services.
(2) DOL has adopted the
determinations of the Department of
Energy regarding Department of Energy
facilities that were contained in the list
of facilities published in the Federal
Register on August 23, 2004 (69 FR
51825). DOL will periodically update
this list as it deems appropriate in its
sole discretion by publishing a revised
list of Department of Energy facilities in
the Federal Register.
(y) Disability means, for purposes of
determining entitlement to payment of
Part B benefits under section 7384s(a)(1)
of the Act, having been determined by
OWCP to have or have had established
chronic beryllium disease, cancer, or
chronic silicosis.
(z) Eligible surviving beneficiary
means any individual who is entitled
under sections 7384s(e), 7384u(e), or
7385s–3(c) and (d) of the Act to receive
a payment on behalf of a deceased
covered Part B employee or a deceased
covered Part E employee.
(aa) Employee means either a current
or former employee.
(bb) Occupational illness means,
under Part B of the Act, a covered
beryllium illness, cancer sustained in
the performance of duty as defined in
§ 30.210(a), specified cancer, chronic
silicosis, or an illness for which DOJ has
awarded compensation under section 5
of RECA.
(cc) OWCP means the Office of
Workers’ Compensation Programs,
United States Department of Labor. One
of the four divisions of OWCP is the
Division of Energy Employees
Occupational Illness Compensation.
(dd) Physician includes surgeons,
podiatrists, dentists, clinical
psychologists, optometrists,
chiropractors, and osteopathic
practitioners within the scope of their
practice as defined by state law. The
term ‘‘physician’’ includes chiropractors
only to the extent that their
reimbursable services are limited to
treatment consisting of manual
manipulation of the spine to correct a
subluxation as demonstrated by x-ray to
exist.
(ee) Qualified physician means any
physician who has not been excluded
under the provisions of subpart H of this
part. Except as otherwise provided by
regulation, a qualified physician shall
be deemed to be designated or approved
by OWCP.
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
(ff) Specified cancer (as defined in
section 4(b)(2) of RECA and in
EEOICPA) means:
(1) Leukemia (other than chronic
lymphocytic leukemia) provided that
the onset of the disease was at least 2
years after first exposure;
(2) Lung cancer (other than in situ
lung cancer that is discovered during or
after a post-mortem exam);
(3) Bone cancer;
(4) Renal cancers; or
(5) The following diseases, provided
onset was at least 5 years after first
exposure:
(i) Multiple myeloma;
(ii) Lymphomas (other than Hodgkin’s
disease); and
(iii) Primary cancer of the:
(A) Thyroid;
(B) Male or female breast;
(C) Esophagus;
(D) Stomach;
(E) Pharynx;
(F) Small intestine;
(G) Pancreas;
(H) Bile ducts;
(I) Gall bladder;
(J) Salivary gland;
(K) Urinary bladder;
(L) Brain;
(M) Colon;
(N) Ovary; or
(O) Liver (except if cirrhosis or
hepatitis B is indicated).
(6) The specified diseases designated
in this section mean the physiological
condition or conditions that are
recognized by the National Cancer
Institute under those names or
nomenclature, or under any previously
accepted or commonly used names or
nomenclature.
(gg) Survivor means:
(1) For claims under Part B of the Act,
and subject to paragraph (gg)(3) of this
section, a surviving spouse, child,
parent, grandchild and grandparent of a
deceased covered Part B employee.
(2) For claims under Part E of the Act,
and subject to paragraph (gg)(3) of this
section, a surviving spouse and child of
a deceased covered Part E employee.
(3) Those individuals listed in
paragraphs (gg)(1) and (gg)(2) of this
section do not include any individuals
not living as of the time OWCP makes
a lump-sum payment or payments to an
eligible surviving beneficiary or
beneficiaries.
(hh) Time of injury means:
(1) In regard to a claim arising out of
exposure to beryllium or silica, the last
date on which a covered Part B
employee was exposed to such
substance in the performance of duty in
accordance with sections 7384n(a) or
7384r(c) of the Act; or
(2) In regard to a claim arising out of
exposure to radiation under Part B, the
PO 00000
Frm 00021
Fmt 4701
Sfmt 4700
78539
last date on which a covered Part B
employee was exposed to radiation in
the performance of duty in accordance
with section 7384n(b) of the Act or, in
the case of a member of the Special
Exposure Cohort, the last date on which
the member of the Special Exposure
Cohort was employed at the Department
of Energy facility or the atomic weapons
employer facility at which the member
was exposed to radiation; or
(3) In regard to a claim arising out of
exposure to a toxic substance, the last
date on which a covered Part E
employee was employed at the
Department of Energy facility or RECA
section 5 facility, as appropriate, at
which the exposure took place.
(ii) Toxic substance means any
material that has the potential to cause
illness or death because of its
radioactive, chemical, or biological
nature.
(jj) Workday means a single workshift
whether or not it occurred on more than
one calendar day.
Information in Program Records
§ 30.10 Are all OWCP records relating to
claims filed under EEOICPA considered
confidential?
All OWCP records relating to claims
for benefits under EEOICPA are
considered confidential and may not be
released, inspected, copied or otherwise
disclosed except as provided in the
Freedom of Information Act and the
Privacy Act of 1974.
§ 30.11 Who maintains custody and
control of claim records?
All OWCP records relating to claims
for benefits filed under the Act are
covered by the Privacy Act system of
records entitled DOL/ESA–49 (Office of
Workers’ Compensation Programs,
Energy Employees Occupational Illness
Compensation Program Act File). This
system of records is maintained by and
under the control of OWCP, and, as
such, all records covered by DOL/ESA–
49 are official records of OWCP. The
protection, release, inspection and
copying of records covered by DOL/
ESA–49 shall be accomplished in
accordance with the rules, guidelines
and provisions of this part, as well as
those contained in 29 CFR parts 70 and
71, and with the notice of the system of
records and routine uses published in
the Federal Register. All questions
relating to access, disclosure, and/or
amendment of claims records
maintained by OWCP are to be resolved
in accordance with this section.
E:\FR\FM\29DER2.SGM
29DER2
78540
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
§ 30.12 What process is used by a person
who wants to obtain copies of or amend
EEOICPA claim records?
(a) A claimant seeking copies of his or
her official EEOICPA file should address
a request to the District Director of the
OWCP district office having custody of
the file.
(b) Any request to amend a record
covered by DOL/ESA–49 should be
directed to the district office having
custody of the official file.
(c) Any administrative appeal taken
from a denial issued by OWCP under
this section shall be filed with the
Solicitor of Labor in accordance with 29
CFR 71.7 and 71.9.
Rights and Penalties
§ 30.15 May EEOICPA benefits be
assigned, transferred or garnished?
(a) Pursuant to section 7385f(a) of the
Act, no claim for EEOICPA benefits may
be assigned or transferred.
(b) Provisions of the Social Security
Act (42 U.S.C. 659) and regulations
issued by the Office of Personnel
Management at 5 CFR part 581 permit
the garnishment of payments of
EEOICPA monetary benefits to collect
overdue alimony and child support. A
request to garnish a payment for either
of these purposes should be submitted
to the district office that is handling the
EEOICPA claim, and must be
accompanied by a copy of the pertinent
state agency or court order.
§ 30.16 What penalties may be imposed in
connection with a claim under the Act?
pwalker on PROD1PC60 with RULES2
(a) Other statutory provisions make it
a crime to file a false or fraudulent claim
or statement with the federal
government in connection with a claim
under the Act. Included among these
provisions is 18 U.S.C. 1001.
Enforcement of criminal provisions that
may apply to claims under the Act is
within the jurisdiction of the
Department of Justice.
(b) In addition, administrative
proceedings may be initiated under the
Program Fraud Civil Remedies Act of
1986 (PFCRA), 31 U.S.C. 3801 et seq., to
impose civil penalties and assessments
against persons or entities who make,
submit or present, or cause to be made,
submitted or presented, false, fictitious
or fraudulent claims or written
statements to OWCP in connection with
a claim under EEOICPA. The
Department’s regulations implementing
PFCRA are found at 29 CFR part 22.
§ 30.17 Is a beneficiary who defrauds the
government in connection with a claim for
EEOICPA benefits still entitled to those
benefits?
When a beneficiary either pleads
guilty to or is found guilty on either
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
federal or state criminal charges of
defrauding the federal or a state
government in connection with a claim
for benefits under the Act or any other
federal or state workers’ compensation
law, the beneficiary forfeits (effective
the date either the guilty plea is
accepted or a verdict of guilty is
returned after trial) any entitlement to
any further benefits for any injury,
illness or death covered by this part for
which the time of injury was on or
before the date of such guilty plea or
verdict. Any subsequent change in or
recurrence of the beneficiary’s medical
condition does not affect termination of
entitlement under this section.
Subpart B—Filing Claims; Evidence
and Burden of Proof; Special
Procedures for Certain Cancer Claims
Filing Claims for Benefits Under
EEOICPA
§ 30.100 In general, how does an employee
file an initial claim for benefits?
(a) To claim benefits under EEOICPA,
an employee must file a claim in
writing. Form EE–1 should be used for
this purpose, but any written
communication that requests benefits
under EEOICPA will be considered a
claim. It will, however, be necessary for
an employee to submit a Form EE–1 for
OWCP to fully develop the claim.
Copies of Form EE–1 may be obtained
from OWCP or on the Internet at
https://www.dol.gov/esa/regs/
compliance/owcp/eeoicp/main.htm.
The employee’s claim must be filed
with OWCP, but another person may do
so on the employee’s behalf.
(b) The employee may choose, at his
or her own option, to file for benefits for
only certain conditions that are
potentially compensable under the Act
(e.g., the employee may not want to
claim for an occupational illness or a
covered illness for which a payment has
been received that would necessitate an
offset of EEOICPA benefits under the
provisions of § 30.505(b) of these
regulations). The employee may
withdraw his or her claim by so
requesting in writing to OWCP at any
time before OWCP determines his or her
eligibility for benefits.
(c) Except as provided in paragraph
(d) of this section, a claim is considered
to be ‘‘filed’’ on the date that the
employee mails his or her claim to
OWCP, as determined by postmark, or
on the date that the claim is received by
OWCP, whichever is the earliest
determinable date. However, in no event
will a claim under Part B of EEOICPA
be considered to be ‘‘filed’’ earlier than
July 31, 2001, nor will a claim under
PO 00000
Frm 00022
Fmt 4701
Sfmt 4700
Part E of EEOICPA be considered to be
‘‘filed’’ earlier than October 30, 2000.
(1) The employee, or the person filing
the claim on behalf of the employee,
shall affirm that the information
provided on the Form EE–1 is true, and
must inform OWCP of any subsequent
changes to that information.
(2) Except for a covered uranium
employee filing a claim under Part B of
the Act, the employee is responsible for
submitting with his or her claim, or
arranging for the submission of, medical
evidence to OWCP that establishes that
he or she sustained an occupational
illness and/or a covered illness. This
required medical evidence is described
in § 30.114 and does not refer to mere
recitations of symptoms the employee
experienced that the employee believes
indicate that he or she sustained an
occupational illness or a covered illness.
(d) For those claims under Part E of
EEOICPA that were originally filed with
DOE as claims for assistance under
former section 7385o of EEOICPA
(which was repealed on October 28,
2004), a claim is considered to be
‘‘filed’’ on the date that the employee
mailed his or her claim to DOE, as
determined by postmark, or on the date
that the claim was received by DOE,
whichever is the earliest determinable
date. However, in no event will a claim
referred to in this paragraph be
considered to be ‘‘filed’’ earlier than
October 30, 2000.
§ 30.101 In general, how is a survivor’s
claim filed?
(a) A survivor of an employee who
sustained an occupational illness or a
covered illness must file a claim for
compensation in writing. Form EE–2
should be used for this purpose, but any
written communication that requests
survivor benefits under the Act will be
considered a claim. It will, however, be
necessary for a survivor to submit a
Form EE–2 for OWCP to fully develop
the claim. Copies of Form EE–2 may be
obtained from OWCP or on the Internet
at https://www.dol.gov/esa/regs/
compliance/owcp/eeoicp/main.htm.
The survivor’s claim must be filed with
OWCP, but another person may do so on
the survivor’s behalf. Although only one
survivor needs to file a claim under this
section to initiate the development
process, OWCP will distribute any
monetary benefits payable on the claim
among all eligible surviving
beneficiaries who have filed claims with
OWCP.
(b) A survivor may choose, at his or
her own option, to file for benefits for
only certain conditions that are
potentially compensable under the Act
(e.g., the survivor may not want to claim
E:\FR\FM\29DER2.SGM
29DER2
pwalker on PROD1PC60 with RULES2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
for an occupational illness or a covered
illness for which a payment has been
received that would necessitate an offset
of EEOICPA benefits under the
provisions of § 30.505(b) of these
regulations). The survivor may
withdraw his or her claim by so
requesting in writing to OWCP at any
time before OWCP determines his or her
eligibility for benefits.
(c) A survivor must be alive to receive
any payment under EEOICPA; there is
no vested right to such payment.
(d) Except as provided in paragraph
(e) of this section, a survivor’s claim is
considered to be ‘‘filed’’ on the date that
the survivor mails his or her claim to
OWCP, as determined by postmark, or
the date that the claim is received by
OWCP, whichever is the earliest
determinable date. However, in no event
will a survivor’s claim under Part B of
the Act be considered to be ‘‘filed’’
earlier than July 31, 2001, nor will a
survivor’s claim under Part E of the Act
be considered to be ‘‘filed’’ earlier than
October 30, 2000.
(1) The survivor, or the person filing
the claim on behalf of the survivor, shall
affirm that the information provided on
the Form EE–2 is true, and must inform
OWCP of any subsequent changes to
that information.
(2) Except for the survivor of a
covered uranium employee claiming
under Part B of the Act, the survivor is
responsible for submitting, or arranging
for the submission of, evidence to
OWCP that establishes that the
employee upon whom the survivor’s
claim is based was eligible for such
benefits, including medical evidence
that establishes that the employee
sustained an occupational illness or a
covered illness. This required medical
evidence is described in § 30.114 and
does not refer to mere recitations by the
survivor of symptoms the employee
experienced that the survivor believes
indicate that the employee sustained an
occupational illness or a covered illness.
(e) For those claims under Part E of
EEOICPA that were originally filed with
DOE as claims for assistance under
former section 7385o of EEOICPA
(which was repealed on October 28,
2004), a claim is considered to be
‘‘filed’’ on the date that the survivor
mailed his or her claim to DOE, as
determined by postmark, or on the date
that the claim was received by DOE,
whichever is the earliest determinable
date. However, in no event will a claim
referred to in this paragraph be
considered to be ‘‘filed’’ earlier than
October 30, 2000.
(f) A spouse or a child of a deceased
DOE contractor employee or RECA
section 5 uranium worker, who is not a
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
covered spouse or covered child under
Part E, may submit a written request to
OWCP for a determination of whether
that deceased DOE contractor employee
or RECA section 5 uranium worker
contracted a covered illness under
section 7385s–4(d) of EEOICPA.
(1) Any such request submitted
pursuant to paragraph (f) of this section
will not be considered a survivor’s
claim for benefits under Part E of the
Act.
(2) As part of its consideration of any
request submitted pursuant to paragraph
(f) of this section, OWCP will apply the
eligibility criteria in subpart C of this
part. However, the adjudicatory
procedures contained in subpart D of
this part will not apply to OWCP’s
consideration of such a request, and
OWCP’s response to the request will not
constitute a final agency decision on
entitlement to any benefits under
EEOICPA.
§ 30.102 In general, how does an employee
file a claim for additional impairment or
wage-loss under Part E of EEOICPA?
(a) An employee previously awarded
impairment benefits by OWCP may file
a claim for additional impairment
benefits. Such claim must be based on
an increase in the employee’s minimum
impairment rating attributable to the
covered illness or illnesses from the
impairment rating that formed the basis
for the last award of such benefits by
OWCP. OWCP will only adjudicate
claims for such an increased rating that
are filed at least two years from the date
of the last award of impairment benefits.
However, OWCP will not wait two years
before it will adjudicate a claim for
additional impairment that is based on
an allegation that the employee
sustained a new covered illness.
(b) An employee previously awarded
wage-loss benefits by OWCP may be
eligible for additional wage-loss benefits
for periods of wage-loss that were not
addressed in a prior claim only if the
employee had not reached his or her
Social Security retirement age at the
time of the prior award. OWCP will
adjudicate claims filed on a yearly basis
in connection with each succeeding
calendar year for which qualifying
wage-loss under Part E is alleged, as
well as claims that aggregate calendar
years for which qualifying wage-loss is
alleged.
(c) Employees should use Form EE–10
to claim for additional impairment or
wage-loss benefits under Part E of
EEOICPA.
(1) The employee, or the person filing
the claim on behalf of the employee,
shall affirm that the information
provided on Form EE–10 is true, and
PO 00000
Frm 00023
Fmt 4701
Sfmt 4700
78541
must inform OWCP of any subsequent
changes to that information.
(2) The employee is responsible for
submitting with any claim filed under
this section, or arranging for the
submission of, factual and medical
evidence establishing that he or she
experienced another calendar year of
qualifying wage-loss, and/or medical
evidence establishing that he or she has
an increased minimum impairment
rating, as appropriate.
§ 30.103 How does a claimant make sure
that OWCP has the evidence necessary to
process the claim?
(a) Claims and certain required
submissions should be made on forms
prescribed by OWCP. Persons
submitting forms shall not modify these
forms or use substitute forms.
Form No.
Title
(1) EE–1
Claim for Benefits Under the Energy Employees Occupational
Illness Compensation Program
Act.
Claim for Survivor Benefits Under
the Energy Employees Occupational Illness Compensation Program Act.
Employment History for a Claim
Under the Energy Employees
Occupational Illness Compensation Program Act.
Employment History Affidavit for a
Claim Under the Energy Employees Occupational Illness
Compensation Program Act.
(2) EE–2
(3) EE–3
(4) EE–4
(b) Copies of the forms listed in this
section are available for public
inspection at the Office of Workers’
Compensation Programs, Employment
Standards Administration, U.S.
Department of Labor, Washington, DC
20210. They may also be obtained from
OWCP district offices and on the
Internet at https://www.dol.gov/esa/regs/
compliance/owcp/eeoicp/main.htm.
Verification of Alleged Employment
§ 30.105 What must DOE do after an
employee or survivor files a claim?
(a) After it receives a claim for
benefits described in §§ 30.100 or
30.101, OWCP may request that DOE
verify the employment history provided
by the claimant. Upon receipt of such a
request, DOE will complete Form EE–5
as soon as possible and transmit the
completed form to OWCP. On this form,
DOE will certify either that it concurs
with the employment history provided
by the claimant, that it disagrees with
such history, or that it can neither
concur nor disagree after making a
reasonable search of its records and also
making a reasonable effort to locate
E:\FR\FM\29DER2.SGM
29DER2
78542
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
pertinent records not already in its
possession.
(b) Claims for additional impairment
or wage-loss benefits under Part E of the
Act described in § 30.102 will not
require any verification of employment
by DOE, since OWCP will have made
any required findings on this particular
issue when it adjudicated the
employee’s initial claim for benefits.
§ 30.106 Can OWCP request employment
verification from other sources?
(a) For most claims filed under
EEOICPA, DOE has access to sufficient
factual information to enable it to fulfill
its obligations described in § 30.105(a).
However, in instances where it lacks
such information, DOE may arrange for
other entities to provide OWCP with the
information necessary to verify an
employment history submitted as part of
a claim. These other entities may consist
of either current or former DOE
contractors and subcontractors, atomic
weapons employers, beryllium vendors,
or other entities with access to relevant
employment information.
(b) On its own initiative, OWCP may
also arrange for entities other than DOE
to perform the employment verification
duties described in § 30.105(a).
Evidence and Burden of Proof
pwalker on PROD1PC60 with RULES2
§ 30.110 Who is entitled to compensation
under the Act?
(a) Under Part B of EEOICPA,
compensation is payable to the
following covered Part B employees, or
their survivors:
(1) A ‘‘covered beryllium employee’’
(as described in § 30.205(a)) with a
covered beryllium illness (as defined in
§ 30.5(o)) who was exposed to beryllium
in the performance of duty (in
accordance with § 30.206).
(2) A ‘‘covered Part B employee with
cancer’’ (as described in § 30.210(a)).
(3) A ‘‘covered Part B employee with
chronic silicosis’’ (as described in
§ 30.220).
(4) A ‘‘covered uranium employee’’
(as defined in § 30.5(s)).
(b) Under Part E of EEOICPA,
compensation is payable to a ‘‘covered
Part E employee’’ (as defined in
§ 30.5(p)), or his or her survivors.
(c) Any claim that does not meet all
of the criteria for at least one of these
categories, as set forth in the regulations
in this part, must be denied.
(d) All claims for benefits under the
Act must comply with the claims
procedures and requirements set forth
in subpart B of this part before any
payment can be made from the Fund.
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
§ 30.111 What is the claimant’s
responsibility with respect to burden of
proof, production of documents,
presumptions, and affidavits?
(a) Except where otherwise provided
in the Act and these regulations, the
claimant bears the burden of proving by
a preponderance of the evidence the
existence of each and every criterion
necessary to establish eligibility under
any compensable claim category set
forth in § 30.110. Proof by a
preponderance of the evidence means
that it is more likely than not that the
proposition to be proved is true. Subject
to the exceptions expressly provided in
the Act and the regulations in this part,
the claimant also bears the burden of
providing to OWCP all written medical
documentation, contemporaneous
records, or other records and documents
necessary to establish any and all
criteria for benefits set forth in these
regulations.
(b) In the event that the claim lacks
required information or supporting
documentation, OWCP will notify the
claimant of the deficiencies and provide
him or her an opportunity for correction
of the deficiencies.
(c) Written affidavits or declarations,
subject to penalty for perjury, by the
employee, survivor or any other person,
will be accepted as evidence of
employment history and survivor
relationship for purposes of establishing
eligibility and may be relied on in
determining whether a claim meets the
requirements of the Act for benefits if,
and only if, such person attests that due
diligence was used to obtain records in
support of the claim, but that no records
exist.
(d) A claimant will not be entitled to
any presumption otherwise provided for
in these regulations if substantial
evidence exists that rebuts the existence
of the fact that is the subject of the
presumption. Substantial evidence
means such relevant evidence as a
reasonable mind might accept as
adequate to support a conclusion. When
such evidence exists, the claimant shall
be notified and afforded the opportunity
to submit additional written medical
documentation or records.
not required to submit all of the
evidence listed above. A claimant may
submit other evidence not listed above
to establish covered employment. To be
acceptable as evidence, all documents
and records must be legible. OWCP will
accept photocopies, certified copies,
and original documents and records.
(b) Pursuant to §§ 30.105 and/or
30.106, DOE or another entity verifying
alleged employment shall certify that it
concurs with the employment
information provided by the claimant,
that it disagrees with the information
provided by the claimant, or, after a
reasonable search of its records and a
reasonable effort to locate pertinent
records not already in its possession, it
can neither concur nor disagree with the
information provided by the claimant.
(1) If DOE or another entity certifies
that it concurs with the employment
information provided by the claimant,
then the criterion for covered
employment will be established.
(2) If DOE or another entity certifies
that it disagrees with the information
provided by the claimant or that after a
reasonable search of its records and a
reasonable effort to locate pertinent
records not already in its possession it
can neither concur nor disagree with the
information provided by the claimant,
OWCP will evaluate the evidence
submitted by the claimant to determine
whether the claimant has established
covered employment by a
preponderance of the evidence. OWCP
may request additional evidence from
the claimant to demonstrate that the
claimant has met the criterion for
covered employment. Nothing in this
section shall be construed to limit
OWCP’s ability to require additional
documentation.
(3) If the only evidence of covered
employment is a self-serving affidavit
and DOE or another entity either
disagrees with the assertion of covered
employment or cannot concur or
disagree with the assertion of covered
employment, then OWCP may reject the
claim based upon a lack of evidence of
covered employment.
§ 30.112 What kind of evidence is needed
to establish covered employment and how
will that evidence be evaluated?
§ 30.113 What are the requirements for
written medical documentation,
contemporaneous records, and other
records or documents?
(a) Evidence of covered employment
may include: employment records; pay
stubs; tax returns; Social Security
records; and written affidavits or
declarations, subject to penalty of
perjury, by the employee, survivor or
any other person. However, no one
document is required to establish
covered employment and a claimant is
(a) All written medical
documentation, contemporaneous
records, and other records or documents
submitted by an employee or his or her
survivor to prove any criteria provided
for in these regulations must be legible.
OWCP will accept photocopies, certified
copies, and original documents and
records.
PO 00000
Frm 00024
Fmt 4701
Sfmt 4700
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
(b) To establish eligibility, the
employee or his or her survivor may be
required to provide, where appropriate,
additional contemporaneous records to
the extent they exist or an authorization
to release additional contemporaneous
records or a statement by the
custodian(s) of the record(s) certifying
that the requested record(s) no longer
exist. Nothing in this section shall be
construed to limit OWCP’s ability to
require additional documentation.
(c) If a claimant submits a certified
statement, by a person with knowledge
of the facts, that the medical records
containing a diagnosis and date of
diagnosis of a covered medical
condition no longer exist, then OWCP
may consider other evidence to
establish a diagnosis and date of
diagnosis of a covered medical
condition. However, if the certified
statement is a self-serving document,
OWCP may reject the claim based upon
a lack of evidence of a covered medical
condition.
pwalker on PROD1PC60 with RULES2
§ 30.114 What kind of evidence is needed
to establish a compensable medical
condition and how will that evidence be
evaluated?
(a) Evidence of a compensable
medical condition may include: a
physician’s report, laboratory reports,
hospital records, death certificates, xrays, magnetic resonance images or
reports, computer axial tomography or
other imaging reports, lymphocyte
proliferation testings, beryllium patch
tests, pulmonary function or exercise
testing results, pathology reports
including biopsy results and other
medical records. A claimant is not
required to submit all of the evidence
listed in this paragraph. A claimant may
submit other evidence that is not listed
in this paragraph to establish a
compensable medical condition.
Nothing in this section shall be
construed to limit OWCP’s ability to
require additional documentation.
(b) The medical evidence submitted
will be used to establish the diagnosis
and the date of diagnosis of the
compensable medical condition.
(1) For covered beryllium illnesses,
additional medical evidence, as set forth
in § 30.207, is required to establish a
beryllium illness.
(2) For chronic silicosis, additional
medical evidence, as set forth in
§ 30.222, is required to establish chronic
silicosis.
(3) For consequential injuries,
illnesses, impairments or diseases, the
claimant must also submit a physician’s
fully rationalized medical report
showing a causal relationship between
the resulting injury, illness, impairment
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
or disease and the compensable medical
condition.
(c) OWCP will evaluate the medical
evidence in accordance with recognized
and accepted diagnostic criteria used by
physicians to determine whether the
claimant has established the medical
condition for which compensation is
sought in accordance with the
requirements of the Act.
Special Procedures for Certain
Radiogenic Cancer Claims
§ 30.115 For those radiogenic cancer
claims that do not seek benefits under Part
B of the Act pursuant to the Special
Exposure Cohort provisions, what will
OWCP do once it determines that an
employee contracted cancer?
(a) Other than claims for a nonradiogenic cancer listed by HHS at 42
CFR 81.30, or claims seeking benefits
under Part E of the Act that have
previously been accepted under section
7384u of the Act, or claims previously
accepted under Part B pursuant to the
Special Exposure Cohort provisions,
OWCP will forward the claim package
(including, but not limited to, Forms
EE–1, EE–2, EE–3, EE–4 and EE–5, as
appropriate) to HHS for dose
reconstruction. At that point in time,
development of the claim by OWCP may
be suspended.
(1) This package will include OWCP’s
initial findings in regard to the
diagnosis and date of diagnosis of the
employee, as well as any employment
history compiled by OWCP (including
information such as dates and locations
worked, and job titles). The package,
however, will not constitute either a
recommended or final decision by
OWCP on the claim.
(2) HHS will then reconstruct the
radiation dose of the employee, after
such further development of the
employment history as it may deem
necessary, and provide OWCP, DOE and
the claimant with the final dose
reconstruction report. The final dose
reconstruction record will be delivered
to OWCP with the final dose
reconstruction report and to the
claimant upon request.
(b) Following its receipt of the
reconstructed dose from HHS, OWCP
will resume its adjudication of the
cancer claim and consider whether the
claimant has met the eligibility criteria
set forth in subpart C of this part.
However, during the period before it
receives a reconstructed dose from HHS,
OWCP may continue to develop other
aspects of a claim, to the extent that it
deems such development to be
appropriate.
PO 00000
Frm 00025
Fmt 4701
Sfmt 4700
78543
Subpart C—Eligibility Criteria
General Provisions
§ 30.200 What is the scope of this
subpart?
The regulations in this subpart
describe the criteria for eligibility for
benefits for claims under Part B of
EEOICPA relating to covered beryllium
illness under sections 7384l, 7384n,
7384s and 7384t of the Act; for cancer
under sections 7384l, 7384n, 7384q and
7384t of the Act; for chronic silicosis
under sections 7384l, 7384r, 7384s and
7384t of the Act; and for claims relating
to covered uranium employees under
sections 7384t and 7384u of the Act.
These regulations also describe the
criteria for eligibility for benefits for
claims under Part E of EEOICPA relating
to covered illnesses under sections
7385s–4 and 7385s–5 of the Act. This
subpart describes the type and extent of
evidence that will be necessary to
establish the criteria for eligibility for
compensation for these illnesses.
Eligibility Criteria for Claims Relating
to Covered Beryllium Illness Under
Part B of EEOICPA
§ 30.205 What are the criteria for eligibility
for benefits relating to beryllium illnesses
covered under Part B of EEOICPA?
To establish eligibility for benefits
under this section, the claimant must
establish the criteria set forth in both
paragraphs (a) and (b) of this section:
(a) The employee is a covered
beryllium employee only if the criteria
in paragraphs (a)(1) and (a)(3) of this
section, or (a)(2) and (a)(3) of this
section, are established:
(1) The employee is a ‘‘current or
former employee as defined in 5 U.S.C.
8101(1)’’ (see § 30.5(t) of this part) who
may have been exposed to beryllium at
a DOE facility or at a facility owned,
operated, or occupied by a beryllium
vendor; or
(2) The employee is a current or
former civilian employee of:
(i) Any entity that contracted with the
DOE to provide management and
operation, management and integration,
or environmental remediation of a DOE
facility; or
(ii) Any contractor or subcontractor
that provided services, including
construction and maintenance, at such a
facility; or
(iii) A beryllium vendor, or of a
contractor or subcontractor of a
beryllium vendor, during a period when
the vendor was engaged in activities
related to the production or processing
of beryllium for sale to, or use by, the
DOE, including periods during which
environmental remediation of a
E:\FR\FM\29DER2.SGM
29DER2
78544
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
vendor’s facility was undertaken
pursuant to a contract between the
vendor and DOE; and
(3) The civilian employee was
exposed to beryllium in the
performance of duty by establishing that
he or she was, during a period when
beryllium dust, particles, or vapor may
have been present at such a facility:
(i) Employed at a DOE facility (as
defined in § 30.5(x) of this part); or
(ii) Present at a DOE facility, or at a
facility owned, operated, or occupied by
a beryllium vendor, because of his or
her employment by the United States, a
beryllium vendor, a contractor or
subcontractor of a beryllium vendor, or
a contractor or subcontractor of the
DOE. Under this paragraph, exposure to
beryllium in the performance of duty
can be established whether or not the
beryllium that may have been present at
such facility was produced or processed
for sale to, or use by, DOE.
(b) The employee has one of the
following:
(1) Beryllium sensitivity as
established by an abnormal beryllium
LPT performed on either blood or lung
lavage cells.
(2) Established chronic beryllium
disease.
(3) Any injury, illness, impairment, or
disability sustained as a consequence of
the conditions specified in paragraphs
(b)(1) and (2) of this section.
pwalker on PROD1PC60 with RULES2
§ 30.206 How does a claimant prove that
the employee was a ‘‘covered beryllium
employee’’ exposed to beryllium dust,
particles or vapor in the performance of
duty?
(a) Proof of employment at or physical
presence at a DOE facility, or a facility
owned, operated, or occupied by a
beryllium vendor, because of
employment by the United States, a
beryllium vendor, or a contractor or
subcontractor of a beryllium vendor
during a period when beryllium dust,
particles, or vapor may have been
present at such a facility, may be made
by the submission of any trustworthy
records that, on their face or in
conjunction with other such records,
establish that the employee was
employed or present at a covered
facility and the time period of such
employment or presence.
(b) If the evidence shows that
exposure occurred while the employee
was employed or present at a facility
during a time frame that is outside the
relevant time frame indicated for that
facility, OWCP may request that DOE
provide additional information on the
facility. OWCP will determine whether
the evidence of record supports
enlarging the relevant time frame for
that facility.
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
(c) If the evidence shows that
exposure occurred while the employee
was employed or present at a facility
that would have to be designated by
DOE as a beryllium vendor under
section 7384m of the Act to be a covered
facility, and that the facility has not
been so designated, OWCP will deny the
claim on the ground that the facility is
not a covered facility.
(d) Records from the following
sources may be considered as evidence
for purposes of establishing
employment or presence at a covered
facility:
(1) Records or documents created by
any federal government agency
(including verified information
submitted for security clearance), any
tribal government, or any state, county,
city or local government office, agency,
department, board or other entity, or
other public agency or office.
(2) Records or documents created by
any vendor, processor, or producer of
beryllium or related products
designated as a beryllium vendor by the
DOE in accordance with section 7384m
of the Act.
(3) Records or documents created as a
by product of any regularly conducted
business activity or by an entity that
acted as a contractor or subcontractor to
the DOE.
§ 30.207 How does a claimant prove a
diagnosis of a beryllium disease covered
under Part B?
(a) Written medical documentation is
required in all cases to prove that the
employee developed a covered
beryllium illness. Proof that the
employee developed a covered
beryllium illness must be made by using
the procedures outlined in paragraphs
(b), (c), or (d) of this section.
(b) Beryllium sensitivity or
sensitization is established with an
abnormal LPT performed on either
blood or lung lavage cells.
(c) Chronic beryllium disease is
established in the following manner:
(1) For diagnoses on or after January
1, 1993, beryllium sensitivity (as
established in accordance with
paragraph (b) of this section), together
with lung pathology consistent with
chronic beryllium disease, including the
following:
(i) A lung biopsy showing granulomas
or a lymphocytic process consistent
with chronic beryllium disease;
(ii) A computerized axial tomography
scan showing changes consistent with
chronic beryllium disease; or
(iii) Pulmonary function or exercise
testing showing pulmonary deficits
consistent with chronic beryllium
disease.
PO 00000
Frm 00026
Fmt 4701
Sfmt 4700
(2) For diagnoses before January 1,
1993, the presence of the following:
(i) Occupational or environmental
history, or epidemiologic evidence of
beryllium exposure; and
(ii) Any three of the following criteria:
(A) Characteristic chest radiographic
(or computed tomography (CT))
abnormalities.
(B) Restrictive or obstructive lung
physiology testing or diffusing lung
capacity defect.
(C) Lung pathology consistent with
chronic beryllium disease.
(D) Clinical course consistent with a
chronic respiratory disorder.
(E) Immunologic tests showing
beryllium sensitivity (skin patch test or
beryllium blood test preferred).
(d) An injury, illness, impairment or
disability sustained as a consequence of
beryllium sensitivity or established
chronic beryllium disease must be
established with a fully rationalized
medical report by a physician that
shows the relationship between the
injury, illness, impairment or disability
and the beryllium sensitivity or
established chronic beryllium disease.
Neither the fact that the injury, illness,
impairment or disability manifests itself
after a diagnosis of beryllium sensitivity
or established chronic beryllium
disease, nor the belief of the claimant
that the injury, illness, impairment or
disability was caused by the beryllium
sensitivity or established chronic
beryllium disease, is sufficient in itself
to prove a causal relationship.
Eligibility Criteria for Claims Relating
to Radiogenic Cancer Under Parts B
and E of EEOICPA
§ 30.210 What are the criteria for eligibility
for benefits relating to radiogenic cancer?
(a) To establish eligibility for benefits
for radiogenic cancer under Part B of
EEOICPA, an employee or his or her
survivor must show that:
(1) The employee has been diagnosed
with one of the forms of cancer
specified in § 30.5(ff) of this part; and
(i) Is a member of the Special
Exposure Cohort (as described in
§ 30.214(a) of this subpart) who, as a
civilian DOE employee or civilian DOE
contractor employee, contracted the
specified cancer after beginning
employment at a DOE facility; or
(ii) Is a member of the Special
Exposure Cohort (as described in
§ 30.214(a) of this subpart) who, as a
civilian atomic weapons employee,
contracted the specified cancer after
beginning employment at an atomic
weapons employer facility (as defined
in § 30.5(e)); or
(2) The employee has been diagnosed
with cancer; and
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
(i)(A) Is/was a civilian DOE employee
who contracted that cancer after
beginning employment at a DOE facility;
or
(B) Is/was a civilian DOE contractor
employee who contracted that cancer
after beginning employment at a DOE
facility; or
(C) Is/was a civilian atomic weapons
employee who contracted that cancer
after beginning employment at an
atomic weapons employer facility; and
(ii) The cancer was at least as likely
as not related to the employment at the
DOE facility or atomic weapons
employer facility; or
(3) The employee has been diagnosed
with an injury, illness, impairment or
disease that arose as a consequence of
the accepted cancer.
(b)(1) To establish eligibility for
benefits for radiogenic cancer under Part
E of EEOICPA, an employee or his or
her survivor must show that:
(i) The employee has been diagnosed
with cancer; and
(A) Is/was a civilian DOE contractor
employee or a civilian RECA section 5
uranium worker who contracted that
cancer after beginning employment at a
DOE facility or a RECA section 5
facility; and
(B) The cancer was at least as likely
as not related to exposure to a toxic
substance of a radioactive nature at a
DOE facility or a RECA section 5
facility; and
(C) It is at least as likely as not that
the exposure to such toxic substance(s)
was related to employment at a DOE
facility or a RECA section 5 facility; or
(ii) The employee has been diagnosed
with an injury, illness, impairment or
disease that arose as a consequence of
the accepted cancer.
(2) Eligibility for benefits for
radiogenic cancer under Part E in a
claim that has previously been accepted
under Part B pursuant to the Special
Exposure Cohort provisions is described
in § 30.230(a) of these regulations.
§ 30.211 How does a claimant establish
that the employee has or had contracted
cancer?
pwalker on PROD1PC60 with RULES2
A claimant establishes that the
employee has or had contracted a
specified cancer (as defined in § 30.5(ff))
or other cancer with medical evidence
that sets forth an explicit diagnosis of
cancer and the date on which that
diagnosis was first made.
§ 30.212 How does a claimant establish
that the employee contracted cancer after
beginning employment at a DOE facility, an
atomic weapons employer facility or a
RECA section 5 facility?
(a) Proof of employment by the DOE
or a DOE contractor at a DOE facility, or
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
by an atomic weapons employer at an
atomic weapons employer facility, or at
a RECA section 5 facility, may be made
by the submission of any trustworthy
records that, on their face or in
conjunction with other such records,
establish that the employee was so
employed and the time period(s) of such
employment.
(b)(1) Except as provided in paragraph
(b)(2) of this section, if the evidence
shows that exposure occurred while the
employee was employed at a facility
during a time frame that is outside the
relevant period indicated for that
facility, OWCP may request that DOE
provide additional information on the
facility. OWCP will determine whether
the evidence of record supports
enlarging the relevant period for that
facility.
(2) OWCP may choose not to request
that DOE provide additional
information on an atomic weapons
employer facility that NIOSH reported
had a potential for significant residual
radiation contamination in its report
dated October 2003 and titled ‘‘Report
on Residual Radioactive and Beryllium
Contamination at Atomic Weapons
Employer Facilities and Beryllium
Vendor Facilities,’’ or any update to that
report, if the evidence referred to in
paragraph (a) of this section establishes
that the employee was employed at that
facility during a period when NIOSH
reported that it had a potential for
significant residual radiation
contamination.
(c) If the evidence shows that
exposure occurred while the employee
was employed by an employer that
would have to be designated by DOE as
an atomic weapons employer under
section 7384l(4) of the Act to be a
covered employer, and that the
employer has not been so designated,
OWCP will deny the claim on the
ground that the employer is not a
covered atomic weapons employer.
(d) Records from the following
sources may be considered as evidence
for purposes of establishing
employment or presence at a covered
facility:
(1) Records or documents created by
any federal government agency
(including verified information
submitted for security clearance), any
tribal government, or any state, county,
city or local government office, agency,
department, board or other entity, or
other public agency or office.
(2) Records or documents created as a
byproduct of any regularly conducted
business activity or by an entity that
acted as a contractor or subcontractor to
the DOE.
PO 00000
Frm 00027
Fmt 4701
Sfmt 4700
78545
§ 30.213 How does a claimant establish
that the radiogenic cancer was at least as
likely as not related to employment at the
DOE facility, the atomic weapons employer
facility, or the RECA section 5 facility?
(a) HHS, with the advice of the
Advisory Board on Radiation and
Worker Health, has issued regulatory
guidelines at 42 CFR part 81 that OWCP
uses to determine whether radiogenic
cancers claimed under Parts B and E
were at least as likely as not related to
employment at a DOE facility, an atomic
weapons employer facility, or a RECA
section 5 facility, as appropriate.
Persons should consult HHS’s
regulations for information regarding
the factual evidence that will be
considered by OWCP, in addition to the
employee’s radiation dose
reconstruction that will be provided to
OWCP by HHS, in making this
particular factual determination.
(b) HHS’s regulations satisfy the legal
requirements in section 7384n(c) of the
Act, which also sets out OWCP’s
obligation to use them in its
adjudication of claims for radiogenic
cancer filed under Part B of the Act, and
provide the factual basis for OWCP to
determine if the ‘‘probability of
causation’’ (PoC) that an employee’s
cancer was sustained in the
performance of duty is 50% or greater
(i.e., it is ‘‘at least as likely as not’’
causally related to employment), as
required under section 7384n(b).
(c) OWCP also uses HHS’s regulations
when it makes the determination
required by section 7385s–4(c)(1)(A) of
the Act, since those regulations provide
the factual basis for OWCP to determine
if ‘‘it is at least as likely as not’’ that
exposure to radiation at a DOE facility
or RECA section 5 facility, as
appropriate, was a significant factor in
aggravating, contributing to, or causing
the employee’s radiogenic cancer
claimed under Part E. For cancer claims
under Part E, if the PoC is less than 50%
and the claimant alleges that the
employee was exposed to additional
toxic substances, OWCP will determine
if the claim is otherwise compensable
pursuant to § 30.230(d) of this part.
§ 30.214 How does a claimant establish
that the employee is a member of the
Special Exposure Cohort?
(a) For purposes of establishing
eligibility as a member of the Special
Exposure Cohort (SEC) under
§ 30.210(a)(1), the employee must have
been a DOE employee, a DOE contractor
employee, or an atomic weapons
employee who meets any of the
following requirements:
(1) The employee was so employed
for a number of workdays aggregating at
E:\FR\FM\29DER2.SGM
29DER2
pwalker on PROD1PC60 with RULES2
78546
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
least 250 workdays before February 1,
1992, at a gaseous diffusion plant
located in Paducah, Kentucky;
Portsmouth, Ohio; or Oak Ridge,
Tennessee; and during such
employment:
(i) Was monitored through the use of
dosimetry badges for exposure at the
plant of the external parts of the
employee’s body to radiation; or
(ii) Worked in a job that had
exposures comparable to a job that is or
was monitored through the use of
dosimetry badges.
(2) The employee was so employed
before January 1, 1974, by DOE or a DOE
contractor or subcontractor on Amchitka
Island, Alaska, and was exposed to
ionizing radiation in the performance of
duty related to the Long Shot, Milrow,
or Cannikin underground nuclear tests.
(3) The employee is a member of a
group or class of employees
subsequently designated as additional
members of the SEC by HHS.
(b) For purposes of satisfying the 250
workday requirement of paragraph (a)(1)
of this section, the claimant may
aggregate the days of service at more
than one gaseous diffusion plant.
(c) Proof of employment by the DOE
or a DOE contractor, or an atomic
weapons employer, for the requisite
time periods set forth in paragraph (a)
of this section, may be made by the
submission of any trustworthy records
that, on their face or in conjunction with
other such records, establish that the
employee was so employed and the time
period(s) of such employment. If the
evidence shows that exposure occurred
while the employee was employed by
an employer that would have to be
designated by DOE as an atomic
weapons employer under section
7384l(4) of the Act to be a covered
employer, and that the employer has not
been so designated, OWCP will deny the
claim on the ground that the employer
is not a covered atomic weapons
employer.
(d) Records from the following
sources may be considered as evidence
for purposes of establishing
employment or presence at a covered
facility:
(1) Records or documents created by
any federal government agency
(including verified information
submitted for security clearance), any
tribal government, or any state, county,
city or local government office, agency,
department, board or other entity, or
other public agency or office.
(2) Records or documents created as a
byproduct of any regularly conducted
business activity or by an entity that
acted as a contractor or subcontractor to
the DOE.
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
§ 30.215 How does a claimant establish
that the employee has sustained an injury,
illness, impairment or disease as a
consequence of a diagnosed cancer?
An injury, illness, impairment or
disease sustained as a consequence of a
diagnosed cancer covered by the
provisions of § 30.210 must be
established with a fully rationalized
medical report by a physician that
shows the relationship between the
injury, illness, impairment or disease
and the cancer. Neither the fact that the
injury, illness, impairment or disease
manifests itself after a diagnosis of a
cancer, nor the belief of the claimant
that the injury, illness, impairment or
disease was caused by the cancer, is
sufficient in itself to prove a causal
relationship.
Eligibility Criteria for Claims Relating
to Chronic Silicosis Under Part B of
EEOICPA
§ 30.220 What are the criteria for eligibility
for benefits relating to chronic silicosis?
To establish eligibility for benefits for
chronic silicosis under Part B of
EEOICPA, an employee or his or her
survivor must show that:
(a) The employee is a civilian DOE
employee, or a civilian DOE contractor
employee, who was present for a
number of workdays aggregating at least
250 workdays during the mining of
tunnels at a DOE facility (as defined in
§ 30.5(x)) located in Nevada or Alaska
for tests or experiments related to an
atomic weapon, and has been diagnosed
with chronic silicosis (as defined in
§ 30.5(j)); or
(b) The employee has been diagnosed
with an injury, illness, impairment or
disease that arose as a consequence of
the accepted chronic silicosis.
§ 30.221 How does a claimant prove
exposure to silica in the performance of
duty?
(a) Proof of the employee’s
employment and presence for the
requisite days during the mining of
tunnels at a DOE facility located in
Nevada or Alaska for tests or
experiments related to an atomic
weapon may be made by the submission
of any trustworthy records that, on their
face or in conjunction with other such
records, establish that the employee was
so employed and present at these sites
and the time period(s) of such
employment and presence.
(b) If the evidence shows that
exposure occurred while the employee
was employed and present at a facility
during a time frame that is outside the
relevant time frame indicated for that
facility, OWCP may request that DOE
provide additional information on the
PO 00000
Frm 00028
Fmt 4701
Sfmt 4700
facility. OWCP will determine whether
the evidence of record supports
enlarging the relevant time frame for
that facility.
(c) Records from the following sources
may be considered as evidence for
purposes of establishing proof of
employment or presence at a covered
facility:
(1) Records or documents created by
any federal government agency
(including verified information
submitted for security clearance), any
tribal government, or any state, county,
city or local government office, agency,
department, board or other entity, or
other public agency or office.
(2) Records or documents created as a
byproduct of any regularly conducted
business activity or by an entity that
acted as a contractor or subcontractor to
the DOE.
(d) For purposes of satisfying the 250
workday requirement of § 30.220(a), the
claimant may aggregate the days of
service at more than one qualifying site.
§ 30.222 How does a claimant establish
that the employee has been diagnosed with
chronic silicosis or has sustained a
consequential injury, illness, impairment or
disease?
(a) A written diagnosis of the
employee’s chronic silicosis (as defined
in § 30.5(j)) shall be made by a medical
doctor and accompanied by one of the
following:
(1) A chest radiograph, interpreted by
an individual certified by NIOSH as a B
reader, classifying the existence of
pneumoconioses of category 1/0 or
higher; or
(2) Results from a computer assisted
tomograph or other imaging technique
that are consistent with silicosis; or
(3) Lung biopsy findings consistent
with silicosis.
(b) An injury, illness, impairment or
disease sustained as a consequence of
accepted chronic silicosis covered by
the provisions of § 30.220(a) must be
established with a fully rationalized
medical report by a physician that
shows the relationship between the
injury, illness, impairment or disease
and the accepted chronic silicosis.
Neither the fact that the injury, illness,
impairment or disease manifests itself
after a diagnosis of accepted chronic
silicosis, nor the belief of the claimant
that the injury, illness, impairment or
disease was caused by the accepted
chronic silicosis, is sufficient in itself to
prove a causal relationship.
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
Eligibility Criteria for Certain Uranium
Employees Under Part B of EEOICPA
§ 30.225 What are the criteria for eligibility
for benefits under Part B of EEOICPA for
certain uranium employees?
In order to be eligible for benefits
under this section, the claimant must
establish the criteria set forth in either
paragraph (a) or paragraph (b) of this
section:
(a) The Attorney General has
determined that the claimant is a
covered uranium employee who is
entitled to payment of $100,000 as
compensation due under section 5 of
RECA for a claim made under that
statute (there is, however, no
requirement that the claimant or
surviving eligible beneficiary has
actually received payment pursuant to
RECA). If a deceased employee’s
survivor(s) has been determined to be
entitled to such an award, his or her
survivor(s), if any, will only be entitled
to EEOICPA compensation in
accordance with section 7384u(e) of the
Act.
(b) The covered uranium employee
has been diagnosed with an injury,
illness, impairment or disease that arose
as a consequence of the medical
condition for which he or she was
determined to be entitled to payment of
$100,000 as compensation due under
section 5 of RECA.
§ 30.226 How does a claimant establish
that a covered uranium employee has
sustained a consequential injury, illness,
impairment or disease?
An injury, illness, impairment or
disease sustained as a consequence of a
medical condition covered by the
provisions of § 30.225(a) must be
established with a fully rationalized
medical report by a physician that
shows the relationship between the
injury, illness, impairment or disease
and the accepted medical condition.
Neither the fact that the injury, illness,
impairment or disease manifests itself
after a diagnosis of a medical condition
covered by the provisions of § 30.225(a),
nor the belief of the claimant that the
injury, illness, impairment or disease
was caused by such a condition, is
sufficient in itself to prove a causal
relationship.
pwalker on PROD1PC60 with RULES2
Eligibility Criteria for Other Claims
Under Part E of EEOICPA
§ 30.230 What are the criteria necessary to
establish that an employee contracted a
covered illness under Part E of EEOICPA?
To establish that an employee
contracted a covered illness under Part
E of the Act, the employee, or his or her
survivor, must show one of the
following:
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
(a) That OWCP has determined under
Part B of EEOICPA that the employee is
a Department of Energy contractor
employee as defined in § 30.5(w), and
that he or she has been awarded
compensation under that Part of the Act
for an occupational illness;
(b) That the Attorney General has
determined that the employee is entitled
to payment of $100,000 as
compensation due under section 5 of
RECA for a claim made under that
statute (however, if a deceased
employee’s survivor has been
determined to be entitled to such an
award, his or her survivor(s), if any, will
only be entitled to benefits under Part
E of EEOICPA in accordance with
section 7385s–3 of the Act);
(c) That the Secretary of Energy has
accepted a positive determination of a
Physicians Panel that the employee
sustained an illness or died due to
exposure to a toxic substance at a DOE
facility under former section 7385o of
EEOICPA, or that the Secretary of
Energy has found significant evidence
contrary to a negative determination of
a Physicians Panel; or
(d)(1) That the employee is a civilian
Department of Energy contractor
employee as defined in § 30.5(w), or a
civilian who was employed in a
uranium mine or mill located in
Colorado, New Mexico, Arizona,
Wyoming, South Dakota, Washington,
Utah, Idaho, North Dakota, Oregon or
Texas at any time during the period
from January 1, 1942 through December
31, 1971, or was employed in the
transport of uranium ore or vanadiumuranium ore from such a mine or mill
during that same period, and that he or
she:
(i) Has been diagnosed with an
illness; and
(ii) That it is at least as likely as not
that exposure to a toxic substance at a
Department of Energy facility or at a
RECA section 5 facility, as appropriate,
was a significant factor in aggravating,
contributing to, or causing the illness;
and
(iii) That it is at least as likely as not
that the exposure to such toxic
substance was related to employment at
a Department of Energy facility or a
RECA section 5 facility, as appropriate.
(2) In making the determination under
paragraph (d)(1)(ii) of this section,
OWCP will consider:
(i) The nature, frequency and duration
of exposure of the covered employee to
the substance alleged to be toxic;
(ii) Evidence of the carcinogenic or
pathogenic properties of the alleged
toxic substance to which the employee
was exposed;
PO 00000
Frm 00029
Fmt 4701
Sfmt 4700
78547
(iii) An opinion of a qualified
physician with expertise in treating,
diagnosing or researching the illness
claimed to be caused or aggravated by
the alleged exposure; and
(iv) Any other evidence that OWCP
determines to have demonstrated
relevance to the relation between a
particular toxic substance and the
claimed illness.
§ 30.231 How does a claimant prove
employment-related exposure to a toxic
substance at a DOE facility or a RECA
section 5 facility?
To establish employment-related
exposure to a toxic substance at a
Department of Energy facility or RECA
section 5 facility as required by
§ 30.230(d), an employee, or his or her
survivor(s), must prove that the
employee was employed at such facility
and that he or she was exposed to a
toxic substance in the course of that
employment.
(a) Proof of employment may be
established by any trustworthy records
that, on their face or in conjunction with
other such records, establish that the
employee was so employed and the time
period(s) of such employment.
(b) Proof of exposure to a toxic
substance may be established by the
submission of any appropriate
document or information that is
evidence that such substance was
present at the facility in which the
employee was employed and that the
employee came into contact with such
substance. OWCP site exposure matrices
may be used to provide probative
factual evidence that a particular
substance was present at either a DOE
facility or a RECA section 5 facility.
§ 30.232 How does a claimant establish
that the employee has been diagnosed with
a covered illness, or sustained an injury,
illness, impairment or disease as a
consequence of a covered illness?
(a) To establish that the employee has
been diagnosed with a covered illness as
required by § 30.230(d), the employee,
or his or her survivor(s), must provide
the following:
(1) The name and address of any
licensed physician who is the source of
a diagnosis based upon documented
medical information that the employee
has or had an illness and that the illness
may have resulted from exposure to a
toxic substance while the employee was
employed at a DOE facility or a RECA
section 5 facility, as appropriate, and, to
the extent practicable, a copy of the
diagnosis and a summary of the
information upon which the diagnosis is
based; and
(2) A signed medical release,
authorizing the release of any diagnosis,
E:\FR\FM\29DER2.SGM
29DER2
78548
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
medical opinion and medical records
documenting the diagnosis or opinion
that the employee has or had an illness
and that the illness may have resulted
from exposure to a toxic substance
while the employee was employed at a
DOE facility or RECA section 5 facility,
as appropriate; and
(3) To the extent practicable and
appropriate, an occupational history
obtained by a physician, an
occupational health professional, or a
DOE-sponsored Former Worker Program
(if such an occupational history is not
reasonably available or is inadequate,
and such history is deemed by OWCP to
be needed for the fair adjudication of
the claim, then OWCP may assist the
claimant in developing this history);
and
(4) Any other information or materials
deemed by OWCP to be necessary to
provide reasonable evidence that the
employee has or had an illness that may
have arisen from exposure to a toxic
substance while employed at a DOE
facility or RECA section 5 facility, as
appropriate.
(b) The employee, or his or her
survivor(s), may also submit to OWCP
other evidence not described in
paragraph (a) of this section showing
that the employee has or had an illness
that resulted from an exposure to a toxic
substance during the course of
employment at either a DOE facility or
a RECA section 5 facility, as
appropriate.
(c) An injury, illness, impairment or
disease sustained as a consequence of a
covered illness (as defined in § 30.5(r))
must be established with a fully
rationalized medical report by a
physician that shows the relationship
between the injury, illness, impairment
or disease and the covered illness.
Neither the fact that the injury, illness,
impairment or disease manifests itself
after a diagnosis of a covered illness, nor
the belief of the claimant that the injury,
illness, impairment or disease was
caused by the covered illness, is
sufficient in itself to prove a causal
relationship.
Subpart D—Adjudicatory Process
pwalker on PROD1PC60 with RULES2
§ 30.300 What process will OWCP use to
decide claims for entitlement and to provide
for administrative review of those
decisions?
OWCP district offices will issue
recommended decisions with respect to
claims for entitlement under Part B and/
or Part E of EEOICPA that are filed
pursuant to the regulations set forth in
subpart B of this part. In circumstances
where a claim is made for more than
one benefit available under Part B and/
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
or Part E of the Act, OWCP may issue
a recommended decision on only part of
that particular claim in order to
adjudicate that portion of the claim as
quickly as possible. Should this occur,
OWCP will issue one or more
recommended decisions on the deferred
portions of the claim when the
adjudication of those portions is
completed. All recommended decisions
granting and/or denying benefits under
Part B and/or Part E of the Act will be
forwarded to the Final Adjudication
Branch (FAB). Claimants will be given
an opportunity to object to all or part of
the recommended decision before the
FAB. The FAB will consider objections
filed by a claimant and conduct a
hearing, if requested to do so by the
claimant, before issuing a final decision
on the claim for entitlement.
§ 30.301 May subpoenas be issued for
witnesses and documents in connection
with a claim under Part B of EEOICPA?
(a) In connection with the
adjudication of a claim under Part B of
EEOICPA, an OWCP district office and/
or a FAB reviewer may, at their own
initiative, issue subpoenas for the
attendance and testimony of witnesses,
and for the production of books,
electronic records, correspondence,
papers or other relevant documents.
Subpoenas will only be issued for
documents if they are relevant and
cannot be obtained by other means, and
for witnesses only where oral testimony
is the best way to ascertain the facts.
(b) A claimant may also request a
subpoena in connection with his or her
claim under Part B of the Act, but such
request may only be made to a FAB
reviewer. No subpoenas will be issued
at the request of the claimant under any
other portion of the claims process. The
decision to grant or deny such request
is within the discretion of the FAB
reviewer. To request a subpoena under
this section, the requestor must:
(1) Submit the request in writing and
send it to the FAB reviewer as early as
possible, but no later than 30 days (as
evidenced by postmark, electronic
marker or other objective date mark)
after the date of the original hearing
request;
(2) Explain why the testimony or
evidence is directly relevant and
material to the issues in the case; and
(3) Establish that a subpoena is the
best method or opportunity to obtain
such evidence because there are no
other means by which the documents or
testimony could have been obtained.
(c) No subpoena will be issued for
attendance of employees or contractors
of OWCP or NIOSH acting in their
official capacities as decision-makers or
PO 00000
Frm 00030
Fmt 4701
Sfmt 4700
policy administrators. For hearings
taking the form of a review of the
written record, no subpoena for the
appearance of witnesses will be
considered.
(d) The FAB reviewer will issue the
subpoena under his or her own name.
It may be served in person or by
certified mail, return receipt requested,
addressed to the person to be served at
his or her last known principal place of
business or residence. A decision to
deny a subpoena requested by a
claimant can only be challenged as part
of a request for reconsideration of any
adverse decision of the FAB which
results from the hearing.
§ 30.302 Who pays the costs associated
with subpoenas?
(a) Witnesses who are not employees
or former employees of the federal
government shall be paid the same fees
and mileage as paid for like services in
the District Court of the United States
where the subpoena is returnable,
except that expert witnesses shall be
paid a fee not to exceed the local
customary fee for such services.
(b) Where OWCP asked that the
witness submit evidence into the case
record or asked that the witness attend,
OWCP shall pay the fees and mileage.
Where the claimant asked for the
subpoena, and where the witness
submitted evidence into the record at
the request of the claimant, the claimant
shall pay the fees and mileage.
§ 30.303 What information may OWCP
request in connection with a claim under
Part E of EEOICPA?
At any time during the course of
development of a claim for benefits
under Part E, OWCP may determine that
it needs relevant information to
adjudicate the claim. When this occurs,
and at the request of OWCP, DOE and/
or any contractor who employed a
Department of Energy contractor
employee must provide to OWCP
information or documents in response
to the request in connection with a
claim under Part E of EEOICPA.
(a) The party to whom the request is
made must respond to OWCP within 90
days of the request with either:
(1) The requested information or
documents; or
(2) A sworn statement that a good
faith search for the requested
information or documents was
conducted, and that the information or
documents could not be located.
(b) DOE and/or the DOE contractor
who employed a Department of Energy
contractor employee must query third
parties under its control to acquire the
requested information or documents.
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
(c) In providing the requested
information or documents, DOE and/or
the DOE contractor who employed a
DOE contractor employee must preserve
the current organization of the requested
information or documents, and must
provide such description and indexing
of the requested information or
documents as OWCP considers
appropriate to facilitate their use by
OWCP.
(d) Information or document requests
may include, but are not limited to,
requests for records, files and other data,
whether paper, electronic, imaged or
otherwise, developed, acquired or
maintained by DOE or the DOE
contractor who employed a DOE
contractor employee. Such information
or documents may include records, files
and data on facility industrial hygiene,
employment of individuals or groups,
exposure and medical records, and
claims applications.
Recommended Decisions on Claims
§ 30.305 How does OWCP determine
entitlement to EEOICPA compensation?
(a) In reaching a recommended
decision with respect to EEOICPA
compensation, OWCP considers the
claim presented by the claimant, the
factual and medical evidence of record,
the dose reconstruction report
calculated by HHS (if any), any report
submitted by DOE and the results of
such investigation as OWCP may deem
necessary.
(b) The OWCP claims staff applies the
law, the regulations and its procedures
when it evaluates the medical evidence
and the facts as reported or obtained
upon investigation.
§ 30.306 What does the recommended
decision contain?
The recommended decision shall
contain findings of fact and conclusions
of law. The recommended decision may
accept or reject the claim in its entirety,
or it may accept or reject a portion of the
claim presented. It is accompanied by a
notice of the claimant’s right to file
objections with, and request a hearing
before, the FAB.
record of such claim to the FAB. Any
new evidence submitted to the district
office following the issuance of the
recommended decision will also be
forwarded to the FAB for consideration.
Hearings and Final Decisions on Claims
§ 30.310 What must the claimant do if he
or she objects to the recommended
decision or wants to request a hearing?
(a) Within 60 days from the date the
recommended decision is issued, the
claimant must state, in writing, whether
he or she objects to any of the findings
of fact and/or conclusions of law
contained in such decision, including
HHS’s reconstruction of the radiation
dose to which the employee was
exposed (if any), and whether a hearing
is desired. This written statement
should be filed with the FAB at the
address indicated in the notice
accompanying the recommended
decision.
(b) For purposes of determining
whether the written statement referred
to in paragraph (a) of this section has
been timely filed with the FAB, the
statement will be considered to be
‘‘filed’’ on the date that the claimant
mails it to the FAB, as determined by
postmark, or on the date that such
written statement is actually received by
the FAB, whichever is the earliest
determinable date.
§ 30.311 What happens if the claimant
does not object to the recommended
decision or request a hearing within 60
days?
(a) If the claimant does not file a
written statement that objects to the
recommended decision and/or requests
a hearing within the period of time
allotted in § 30.310, the FAB may issue
a final decision accepting the
recommendation of the district office as
provided in § 30.316.
(b) If the recommended decision
accepts all or part of a claim for
compensation, the FAB may issue a
final decision at any time after receiving
written notice from the claimant that he
or she waives any objection to all or part
of the recommended decision.
pwalker on PROD1PC60 with RULES2
§ 30.307 To whom is the recommended
decision sent?
(a) A copy of the recommended
decision will be mailed to the claimant’s
last known address and to the
claimant’s designated representative
before OWCP, if any. Notification to
either the claimant or the representative
will be considered notification to both
parties.
(b) At the same time it issues a
recommended decision on a claim, the
OWCP district office will forward the
§ 30.312 What will the FAB do if the
claimant objects to the recommended
decision but does not request a hearing?
If the claimant files a written
statement that objects to the
recommended decision within the
period of time allotted in § 30.310 but
does not request a hearing, the FAB will
consider any objections by means of a
review of the written record. If the
claimant only objects to part of the
recommended decision, the FAB may
issue a final decision accepting the
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
PO 00000
Frm 00031
Fmt 4701
Sfmt 4700
78549
remaining part of the recommendation
of the district office without first
reviewing the written record (see
§ 30.316).
§ 30.313 How is a review of the written
record conducted?
(a) The FAB reviewer will consider
the written record forwarded by the
district office and any additional
evidence and/or argument submitted by
the claimant. The reviewer may also
conduct whatever investigation is
deemed necessary.
(b) The claimant should submit, with
his or her written statement that objects
to the recommended decision, all
evidence or argument that he or she
wants to present to the reviewer.
However, evidence or argument may be
submitted at any time up to the date
specified by the reviewer for the
submission of such evidence or
argument.
(c) Any objection that is not presented
to the FAB reviewer, including any
objection to HHS’s reconstruction of the
radiation dose to which the employee
was exposed (if any), whether or not the
pertinent issue was previously
presented to the district office, is
deemed waived for all purposes.
§ 30.314
How is a hearing conducted?
(a) The FAB reviewer retains
complete discretion to set the time and
place of the hearing, including the
amount of time allotted for the hearing,
considering the issues to be resolved. At
the discretion of the reviewer, the
hearing may be conducted by telephone
or teleconference. As part of the hearing
process, the FAB reviewer will consider
the written record forwarded by the
district office and any additional
evidence and/or argument submitted by
the claimant. The reviewer may also
conduct whatever investigation is
deemed necessary.
(1) The FAB reviewer will try to set
the hearing at a place that is within
commuting distance of the claimant’s
residence, but will not be able to do so
in all cases. Therefore, for reasons of
economy, the claimant may be required
to travel a roundtrip distance of up to
200 miles to attend the hearing.
(2) In unusual circumstances, the FAB
reviewer may set a place for the hearing
that is more than 200 miles roundtrip
from the claimant’s residence. However,
in that situation, OWCP will reimburse
the claimant for reasonable and
necessary travel expenses incurred to
attend the hearing if he or she submits
a written reimbursement request that
documents such expenses.
(b) Unless otherwise directed in
writing by the claimant, the FAB
E:\FR\FM\29DER2.SGM
29DER2
78550
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
reviewer will mail a notice of the time
and place of the hearing to the claimant
and any representative at least 30 days
before the scheduled hearing date. If the
claimant only objects to part of the
recommended decision, the FAB
reviewer may issue a final decision
accepting the remaining part of the
recommendation of the district office
without first holding a hearing (see
§ 30.316). Any objection that is not
presented to the FAB reviewer,
including any objection to HHS’s
reconstruction of the radiation dose to
which the employee was exposed (if
any), whether or not the pertinent issue
was previously presented to the district
office, is deemed waived for all
purposes.
(c) The hearing is an informal process,
and the reviewer is not bound by
common law or statutory rules of
evidence, or by technical or formal rules
of procedure. The reviewer may conduct
the hearing in such manner as to best
ascertain the rights of the claimant.
During the hearing process, the claimant
may state his or her arguments and
present new written evidence and/or
testimony in support of the claim.
(d) Testimony at hearings is recorded,
then transcribed and placed in the
record. Oral testimony shall be made
under oath.
(e) The FAB reviewer will furnish a
transcript of the hearing to the claimant,
who has 20 days from the date it is sent
to submit any comments to the
reviewer.
(f) The claimant will have 30 days
after the hearing is held to submit
additional evidence or argument, unless
the reviewer, in his or her sole
discretion, grants an extension. Only
one such extension may be granted.
(g) The reviewer determines the
conduct of the hearing and may
terminate the hearing at any time he or
she determines that all relevant
evidence has been obtained, or because
of misbehavior on the part of the
claimant and/or representative at or
near the place of the oral presentation.
pwalker on PROD1PC60 with RULES2
§ 30.315 May a claimant postpone a
hearing?
(a) The FAB will entertain any
reasonable request for scheduling the
time and place of the hearing, but such
requests should be made at the time that
the hearing is requested. Scheduling is
at the discretion of the FAB, and is not
reviewable. In most instances, once the
hearing has been scheduled and
appropriate written notice has been
mailed, it cannot be postponed at the
claimant’s request for any reason except
those stated in paragraph (b) of this
section, unless the FAB reviewer can
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
reschedule the hearing on the same
docket (that is, during the same hearing
trip). If a request to postpone a
scheduled hearing does not meet one of
the tests of paragraph (b) of this section
and cannot be accommodated on the
same docket, no further opportunity for
a hearing will be provided. Instead, the
FAB will consider the claimant’s
objections by means of a review of the
written record. In the alternative, a
teleconference may be substituted for
the hearing at the discretion of the
reviewer.
(b) Where the claimant or the
representative appointed by the
claimant in accordance with § 30.600 of
this part has a medical reason that
prevents attendance at the hearing, or
where the death or illness of the
claimant’s parent , spouse, or child
prevents the claimant from attending
the hearing as scheduled, a
postponement may be granted in the
discretion of the FAB if the claimant or
the representative provides at least 24
hours notice and a reasonable
explanation supporting his or her
inability to attend the scheduled
hearing.
(c) At any time after requesting a
hearing, the claimant can request a
change to a review of the written record
by making a written request to the FAB.
Once such a change is made, no further
opportunity for a hearing will be
provided.
§ 30.316 How does the FAB issue a final
decision on a claim?
(a) If the claimant does not file a
written statement that objects to the
recommended decision and/or requests
a hearing within the period of time
allotted in § 30.310, or if the claimant
waives any objections to all or part of
the recommended decision, the FAB
may issue a final decision accepting the
recommendation of the district office,
either in whole or in part (see §§ 30.311,
30.312 and 30.314(b)).
(b) If the claimant objects to all or part
of the recommended decision, the FAB
reviewer will issue a final decision on
the claim after either the hearing or the
review of the written record, and after
completing such further development of
the case as he or she may deem
necessary.
(c) Any recommended decision (or
part thereof) that is pending either a
hearing or a review of the written record
for more than one year from the date the
FAB received the written statement
described in § 30.310(a), or the date the
Director reopened the claim for issuance
of a new final decision pursuant to
§ 30.320(a), shall be considered a final
decision of the FAB on the one-year
PO 00000
Frm 00032
Fmt 4701
Sfmt 4700
anniversary of such date. Any
recommended decision described in
§ 30.311 that is pending at the FAB for
more than one year from the date that
the period of time described in § 30.310
expired shall be considered a final
decision of the FAB on the one-year
anniversary of such date.
(d) The decision of the FAB, whether
issued pursuant to paragraph (a), (b) or
(c) of this section, shall be final upon
the date of issuance of such decision,
unless a timely request for
reconsideration under § 30.319 has been
filed.
(e) A copy of the final decision of the
FAB will be mailed to the claimant’s
last known address and to the
claimant’s designated representative
before OWCP, if any. Notification to
either the claimant or the representative
will be considered notification to both
parties.
§ 30.317 Can the FAB request a further
response from the claimant or return a
claim to the district office?
At any time before the issuance of its
final decision, the FAB may request that
the claimant submit additional evidence
or argument, or return the claim to the
district office for further development
and/or issuance of a newly
recommended decision without issuing
a final decision, whether or not
requested to do so by the claimant.
§ 30.318 Can the FAB consider objections
to HHS’s reconstruction of a radiation dose
or to the guidelines OWCP uses to
determine if a claimed cancer was at least
as likely as not related to employment?
(a) If the claimant objects to HHS’s
reconstruction of the radiation dose to
which the employee was exposed, the
FAB will evaluate the factual findings
upon which HHS based its dose
reconstruction. If these factual findings
do not appear to be supported by
substantial evidence, the claim will be
returned to the district office for referral
to HHS for further consideration.
(b) The methodology used by HHS in
arriving at reasonable estimates of the
radiation doses received by an
employee, established by regulations
issued by HHS at 42 CFR part 82, is
binding on the FAB. The FAB reviewer
may determine, however, that objections
concerning the application of that
methodology should be considered by
HHS and may return the case to the
district office for referral to HHS for
such consideration.
(c) The methodology that OWCP uses
to determine if a claimed cancer was at
least as likely as not related to
employment at a DOE facility, an atomic
weapons employer facility, or a RECA
section 5 facility, established by
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
regulations issued by HHS at 42 CFR
part 81, is also binding on the FAB (see
§ 30.213). However, since OWCP applies
this methodology when it makes these
determinations, the FAB reviewer may
consider objections to the manner in
which OWCP applied HHS’s regulatory
guidelines.
§ 30.319 May a claimant request
reconsideration of a final decision of the
FAB?
pwalker on PROD1PC60 with RULES2
(a) A claimant may request
reconsideration of a final decision of the
FAB by filing a written request with the
FAB within 30 days from the date of
issuance of such decision. If a timely
request for reconsideration is made, the
decision in question will no longer be
considered ‘‘final’’ under § 30.316(d).
(b) For purposes of determining
whether the written request referred to
in paragraph (a) of this section has been
timely filed with the FAB, the request
will be considered to be ‘‘filed’’ on the
date that the claimant mails it to the
FAB, as determined by postmark, or on
the date that such written request is
actually received by the FAB, whichever
is the earliest determinable date.
(c) A hearing is not available as part
of the reconsideration process. If the
FAB grants the request for
reconsideration, it will consider the
written record of the claim again and
issue a new final decision on the claim.
A new final decision that is issued after
the FAB grants a request for
reconsideration will be ‘‘final’’ upon the
date of issuance of such new decision.
(1) Instead of issuing a new final
decision after granting a request for
reconsideration, the FAB may return the
claim to the district office for further
development as provided in § 30.317.
(2) If the FAB denies the request for
reconsideration, the FAB decision that
formed the basis for the request will be
considered ‘‘final’’ upon the date the
request is denied, and no further
requests for reconsideration of that
particular final decision of the FAB will
be entertained.
(d) A claimant may not seek judicial
review of a decision on his or her claim
under EEOICPA until OWCP’s decision
on the claim is final pursuant to either
§ 30.316(d) (for claims in which no
request for reconsideration was filed
with the FAB) or paragraph (c) of this
section (for claims in which a request
for reconsideration was filed with the
FAB).
Reopening Claims
§ 30.320 Can a claim be reopened after the
FAB has issued a final decision?
(a) At any time after the FAB has
issued a final decision pursuant to
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
§ 30.316, and without regard to whether
new evidence or information is
presented or obtained, the Director for
Energy Employees Occupational Illness
Compensation may reopen a claim and
return it to the FAB for issuance of a
new final decision, or to the district
office for such further development as
may be necessary, to be followed by a
new recommended decision. The
Director may also vacate any other type
of decision issued by the FAB.
(b) At any time after the FAB has
issued a final decision pursuant to
§ 30.316, a claimant may file a written
request that the Director for Energy
Employees Occupational Illness
Compensation reopen his or her claim,
provided that the claimant also submits
new evidence of either covered
employment or exposure to a toxic
substance, or identifies either a change
in the PoC guidelines, a change in the
dose reconstruction methods or an
addition of a class of employees to the
Special Exposure Cohort.
(1) If the Director concludes that the
evidence submitted or matter identified
in support of the claimant’s request is
material to the claim, the Director will
reopen the claim and return it to the
district office for such further
development as may be necessary, to be
followed by a new recommended
decision.
(2) New evidence of a medical
condition described in subpart C of
these regulations is not sufficient to
support a written request to reopen a
claim for such a condition under
paragraph (b) of this section.
(c) The decision whether or not to
reopen a claim under this section is
solely within the discretion of the
Director for Energy Employees
Occupational Illness Compensation and
is not reviewable. If the Director reopens
a claim pursuant to paragraphs (a) or (b)
of this section and returns it to the
district office, the resulting new
recommended decision will be subject
to the adjudicatory process described in
this subpart. However, neither the
district office nor the FAB can consider
any objection concerning the Director’s
decision to reopen a claim under this
section.
Subpart E—Medical and Related
Benefits
Medical Treatment and Related Issues
§ 30.400 What are the basic rules for
obtaining medical treatment?
(a) A covered Part B employee or a
covered Part E employee who fits into
at least one of the compensable claim
categories described in subpart C of this
part is entitled to receive all medical
PO 00000
Frm 00033
Fmt 4701
Sfmt 4700
78551
services, appliances or supplies that a
qualified physician prescribes or
recommends and that OWCP considers
necessary to treat his or her
occupational illness or covered illness,
retroactive to the date the claim for
benefits for that occupational illness or
covered illness under Part B or Part E of
EEOICPA was filed. In situations where
the occupational illness or covered
illness is a secondary cancer, such
treatment may include treatment of the
underlying primary cancer when it is
medically necessary or related to
treatment of the secondary cancer;
however, payment for medical treatment
of the underlying primary cancer under
these circumstances does not constitute
a determination by OWCP that the
primary cancer is a covered illness
under Part E of EEOICPA. The employee
need not be disabled to receive such
treatment. When a survivor receives
payment, OWCP will pay for such
treatment if the employee died before
the claim was paid. If there is any doubt
as to whether a specific service,
appliance or supply is necessary to treat
the occupational illness or covered
illness, the employee should consult
OWCP prior to obtaining it.
(b) If a claimant disagrees with the
decision of OWCP that medical benefits
provided under paragraph (a) of this
section are not necessary to treat an
occupational illness or covered illness,
he or she may choose to utilize the
adjudicatory process described in
subpart D of this part.
(c) Any qualified physician or
qualified hospital may provide medical
services, appliances and supplies to the
covered Part B employee or the covered
Part E employee. A qualified provider of
medical support services may also
furnish appropriate services, appliances,
and supplies. OWCP may apply a test of
cost-effectiveness when it decides if
appliances and supplies are necessary to
treat an occupational illness or covered
illness. With respect to prescribed
medications, OWCP may require the use
of generic equivalents where they are
available.
§ 30.401 What are the special rules for the
services of chiropractors?
(a) The services of chiropractors that
may be reimbursed by OWCP are
limited to treatment to correct a spinal
subluxation. The costs of physical and
related laboratory tests performed by or
required by a chiropractor to diagnose
such a subluxation are also payable.
(b) A diagnosis of spinal subluxation
as demonstrated by x-ray to exist must
appear in the chiropractor’s report
before OWCP can consider payment of
a chiropractor’s bill.
E:\FR\FM\29DER2.SGM
29DER2
78552
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
(c) A chiropractor may interpret his or
her x-rays to the same extent as any
other physician. To be given any weight,
the medical report must state that x-rays
support the finding of spinal
subluxation. OWCP will not necessarily
require submission of the x-ray, or a
report of the x-ray, but the report must
be available for submission on request.
(d) A chiropractor may also provide
services in the nature of physical
therapy under the direction of a
qualified physician.
§ 30.402 What are the special rules for the
services of clinical psychologists?
A clinical psychologist may serve as
a physician within the scope of his or
her practice as defined by state law.
Therefore, a clinical psychologist may
not serve as a physician for conditions
that include a physical component
unless the applicable state law allows
clinical psychologists to treat physical
conditions. A clinical psychologist may
also perform testing, evaluation, and
other services under the direction of a
qualified physician.
§ 30.403 Will OWCP pay for the services of
an attendant?
OWCP will authorize payment for
personal care services under section
7384t of the Act, whether or not such
care includes medical services, so long
as the personal care services have been
determined to be medically necessary
and are provided by a home health aide,
licensed practical nurse, or similarly
trained individual. If a claimant
disagrees with the decision of OWCP
that personal care services are not
medically necessary, he or she may
utilize the adjudicatory process
described in subpart D of this part.
pwalker on PROD1PC60 with RULES2
§ 30.404 Will OWCP pay for transportation
to obtain medical treatment?
(a) The employee is entitled to
reimbursement for reasonable and
necessary expenses, including
transportation, incident to obtaining
authorized medical services, appliances
or supplies. To determine what is a
reasonable distance to travel, OWCP
will consider the availability of services,
the employee’s condition, and the
means of transportation. Generally, a
roundtrip distance of up to 200 miles is
considered a reasonable distance to
travel.
(b) If travel of more than 200 miles is
contemplated, or air transportation or
overnight accommodations will be
needed, the employee must submit a
written request to OWCP for prior
authorization with information
describing the circumstances and
necessity for such travel expenses.
OWCP will approve the request if it
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
determines that the travel expenses are
reasonable and necessary, and are
incident to obtaining authorized
medical services, appliances or
supplies. Requests for travel expenses
that are often approved include those
resulting from referrals to a specialist for
further medical treatment, and those
involving air transportation of an
employee who lives in a remote
geographical area with limited local
medical services.
(c) If a claimant disagrees with the
decision of OWCP that requested travel
expenses are either not reasonable or
necessary, or are not incident to
obtaining authorized medical services,
appliances or supplies, he or she may
utilize the adjudicatory process
described in subpart D of this part.
(d) The standard form designated for
medical travel refund requests is Form
OWCP–957 and must be used to seek
reimbursement under this section. This
form can be obtained from OWCP.
§ 30.405 After selecting a treating
physician, may an employee choose to be
treated by another physician instead?
(a) OWCP will provide the employee
with an opportunity to designate a
treating physician when it accepts the
claim. When the physician originally
selected to provide treatment for an
occupational illness or a covered illness
refers the employee to a specialist for
further medical care, the employee need
not consult OWCP for approval. In all
other instances, however, the employee
must submit a written request to OWCP
with his or her reasons for desiring a
change of physician.
(b) OWCP will approve the request if
it determines that the reasons submitted
are sufficient. Requests that are often
approved include those for transfer of
care from a general practitioner to a
physician who specializes in treating
the occupational illnesses or covered
illnesses covered by EEOICPA, or the
need for a new physician when an
employee has moved.
(c) If a claimant disagrees with the
decision of OWCP that insufficient
reasons for a change of physician have
been submitted, he or she may utilize
the adjudicatory process described in
subpart D of this part.
§ 30.406 Are there any exceptions to these
procedures for obtaining medical care?
In cases involving emergencies or
unusual circumstances, OWCP may
authorize treatment in a manner other
than as stated in this subpart.
PO 00000
Frm 00034
Fmt 4701
Sfmt 4700
Directed Medical Examinations
§ 30.410 Can OWCP require an employee
to be examined by another physician?
(a) OWCP sometimes needs a second
opinion from a medical specialist. The
employee must submit to examination
by a qualified physician who conforms
to the standards regarding conflicts of
interest adopted by OWCP as often and
at such times and places as OWCP
considers reasonably necessary. Also,
OWCP may send a case file for second
opinion review to a qualified physician
who conforms to the standards
regarding conflicts of interest adopted
by OWCP where an actual examination
is not needed, or where the employee is
deceased.
(b) If the initial examination is
disrupted by someone accompanying
the employee, OWCP will schedule
another examination with a different
qualified physician who conforms to the
standards regarding conflicts of interest
adopted by OWCP. The employee will
not be entitled to have anyone else
present at the subsequent examination
unless OWCP decides that exceptional
circumstances exist. For example, where
a hearing-impaired employee needs an
interpreter, the presence of an
interpreter would be allowed.
§ 30.411 What happens if the opinion of
the physician selected by OWCP differs
from the opinion of the physician selected
by the employee?
(a) If one medical opinion holds more
probative value than the other, OWCP
will base its determination of coverage
on the medical opinion with the greatest
probative value. A difference in medical
opinion sufficient to be considered a
conflict only occurs when two reports of
virtually equal weight and rationale
reach opposing conclusions.
(b) If a conflict exists between the
medical opinion of the employee’s
physician and the medical opinion of a
second opinion physician, an OWCP
medical adviser or consultant, or a
physician submitting an impairment
evaluation that meets the criteria set out
in § 30.905 of this part, OWCP shall
appoint a third physician who conforms
to the standards regarding conflicts of
interest adopted by OWCP to make an
examination or an impairment
evaluation. This is called a referee
examination or a referee impairment
evaluation. OWCP will select a
physician who is qualified in the
appropriate specialty and who has had
no prior connection with the case. Also,
a case file may be sent to a physician
who conforms to the standards
regarding conflicts of interest adopted
by OWCP for a referee medical review
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
where there is no need for an actual
examination, or where the employee is
deceased.
(c) If the initial referee examination or
referee impairment evaluation is
disrupted by someone accompanying
the employee, OWCP will schedule
another examination or impairment
evaluation with a different qualified
physician who conforms to the
standards regarding conflicts of interest
adopted by OWCP. The employee will
not be entitled to have anyone else
present at the subsequent referee
examination or referee impairment
evaluation unless OWCP decides that
exceptional circumstances exist. For
example, where a hearing-impaired
employee needs an interpreter, the
presence of an interpreter would be
allowed.
(b) The report shall be submitted
directly to OWCP as soon as possible
after medical examination or treatment
is received, either by the employee or
the physician.
§ 30.417 What additional medical
information may OWCP require to support
continuing payment of benefits?
In all cases requiring hospital
treatment or prolonged care, OWCP will
request detailed narrative reports from
the attending physician at periodic
intervals. The physician will be asked to
describe continuing medical treatment
for the occupational illness or covered
illness accepted by OWCP, a prognosis,
and the physician’s opinion as to the
continuing causal relationship between
the need for additional treatment and
the occupational illness or covered
illness.
§ 30.412 Who pays for second opinion and
referee examinations?
Medical Bills
OWCP will pay second opinion and
referee medical specialists directly.
OWCP will also reimburse the employee
for all necessary and reasonable
expenses incident to such an
examination, including transportation
costs and actual wages the employee
lost for the time needed to submit to an
examination required by OWCP.
§ 30.420 How should medical bills and
reimbursement requests be submitted?
Medical Reports
§ 30.415 What are the requirements for
medical reports?
In general, medical reports from the
employee’s attending physician should
include the following:
(a) Dates of examination and
treatment;
(b) History given by the employee;
(c) Physical findings;
(d) Results of diagnostic tests;
(e) Diagnosis;
(f) Course of treatment;
(g) A description of any other
conditions found due to the claimed
occupational illness or covered illness;
(h) The treatment given or
recommended for the claimed
occupational illness or covered illness;
and
(i) All other material findings.
pwalker on PROD1PC60 with RULES2
§ 30.416 How and when should medical
reports be submitted?
(a) The initial medical report (and any
subsequent reports) should be made in
narrative form on the physician’s
letterhead stationery. The physician
should use the Form EE–7 as a guide for
the preparation of his or her initial
medical report in support of a claim
under Part B and/or Part E of EEOICPA.
The report should bear the physician’s
signature or signature stamp. OWCP
may require an original signature on the
report.
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
Usually, medical providers submit
their bills directly for processing. The
rules for submitting and processing
provider bills and reimbursement
requests are stated in subpart H of this
part. An employee requesting
reimbursement for out-of-pocket
medical expenses must submit a Form
OWCP–915 and meet the requirements
described in § 30.702.
§ 30.421 What are the time frames for
submitting bills and reimbursement
requests?
To be considered for payment, bills
and reimbursement requests must be
submitted by the end of the calendar
year after the year when the expense
was incurred, or by the end of the
calendar year after the year when OWCP
first accepted the claim as compensable
under subpart D of this part, whichever
is later.
§ 30.422 If an employee is only partially
reimbursed for a medical expense, must the
provider refund the balance of the amount
paid to the employee?
(a) The OWCP fee schedule sets
maximum limits on the amounts
payable for many services. The
employee may be only partially
reimbursed for out-of-pocket medical
expenses because the amount he or she
paid to the medical provider for a
service exceeds the maximum allowable
charge set by the OWCP fee schedule.
(b) If this happens, the employee will
be advised of the maximum allowable
charge for the service in question and of
his or her responsibility to ask the
provider to refund to the employee, or
credit to the employee’s account, the
amount he or she paid that exceeds the
PO 00000
Frm 00035
Fmt 4701
Sfmt 4700
78553
maximum allowable charge. The
provider that the employee paid, but not
the employee, may request
reconsideration of the fee determination
as set forth in § 30.712.
(c) If the provider does not refund to
the employee or credit to his or her
account the amount of money paid in
excess of the charge that OWCP allows,
the employee should submit
documentation of the attempt to obtain
such refund or credit to OWCP. OWCP
may authorize reasonable
reimbursement to the employee after
reviewing the facts and circumstances of
the case.
Subpart F—Survivors; Payments and
Offsets; Overpayments
Survivors
§ 30.500 What special statutory definitions
apply to survivors under EEOICPA?
(a) For the purposes of paying
compensation to survivors under both
Parts B and E of EEOICPA, OWCP will
use the following definitions:
(1) Surviving spouse means the wife
or husband of a deceased covered Part
B employee or deceased covered Part E
employee who was married to that
individual for the 365 consecutive days
immediately prior to the death of that
individual.
(2) Child or children includes a
recognized natural child of a deceased
covered Part B employee or deceased
covered Part E employee, a stepchild
who lived with that individual in a
regular parent-child relationship, and an
adopted child of that individual.
However, to be a ‘‘covered’’ child under
Part E only, such child must have been,
as of the date of the deceased covered
Part E employee’s death, either under
the age of 18 years, or under the age of
23 years and a full-time student who
was continuously enrolled in one or
more educational institutions since
attaining the age of 18 years, or any age
and incapable of self-support.
(b) For the purposes of paying
compensation to survivors only under
Part B of EEOICPA, OWCP will use the
following additional definitions:
(1) Parent includes fathers and
mothers of a deceased covered Part B
employee through adoption.
(2) Grandchild means a child of a
child of a deceased covered Part B
employee.
(3) Grandparent means a parent of a
parent of a deceased covered Part B
employee.
E:\FR\FM\29DER2.SGM
29DER2
78554
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
pwalker on PROD1PC60 with RULES2
§ 30.501 What order of precedence will
OWCP use to determine which survivors
are entitled to receive compensation under
EEOICPA?
(a) Under Part B of the Act, if OWCP
determines that a survivor or survivors
are entitled to receive compensation
under EEOICPA because a covered Part
B employee who would otherwise have
been entitled to benefits is deceased,
that compensation will be disbursed as
follows, subject to the qualifications set
forth in § 30.5(gg)(3) of these
regulations:
(1) If there is a surviving spouse, the
compensation shall be paid to that
individual.
(2) If there is no surviving spouse, the
compensation shall be paid in equal
shares to all children of the deceased
covered Part B employee.
(3) If there is no surviving spouse and
no children, the compensation shall be
paid in equal shares to the parents of the
deceased covered Part B employee.
(4) If there is no surviving spouse, no
children and no parents, the
compensation shall be paid in equal
shares to all grandchildren of the
deceased covered Part B employee.
(5) If there is no surviving spouse, no
children, no parents and no
grandchildren, the compensation shall
be paid in equal shares to the
grandparents of the deceased covered
Part B employee.
(6) Notwithstanding paragraphs (a)(1)
through (a)(5) of this section, if there is
a surviving spouse and at least one child
of the deceased covered Part B
employee who is a minor at the time of
payment and who is not a recognized
natural child or adopted child of such
surviving spouse, half of the
compensation shall be paid to the
surviving spouse, and the other half of
the compensation shall be paid in equal
shares to each child of the deceased
covered Part B employee who is a minor
at the time of payment.
(b) Under Part E of the Act, if OWCP
determines that a survivor or survivors
are entitled to receive compensation
under EEOICPA because a covered Part
E employee who would otherwise have
been entitled to benefits is deceased,
that compensation will be disbursed as
follows, subject to the qualifications set
forth in § 30.5(gg)(3) of these
regulations:
(1) If there is a surviving spouse, the
compensation shall be paid to that
individual.
(2) If there is no surviving spouse, the
compensation shall be paid in equal
shares to all ‘‘covered’’ children of the
deceased covered Part E employee.
(3) Notwithstanding paragraphs (b)(1)
and (b)(2) of this section, if there is a
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
surviving spouse and at least one
‘‘covered’’ child of the deceased covered
Part E employee who is living at the
time of payment and who is not a
recognized natural child or adopted
child of such surviving spouse, then
half of such payment shall be made to
such surviving spouse, and the other
half of such payment shall be made in
equal shares to each ‘‘covered’’ child of
the employee who is living at the time
of payment.
§ 30.502 When is entitlement for survivors
determined for purposes of EEOICPA?
Entitlement to any lump-sum
payment for survivors under EEOICPA,
other than for ‘‘covered’’ children under
Part E, will be determined as of the time
OWCP makes such a payment. As noted
in § 30.500(a)(2) of these regulations, a
child of a deceased Part E employee will
only qualify as a ‘‘covered’’ child of that
individual if he or she satisfied one of
the additional statutory criteria for a
‘‘covered’’ child as of the date of the
deceased Part E employee’s death.
Payment of Claims and Offset for
Certain Payments
§ 30.505 What procedures will OWCP
follow before it pays any compensation?
(a) In cases involving the approval of
a claim, whether in whole or in part,
OWCP shall take all necessary steps to
determine the amount of any offset or
coordination of EEOICPA benefits
before paying any benefits, and to verify
the identity of the covered Part B
employee, the covered Part E employee,
or the eligible surviving beneficiary or
beneficiaries. To perform these tasks,
OWCP may conduct any investigation,
require any claimant to provide or
execute any affidavit, record or
document, or authorize the release of
any information as OWCP deems
necessary to ensure that the
compensation payment is made in the
correct amount and to the correct person
or persons. OWCP shall also require
every claimant under Part B of the Act
to execute and provide any necessary
affidavit described in § 30.620 of these
regulations. Should a claimant fail or
refuse to execute an affidavit or release
of information, or fail or refuse to
provide a requested document or record
or to provide access to information,
such failure or refusal may be deemed
to be a rejection of the payment, unless
the claimant does not have and cannot
obtain the legal authority to provide,
release, or authorize access to the
required information, records, or
documents.
(b) To determine the amount of any
offset, OWCP shall require the covered
Part B employee, covered Part E
PO 00000
Frm 00036
Fmt 4701
Sfmt 4700
employee or each eligible surviving
beneficiary filing a claim under this part
to execute and provide an affidavit (or
declaration made under oath on Form
EE–1 or EE–2) reporting the amount of
any payment made pursuant to a final
judgment or settlement in litigation
seeking damages. Even if someone other
than the covered Part B employee or the
covered Part E employee receives a
payment pursuant to a final judgment or
settlement in litigation seeking damages
(e.g., the surviving spouse of a deceased
covered Part B employee or a deceased
covered Part E employee), the receipt of
any such payment must be reported.
(1) For the purposes of this paragraph
(b) only, ‘‘litigation seeking damages’’
refers to any request or demand for
money (other than for workers’
compensation) by the covered Part B
employee or the covered Part E
employee, or by another individual if
the covered Part B employee or the
covered Part E employee is deceased,
made or sought in a civil action or in
anticipation of the filing of a civil
action, for injuries incurred on account
of an exposure for which compensation
is payable under EEOICPA. This term
does not also include any request or
demand for money made or sought
pursuant to a life insurance or health
insurance contract, or any request or
demand for money made or sought by
an individual other than the covered
Part B employee or the covered Part E
employee in that individual’s own right
(e.g., a spouse’s claim for loss of
consortium), or any request or demand
for money made or sought by the
covered Part B employee or the covered
Part E employee (or the estate of a
deceased covered Part B employee or
deceased covered Part E employee) not
for injuries incurred on account of an
exposure for which compensation is
payable under the EEOICPA (e.g., a
covered Part B employee’s or a covered
Part E employee’s claim for damage to
real or personal property).
(2) If a payment has been made
pursuant to a final judgment or
settlement in litigation seeking damages,
OWCP shall subtract a portion of the
dollar amount of such payment from the
benefit payments to be made under
EEOICPA. OWCP will calculate the
amount to be subtracted from the benefit
payments in the following manner:
(i) OWCP will first determine the
value of the payment made pursuant to
either a final judgment or settlement in
litigation seeking damages by adding the
dollar amount of any monetary damages
(excluding contingent awards) and any
medical expenses for treatment
provided on or after the date the
covered Part B employee or the covered
E:\FR\FM\29DER2.SGM
29DER2
pwalker on PROD1PC60 with RULES2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
Part E employee filed a claim for
EEOICPA benefits that were paid for
under the final judgment or settlement.
In the event that these payments include
a ‘‘structured’’ settlement (where a party
makes an initial cash payment and also
arranges, usually through the purchase
of an annuity, for payments in the
future), OWCP will usually accept the
cost of the annuity to the purchaser as
the dollar amount of the right to receive
the future payments.
(ii) OWCP will then make certain
deductions from the above dollar
amount to arrive at the dollar amount to
be subtracted from any unpaid
EEOICPA benefits. Allowable
deductions consist of attorney’s fees
OWCP deems reasonable, and itemized
costs of suit (out-of-pocket expenditures
not part of the normal overhead of a law
firm’s operation like filing fees, travel
expenses, witness fees, and court
reporter costs for transcripts) provided
that adequate supporting documentation
is submitted to OWCP.
(iii) The EEOICPA benefits that will
be reduced will consist of any unpaid
lump-sum payments payable in the
future and medical benefits payable in
the future. In those cases where it has
not yet paid EEOICPA benefits, OWCP
will reduce such benefits on a dollarfor-dollar basis, beginning with the
lump-sum payments first. If the amount
to be subtracted exceeds the lump-sum
payments, OWCP will reduce ongoing
EEOICPA medical benefits payable in
the future by the amount of any
remaining surplus. This means that
OWCP will apply the amount it would
otherwise pay to reimburse the covered
Part B employee or the covered Part E
employee for any ongoing EEOICPA
medical treatment to the remaining
surplus until it is absorbed. In addition
to this reduction of ongoing EEOICPA
medical benefits, OWCP will not be the
first payer for any medical expenses that
are the responsibility of another party
(who will instead be the first payer) as
part of a final judgment or settlement in
litigation seeking damages.
(3) The above reduction of EEOICPA
benefits will not occur if an EEOICPA
claimant had his or her award under
section 5 of RECA reduced by the full
amount of the payment made pursuant
to a final judgment or settlement in
litigation seeking damages. It will also
not occur if an EEOICPA claimant’s
prior payment of EEOICPA benefits, or
his or her workers’ compensation
benefits, were offset to reflect the full
amount of the payment made pursuant
to a final judgment or settlement in
litigation seeking damages. However, if
the prior reduction or offset of the above
benefits did not reflect the full amount
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
of the payment made pursuant to a final
judgment or settlement in litigation
seeking damages, OWCP will reduce
currently payable EEOICPA benefits by
the amount of any surplus final
judgment or settlement payment that
remains.
(c) Except as provided in § 30.506(b)
of these regulations, when OWCP has
verified the identity of every claimant
who is entitled to the compensation
payment, or to a share of the
compensation payment, and has
determined the correct amount of the
payment or the share of the payment,
OWCP shall notify every claimant, every
duly appointed guardian or conservator
of a claimant, or every person with
power of attorney for a claimant, and
require such person or persons to
complete a Form EN–20 providing
payment information. Such form shall
be signed and returned to OWCP within
sixty days of the date of the form or
within such greater period as may be
allowed by OWCP. Failure to sign and
return the form within the required time
may be deemed to be a rejection of the
payment. If the claimant dies before the
payment is received, the person who
receives the payment shall return it to
OWCP for redetermination of the correct
disbursement of the payment. No
payment shall be made until OWCP has
made a determination concerning the
survivors related to a respective claim
for benefits.
(d) The total amount of compensation
(other than medical benefits) under Part
E that can be paid to all claimants as a
result of the exposure of a covered Part
E employee shall not be more than
$250,000 in any circumstances.
§ 30.506 To whom and in what manner will
OWCP pay compensation?
(a) Except with respect to claims
under Part B of the Act for beryllium
sensitivity, payment shall be made to
the covered Part B employee or the
covered Part E employee, to the duly
appointed guardian or conservator of
that individual, or to the person with
power of attorney for that individual,
unless the covered Part B employee or
covered Part E employee is deceased at
the time of the payment. In all cases
involving a deceased covered Part B
employee or deceased covered Part E
employee, payment shall be made to the
eligible surviving beneficiary or
beneficiaries, to the duly appointed
guardian or conservator of the eligible
surviving beneficiary or beneficiaries, or
to every person with power of attorney
for an eligible surviving beneficiary, in
accordance with the terms and
conditions specified in sections
PO 00000
Frm 00037
Fmt 4701
Sfmt 4700
78555
7384s(e), 7384u(e), and 7385s–3(c) and
(d) of EEOICPA.
(b) Under Part B of the Act,
compensation for any consequential
injury, illness, impairment or disease is
limited to payment of medical benefits
for that injury, illness, impairment or
disease. Under Part E of the Act,
compensation for any consequential
injury, illness, impairment or disease
consists of medical benefits for that
injury, illness, impairment or disease, as
well as any additional monetary benefits
that are consistent with the terms of
§ 30.505(d).
(c) Rejected compensation payments,
or shares of compensation payments,
shall not be distributed to other eligible
surviving beneficiaries, but shall be
returned to the Fund.
(d) No covered Part B employee may
receive more than one lump-sum
payment under Part B of EEOICPA for
any occupational illnesses he or she
contracted. However, any individual,
including a covered Part B employee
who has received a lump-sum payment
for his or her own occupational illness
or illnesses, may receive one lump-sum
payment for each deceased covered Part
B employee for whom he or she
qualifies as an eligible surviving
beneficiary under Part B of the Act.
§ 30.507 What compensation will be
provided to covered Part B employees who
only establish beryllium sensitivity under
Part B of EEOICPA?
The establishment of beryllium
sensitivity does not entitle a covered
Part B employee, or the eligible
surviving beneficiary or beneficiaries of
a deceased covered Part B employee, to
any lump-sum payment provided for
under Part B. Instead, a covered Part B
employee whose sole accepted
occupational illness is beryllium
sensitivity shall receive beryllium
sensitivity monitoring, as well as
medical benefits for the treatment of this
occupational illness in accordance with
§ 30.400 of these regulations.
§ 30.508 What is beryllium sensitivity
monitoring?
Beryllium sensitivity monitoring shall
consist of medical examinations to
confirm and monitor the extent and
nature of a covered Part B employee’s
beryllium sensitivity. Monitoring shall
also include regular medical
examinations, with diagnostic testing, to
determine if the covered Part B
employee has established chronic
beryllium disease.
E:\FR\FM\29DER2.SGM
29DER2
78556
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
§ 30.509 Under what circumstances may a
survivor claiming under Part E of the Act
choose to receive the benefits that would
otherwise be payable to a covered Part E
employee who is deceased?
(a) If a covered Part E employee dies
after filing a claim but before monetary
benefits are paid under Part E of the Act,
and his or her death is from a cause
other than a covered illness, his or her
survivor can choose to receive either the
survivor benefits payable on account of
the death of that covered Part E
employee, or the monetary benefits that
would otherwise have been payable to
the covered Part E employee.
(b) For the purposes of this section
only, a death ‘‘from a cause other than
a covered illness’’ refers only to a death
that was solely caused by a non-covered
illness or illnesses. Therefore, the
choice referred to in paragraph (a) of
this section will not be available if a
covered illness contributed to the death
of the covered Part E employee in any
manner. In those instances, survivor
benefits will still be payable to the
claimant, but he or she cannot choose to
receive the monetary benefits that
would have otherwise been payable to
the deceased covered Part E employee
in lieu of survivor benefits.
(c) OWCP only makes impairment
determinations based on rationalized
medical evidence in the case file that is
sufficiently detailed and meets the
various requirements for the many
different types of impairment
determinations possible under the
AMA’s Guides. Therefore, OWCP will
only make an impairment determination
for a deceased covered Part E employee
pursuant to this section if the medical
evidence of record is sufficient to satisfy
the pertinent requirements in the
AMA’s Guides and subpart J of this part.
Overpayments
pwalker on PROD1PC60 with RULES2
§ 30.510 How does OWCP notify an
individual of a payment made on a claim?
(a) In addition to providing narrative
descriptions to recipients of benefits
paid or payable, OWCP includes on
each check a clear indication of the
reason the payment is being made. For
payments sent by electronic funds
transfer, a notification of the date and
amount of payment appears on the
statement from the recipient’s financial
institution.
(b) By these means, OWCP puts the
recipient on notice that a payment was
made and the amount of the payment.
If the amount received differs from the
amount indicated on the written notice
or bank statement, the recipient is
responsible for notifying OWCP of the
difference. Absent affirmative evidence
to the contrary, the recipient will be
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
presumed to have received the notice of
payment, whether mailed or transmitted
electronically.
§ 30.511 What is an ‘‘overpayment’’ for
purposes of EEOICPA?
An ‘‘overpayment’’ is any amount of
compensation paid under sections
7384s, 7384t, 7384u, 7385s–2 or 7385s–
3 of the EEOICPA to a recipient that
constitutes, as of the time OWCP makes
such payment:
(a) Payment where no amount is
payable under this part; or
(b) Payment in excess of the correct
amount determined by OWCP.
§ 30.512 What does OWCP do when an
overpayment is identified?
Before seeking to recover an
overpayment or adjust benefits, OWCP
will advise the recipient of the
overpayment in writing that:
(a) The overpayment exists, and the
amount of overpayment;
(b) A preliminary finding shows
either that the recipient was or was not
at fault in the creation of the
overpayment;
(c) He or she has the right to inspect
and copy OWCP records relating to the
overpayment; and
(d) He or she has the right to present
written evidence which challenges the
fact or amount of the overpayment, and/
or challenges the preliminary finding
that he or she was at fault in the creation
of the overpayment. He or she may also
request that recovery of the
overpayment be waived. Any
submission of evidence or request that
recovery of the overpayment be waived
must be presented to OWCP within 30
days of the date of the written notice of
overpayment.
§ 30.513 Under what circumstances may
OWCP waive recovery of an overpayment?
(a) OWCP may consider waiving
recovery of an overpayment only if the
recipient was not at fault in accepting or
creating the overpayment. Recipients of
benefits paid under EEOICPA are
responsible for taking all reasonable
measures to ensure that payments
received from OWCP are proper. The
recipient must show good faith and
exercise a high degree of care in
reporting events which may affect
entitlement to or the amount of benefits.
A recipient who has done any of the
following will be found to be at fault
with respect to creating an
overpayment:
(1) Made an incorrect statement as to
a material fact which he or she knew or
should have known to be incorrect; or
(2) Failed to provide information
which he or she knew or should have
known to be material; or
PO 00000
Frm 00038
Fmt 4701
Sfmt 4700
(3) Accepted a payment which he or
she knew or should have known to be
incorrect. (This provision applies only
to the overpaid individual.)
(b) Whether or not OWCP determines
that a recipient was at fault with respect
to the creation of an overpayment
depends on the circumstances
surrounding the overpayment. The
degree of care expected may vary with
the complexity of those circumstances
and the recipient’s capacity to realize
that he or she is being overpaid.
§ 30.514 If OWCP finds that the recipient of
an overpayment was not at fault, what
criteria are used to decide whether to waive
recovery of it?
If OWCP finds that the recipient of an
overpayment was not at fault,
repayment will still be required unless:
(a) Adjustment or recovery of the
overpayment would defeat the purpose
of the Act (see § 30.516); or
(b) Adjustment or recovery of the
overpayment would be against equity
and good conscience (see § 30.517).
§ 30.515 Is a recipient responsible for an
overpayment that resulted from an error
made by OWCP?
(a) The fact that OWCP may have
erred in making the overpayment does
not by itself relieve the recipient of the
overpayment from liability for
repayment if the recipient also was at
fault in accepting the overpayment.
(b) However, OWCP may find that the
recipient was not at fault if failure to
report an event affecting compensation
benefits, or acceptance of an incorrect
payment, occurred because:
(1) The recipient relied on
misinformation given in writing by
OWCP regarding the interpretation of a
pertinent provision or EEOICPA of this
part; or
(2) OWCP erred in calculating either
the percentage of impairment or wageloss under Part E of EEOICPA.
§ 30.516 Under what circumstances would
recovery of an overpayment defeat the
purpose of the Act?
Recovery of an overpayment will
defeat the purpose of the Act if such
recovery would cause hardship to the
recipient because:
(a) The recipient from whom OWCP
seeks recovery needs substantially all of
his or her current income to meet
current ordinary and necessary living
expenses; and
(b) The recipient’s assets do not
exceed two months’ expenditures as
determined by OWCP using the Bureau
of Labor Statistics Consumer
Expenditure Survey tables.
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
§ 30.517 Under what circumstances would
recovery of an overpayment be against
equity and good conscience?
(a) Recovery of an overpayment is
considered to be against equity and
good conscience when the recipient
would experience severe financial
hardship in attempting to repay the
debt.
(b) Recovery of an overpayment is
also considered to be against equity and
good conscience when the recipient, in
reliance on such payments or on notice
that such payments would be made,
gives up a valuable right or changes his
or her position for the worse. In making
such a decision, OWCP does not
consider the recipient’s current ability
to repay the overpayment.
(1) To establish that a valuable right
has been relinquished, it must be shown
that the right was in fact valuable, that
it cannot be regained, and that the
action was based chiefly or solely in
reliance on the payments or on the
notice of payment. Gratuitous transfers
of funds to other individuals are not
considered relinquishments of valuable
rights.
(2) To establish that a recipient’s
position has changed for the worse, it
must be shown that the decision made
would not otherwise have been made
but for the receipt of benefits, and that
this decision resulted in a loss.
§ 30.518 Can OWCP require the recipient
of the overpayment to submit additional
financial information?
(a) The recipient of the overpayment
is responsible for providing information
about income, expenses and assets as
specified by OWCP. This information is
needed to determine whether or not
recovery of an overpayment would
defeat the purpose of the Act, or would
be against equity and good conscience.
This information will also be used to
determine the repayment schedule, if
necessary.
(b) Failure to submit this requested
information within 30 days of the
request shall result in denial of waiver,
and no further request for waiver shall
be considered until the requested
information is furnished.
pwalker on PROD1PC60 with RULES2
§ 30.519 How does OWCP communicate
its final decision concerning recovery of an
overpayment?
(a) After considering any written
documentation or argument submitted
to OWCP within the 30-day period set
out in § 30.512(d), OWCP will issue a
final decision on the overpayment.
OWCP will send a copy of the final
decision to the individual from whom
recovery is sought and his or her
representative, if any.
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
(b) The provisions of subpart D of this
part do not apply to any decision
regarding the recovery of an
overpayment.
§ 30.520
How are overpayments collected?
(a) When an overpayment has been
made to a recipient who is entitled to
further payments, the recipient shall
refund to OWCP the amount of the
overpayment as soon as the error is
discovered or his or her attention is
called to same. If no refund is made,
OWCP shall recover the overpayment by
reducing any further lump-sum
payments due currently or in the future,
taking into account the financial
circumstances of the recipient, and any
other relevant factors, so as to minimize
any hardship. Should the recipient die
before collection has been completed,
further collection shall be made by
decreasing later payments, if any,
payable under EEOICPA with respect to
the underlying occupational illness or
covered illness.
(b) When an overpayment has been
made to a recipient and OWCP is unable
to recover the overpayment by reducing
compensation due currently, the
recipient shall refund to OWCP the
amount of the overpayment as soon as
the error is discovered or his or her
attention is called to same. The
overpayment is subject to the provisions
of the Federal Claims Collection Act of
1966, as amended (31 U.S.C. 3701 et
seq.), and may be reported to the
Internal Revenue Service as income. If
the recipient fails to make such refund,
OWCP may recover the overpayment
through any available means, including
offset of salary, annuity benefits, or
other Federal payments, including tax
refunds as authorized by the Tax Refund
Offset Program, or referral of the debt to
a collection agency or to the Department
of Justice.
Subpart G—Special Provisions
78557
authorization of the first individual. In
addition, OWCP will recognize only
certain types of individuals (see
§ 30.601). For the purposes of paragraph
(b) of this section, a ‘‘representative’’
does not include a person who only has
a power of attorney to act on behalf of
a claimant.
(c) A properly appointed
representative who is recognized by
OWCP may make a request or give
direction to OWCP regarding the claims
process, including a hearing. This
authority includes presenting or
eliciting evidence, making arguments on
facts or the law, and obtaining
information from the case file, to the
same extent as the claimant.
(1) Any notice requirement contained
in this part or EEOICPA is fully satisfied
if served on the representative, and has
the same force and effect as if sent to the
claimant.
(2) A representative does not have
authority to sign the Form EN–20,
described in § 30.505(c) of these
regulations, which collects information
necessary for issuance of a
compensation payment.
§ 30.601 Who may serve as a
representative?
A claimant may authorize any
individual to represent him or her in
regard to a claim under EEOICPA,
unless that individual’s service as a
representative would violate any
applicable provision of law (such as 18
U.S.C. 205 and 208). A federal employee
may act as a representative only:
(a) On behalf of immediate family
members, defined as a spouse, children,
parents, and siblings of the
representative, provided no fee or
gratuity is charged; or
(b) While acting as a union
representative, defined as any officially
sanctioned union official, and no fee or
gratuity is charged.
Representation
§ 30.602 Who is responsible for paying the
representative’s fee?
§ 30.600 May a claimant designate a
representative?
A representative may charge the
claimant a fee for services and for costs
associated with the representation
before OWCP. The claimant is solely
responsible for paying the fee and other
costs. OWCP will not reimburse the
claimant, nor is it in any way liable for
the amount of the fee and costs.
(a) The claims process under this part
is informal, and OWCP acts as an
impartial evaluator of the evidence. A
claimant need not be represented to file
a claim or receive a payment.
Nevertheless, a claimant may appoint
one individual to represent his or her
interests, but the appointment must be
in writing.
(b) There can be only one
representative at any one time, so after
one representative has been properly
appointed, OWCP will not recognize
another individual as a representative
until the claimant withdraws the
PO 00000
Frm 00039
Fmt 4701
Sfmt 4700
§ 30.603 Are there any limitations on what
the representative may charge the claimant
for his or her services?
(a) Notwithstanding any contract, the
representative may not receive, for
services rendered in connection with a
claim pending before OWCP, more than
the percentages of the lump-sum
E:\FR\FM\29DER2.SGM
29DER2
78558
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
payment made to the claimant set out in
paragraph (b) of this section.
(b) The percentages referred to in
paragraph (a) of this section are:
(1) 2 percent for the filing of an initial
claim with OWCP, provided that the
representative was retained prior to the
filing of the initial claim; plus
(2) 10 percent of the difference
between the lump-sum payment made
to the claimant and the amount
proposed in the recommended decision
with respect to objections to a
recommended decision.
(c)(1) Any representative who violates
this section shall be fined not more than
$5,000.
(2) The authority to prosecute
violations of this limitation lies with the
Department of Justice.
(d) The fee limitations described in
this section shall not apply with respect
to representative services that are
rendered in connection with a petition
filed with a U.S. District Court seeking
review of an OWCP decision that is final
pursuant to § 30.316(d), or with respect
to any subsequent appeal in such a
proceeding.
Third Party Liability
§ 30.605 What rights does the United
States have upon payment of compensation
under EEOICPA?
If an occupational illness or covered
illness for which compensation is
payable under EEOICPA is caused,
wholly or partially, by someone other
than a federal employee acting within
the scope of his or her employment, a
DOE contractor or subcontractor, a
beryllium vendor, an atomic weapons
employer or a RECA section 5 mine or
mill, the United States is subrogated for
the full amount of any payment of
compensation under EEOICPA to any
right or claim that the individual to
whom the payment was made may have
against any person or entity on account
of such occupational illness or covered
illness.
pwalker on PROD1PC60 with RULES2
§ 30.606 Under what circumstances must a
recovery of money or other property in
connection with an illness for which
benefits are payable under EEOICPA be
reported to OWCP?
Any person who has filed an
EEOICPA claim that has been accepted
by OWCP (whether or not compensation
has been paid), or who has received
EEOICPA benefits in connection with a
claim filed by another, is required to
notify OWCP of the receipt of money or
other property as a result of a settlement
or judgment in connection with the
circumstances of that claim.
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
§ 30.607 How is a structured settlement
(that is, a settlement providing for receipt of
funds over a specified period of time)
treated for purposes of reporting the
recovery?
In this situation, the recovery to be
reported is the present value of the right
to receive all of the payments included
in the structured settlement, allocated in
the case of multiple recipients in the
same manner as single payment
recoveries.
§ 30.608 How does the United States
calculate the amount to which it is
subrogated?
The subrogated amount of a specific
claim consists of the total money paid
by OWCP from the Energy Employees
Occupational Illness Compensation
Fund with respect to that claim to or on
behalf of a covered Part B employee, a
covered Part E employee or an eligible
surviving beneficiary, less charges for
any medical file review (i.e., the
physician did not examine the
employee) done at the request of OWCP.
Charges for medical examinations also
may be subtracted if the covered Part B
employee, covered Part E employee or
an eligible surviving beneficiary
establishes that the examinations were
required to be made available to the
covered Part B employee or covered Part
E employee under a statute other than
EEOICPA.
§ 30.609 Is a settlement or judgment
received as a result of allegations of
medical malpractice in treating an illness
covered by EEOICPA a recovery that must
be reported to OWCP?
Since an injury caused by medical
malpractice in treating an occupational
illness or covered illness compensable
under EEOICPA is also covered under
EEOICPA, any recovery in a suit
alleging such an injury is treated as a
recovery that must be reported to
OWCP.
§ 30.610 Are payments to a covered Part B
employee, a covered Part E employee or an
eligible surviving beneficiary as a result of
an insurance policy which the employee or
eligible surviving beneficiary has
purchased a recovery that must be reported
to OWCP?
Since payments received by a covered
Part B employee, a covered Part E
employee or an eligible surviving
beneficiary pursuant to an insurance
policy purchased by someone other than
a liable third party are not payments in
satisfaction of liability for causing an
occupational illness or covered illness
compensable under the Act, they are not
considered a recovery that must be
reported to OWCP.
PO 00000
Frm 00040
Fmt 4701
Sfmt 4700
§ 30.611 If a settlement or judgment is
received for more than one medical
condition, can the amount paid on a single
EEOICPA claim be attributed to different
conditions for purposes of calculating the
amount to which the United States is
subrogated?
(a) All medical conditions accepted
by OWCP in connection with a single
claim are treated as the same illness for
the purpose of computing the amount
which the United States is entitled to
offset in connection with the receipt of
a recovery from a third party, except
that an injury caused by medical
malpractice in treating an illness
covered under EEOICPA will be treated
as a separate injury.
(b) If an illness covered under
EEOICPA is caused under
circumstances creating a legal liability
in more than one person, other than the
United States, a DOE contractor or
subcontractor, a beryllium vendor or an
atomic weapons employer, to pay
damages, OWCP will determine whether
recoveries received from one or more
third parties should be attributed to
separate conditions for which
compensation is payable in connection
with a single EEOICPA claim. If such an
attribution is both practicable and
equitable, as determined by OWCP, in
its discretion, the conditions will be
treated as separate injuries for purposes
of calculating the amount to which the
United States is subrogated.
Effect of Tort Suits Against Beryllium
Vendors and Atomic Weapons
Employers
§ 30.615 What type of tort suits filed
against beryllium vendors or atomic
weapons employers may disqualify certain
claimants from receiving benefits under
Part B of EEOICPA?
(a) A tort suit (other than an
administrative or judicial proceeding for
workers’ compensation) that includes a
claim arising out of a covered Part B
employee’s employment-related
exposure to beryllium or radiation, filed
against a beryllium vendor or an atomic
weapons employer, by a covered Part B
employee or an eligible surviving
beneficiary or beneficiaries of a
deceased covered Part B employee, will
disqualify that otherwise eligible
individual or individuals from receiving
benefits under Part B of EEOICPA
unless such claim is terminated in
accordance with the requirements of
§§ 30.616 through 30.619 of these
regulations.
(b) The term ‘‘claim arising out of a
covered Part B employee’s employmentrelated exposure to beryllium or
radiation’’ used in paragraph (a) of this
section includes a claim that is
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
derivative of a covered Part B
employee’s employment-related
exposure to beryllium or radiation, such
as a claim for loss of consortium raised
by a covered Part B employee’s spouse.
(c) If all claims arising out of a
covered Part B employee’s employmentrelated exposure to beryllium or
radiation are terminated in accordance
with the requirements of §§ 30.616
through 30.619 of these regulations,
proceeding with the remaining portion
of the tort suit filed against a beryllium
vendor or an atomic weapons employer
will not disqualify an otherwise eligible
individual or individuals from receiving
benefits under Part B of EEOICPA.
§ 30.616 What happens if this type of tort
suit was filed prior to October 30, 2000?
(a) If a tort suit described in § 30.615
was filed prior to October 30, 2000, the
claimant or claimants will not be
disqualified from receiving any
EEOICPA benefits to which they may be
found entitled if the tort suit was
terminated in any manner prior to
December 28, 2001.
(b) If a tort suit described in § 30.615
was filed prior to October 30, 2000 and
was pending as of December 28, 2001,
the claimant or claimants will be
disqualified from receiving any benefits
under Part B of EEOICPA unless they
dismissed all claims arising out of a
covered Part B employee’s employmentrelated exposure to beryllium or
radiation that were included in the tort
suit prior to December 31, 2003.
pwalker on PROD1PC60 with RULES2
§ 30.617 What happens if this type of tort
suit was filed during the period from
October 30, 2000 through December 28,
2001?
(a) If a tort suit described in § 30.615
was filed during the period from
October 30, 2000 through December 28,
2001, the claimant or claimants will be
disqualified from receiving any benefits
under Part B of EEOICPA unless they
dismiss all claims arising out of a
covered Part B employee’s employmentrelated exposure to beryllium or
radiation that are included in the tort
suit on or before the last permissible
date described in paragraph (b) of this
section.
(b) The last permissible date is the
later of:
(1) April 30, 2003; or
(2) The date that is 30 months after
the date the claimant or claimants first
became aware that an illness of the
covered Part B employee may be
connected to his or her exposure to
beryllium or radiation covered by
EEOICPA. For purposes of determining
when this 30-month period begins, ‘‘the
date the claimant or claimants first
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
became aware’’ will be deemed to be the
date they received either a reconstructed
dose from HHS, or a diagnosis of a
covered beryllium illness, as applicable.
§ 30.618 What happens if this type of tort
suit was filed after December 28, 2001?
(a) If a tort suit described in § 30.615
was filed after December 28, 2001, the
claimant or claimants will be
disqualified from receiving any benefits
under Part B of EEOICPA if a judgment
is entered against them.
(b) If a tort suit described in § 30.615
was filed after December 28, 2001 and
a judgment has not yet been entered
against the claimant or claimants, they
will also be disqualified from receiving
any benefits under Part B of EEOICPA
unless, prior to entry of any judgment,
they dismiss all claims arising out of a
covered Part B employee’s employmentrelated exposure to beryllium or
radiation that are included in the tort
suit on or before the last permissible
date described in paragraph (c) of this
section.
(c) The last permissible date is the
later of:
(1) April 30, 2003; or
(2) The date that is 30 months after
the date the claimant or claimants first
became aware that an illness of the
covered Part B employee may be
connected to his or her exposure to
beryllium or radiation covered by
EEOICPA. For purposes of determining
when this 30-month period begins, ‘‘the
date the claimant or claimants first
became aware’’ will be deemed to be the
date they received either a reconstructed
dose from HHS, or a diagnosis of a
covered beryllium illness, as applicable.
§ 30.619 Do all the parties to this type of
tort suit have to take these actions?
The type of tort suits described in
§ 30.615 may be filed by more than one
individual, each with a different cause
of action. For example, a tort suit may
be filed against a beryllium vendor by
both a covered Part B employee and his
or her spouse, with the covered Part B
employee claiming for chronic
beryllium disease and the spouse
claiming for loss of consortium due to
the covered Part B employee’s exposure
to beryllium. However, since the spouse
of a living covered Part B employee
could not be an eligible surviving
beneficiary under Part B of EEOICPA,
the spouse would not have to comply
with the termination requirements of
§§ 30.616 through 30.618. A similar
result would occur if a tort suit were
filed by both the spouse of a deceased
covered Part B employee and other
family members (such as children of the
deceased covered part B employee). In
PO 00000
Frm 00041
Fmt 4701
Sfmt 4700
78559
this case, the spouse would be the only
eligible surviving beneficiary of the
deceased covered Part B employee
under Part B of the EEOICPA because
the other family members could not be
eligible for benefits while he or she was
alive. As a result, the spouse would be
the only party to the tort suit who
would have to comply with the
termination requirements of §§ 30.616
through 30.618.
§ 30.620 How will OWCP ascertain whether
a claimant filed this type of tort suit and if
he or she has been disqualified from
receiving any benefits under Part B of
EEOICPA?
Prior to authorizing payment on a
claim under Part B of EEOICPA, OWCP
will require each claimant to execute
and provide an affidavit stating if he or
she filed a tort suit (other than an
administrative or judicial proceeding for
workers’ compensation) against either a
beryllium vendor or an atomic weapons
employer that included a claim arising
out of a covered Part B employee’s
employment-related exposure to
beryllium or radiation, and if so, the
current status of such tort suit. OWCP
may also require the submission of any
supporting evidence necessary to
confirm the particulars of any affidavit
provided under this section.
Coordination of Part E Benefits With
State Workers’ Compensation Benefits
§ 30.625 What does ‘‘coordination of
benefits’’ mean under Part E of EEOICPA?
In general, ‘‘coordination of benefits’’
under Part E of the Act occurs when
compensation to be received under Part
E is reduced by OWCP, pursuant to
section 7385s–11 of EEOICPA, to reflect
certain benefits the beneficiary receives
under a state workers’ compensation
program for the same covered illness.
§ 30.626 How will OWCP coordinate
compensation payable under Part E of
EEOICPA with benefits from state workers’
compensation programs?
(a) OWCP will reduce the
compensation payable under Part E by
the amount of benefits the claimant
receives from a state workers’
compensation program by reason of the
same covered illness, after deducting
the reasonable costs to the claimant of
obtaining those benefits.
(b) To determine the amount of any
reduction of EEOICPA compensation,
OWCP shall require the covered Part E
employee or each eligible surviving
beneficiary filing a claim under Part E
to execute and provide affidavits
reporting the amount of any benefit
received pursuant to a claim filed in a
state workers’ compensation program
for the same covered illness.
E:\FR\FM\29DER2.SGM
29DER2
pwalker on PROD1PC60 with RULES2
78560
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
(c) If a covered Part E employee or a
survivor of such employee receives
benefits through a state workers’
compensation program pursuant to a
claim for the same covered illness,
OWCP shall reduce a portion of the
dollar amount of such state workers’
benefit from the compensation payable
under Part E. OWCP will calculate the
net amount of the state workers’
compensation benefit amount to be
subtracted from the compensation
payment under Part E in the following
manner:
(1) OWCP will first determine the
dollar value of the benefits received by
that individual from a state workers’
compensation program by including all
benefits, other than medical and
vocational rehabilitation benefits,
received for the same covered illness or
injury sustained as a consequence of a
covered illness.
(2) OWCP will then make certain
deductions from the above dollar benefit
received under a state workers’
compensation program to arrive at the
dollar amount that will be subtracted
from any compensation payable under
Part E of EEOICPA.
(i) Allowable deductions consist of
reasonable costs in obtaining state
workers’ compensation benefits
incurred by that individual, including
but not limited to attorney’s fees OWCP
deems reasonable and itemized costs of
suit (out-of-pocket expenditures not part
of the normal overhead of a law firm’s
operation like filing, travel expenses,
witness fees, and court reporter costs for
transcripts), provided that adequate
supporting documentation is submitted
to OWCP for its consideration.
(ii) The EEOICPA benefits that will be
reduced will consist of any unpaid
monetary payments payable in the
future and medical benefits payable in
the future. In those cases where it has
not yet paid EEOICPA benefits under
Part E, OWCP will reduce such benefits
on a dollar-for-dollar basis, beginning
with the current monetary payments
first. If the amount to be subtracted
exceeds the monetary payments
currently payable, OWCP will reduce
ongoing EEOICPA medical benefits
payable in the future by the amount of
any remaining surplus. This means that
OWCP will apply the amount it would
otherwise pay to reimburse the covered
Part E employee for any ongoing
EEOICPA medical treatment to the
remaining surplus until it is absorbed
(or until further monetary benefits
become payable that are sufficient to
absorb the surplus).
(3) The above coordination of benefits
will not occur if the beneficiary under
a state workers’ compensation program
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
receives state workers’ compensation
benefits for both a covered and a noncovered illness arising out of and in the
course of the same work-related
incident.
§ 30.627 Under what circumstances will
OWCP waive the statutory requirement to
coordinate these benefits?
A waiver to the requirement to
coordinate Part E benefits with benefits
paid under a state workers’
compensation program may be granted
if OWCP determines that the
administrative costs and burdens of
coordinating benefits in a particular
case or class of cases justifies the
waiver. This decision is exclusively
within the discretion of OWCP.
Subpart H—Information for Medical
Providers
Medical Records and Bills
§ 30.700 What kinds of medical records
must providers keep?
Federal Government medical officers,
private physicians and hospitals are
required to keep records of all cases
treated by them under EEOICPA so they
can supply OWCP with a history of the
claimed occupational illness or covered
illness, a description of the nature and
extent of the claimed occupational
illness or covered illness, the results of
any diagnostic studies performed, and
the nature of the treatment rendered.
This requirement terminates after a
provider has supplied OWCP with the
above-noted information, and otherwise
terminates ten years after the record was
created.
§ 30.701 How are medical bills to be
submitted?
(a) All charges for medical and
surgical treatment, appliances or
supplies furnished to employees, except
for treatment and supplies provided by
nursing homes, shall be supported by
medical evidence as provided in
§ 30.700. The physician or provider
shall itemize the charges on Form
OWCP–1500 or CMS–1500 (for
professional charges), Form OWCP–04
or UB–04 (for hospitals), an electronic
or paper-based bill that includes
required data elements (for pharmacies),
or other form as warranted, and submit
the form or bill promptly for processing.
(b) The provider shall identify each
service performed using the Physician’s
Current Procedural Terminology (CPT)
code, the Healthcare Common
Procedure Coding System (HCPCS)
code, the National Drug Code (NDC)
number, or the Revenue Center Code
(RCC), with a brief narrative description.
Where no code is applicable, a detailed
PO 00000
Frm 00042
Fmt 4701
Sfmt 4700
description of services performed
should be provided.
(c) For professional charges billed on
Form OWCP–1500 or CMS–1500, the
provider shall also state each diagnosed
condition and furnish the corresponding
diagnostic code using the ‘‘International
Classification of Disease, 9th Edition,
Clinical Modification’’ (ICD–9–CM), or
as revised. A separate bill shall be
submitted when the employee is
discharged from treatment or monthly,
if treatment for the occupational illness
is necessary for more than 30 days.
(1)(i) Hospitals shall submit charges
for medical and surgical treatment or
supplies promptly on Form OWCP–04
or UB–04. The provider shall identify
each outpatient radiology service,
outpatient pathology service and
physical therapy service performed,
using HCPCS/CPT codes with a brief
narrative description. The charge for
each individual service, or the total
charge for all identical services, should
also appear on the form.
(ii) Other outpatient hospital services
for which HCPCS/CPT codes exist shall
also be coded individually using the
coding scheme noted in this section.
Services for which there are no HCPCS/
CPT codes available can be presented
using the RCCs described in the
‘‘National Uniform Billing Data
Elements Specifications,’’ current
edition. The provider shall also furnish
the diagnostic code using the ICD–9–
CM. If the outpatient hospital services
include surgical and/or invasive
procedures, the provider shall code each
procedure using the proper HCPCS/CPT
codes and furnishing the corresponding
diagnostic codes using the ICD–9–CM.
(2) Pharmacies shall itemize charges
for prescription medications,
appliances, or supplies on electronic or
paper-based bills and submit them
promptly for processing. Bills for
prescription medications must include
all required data elements, including the
NDC number assigned to the product,
the generic or trade name of the drug
provided, the prescription number, the
quantity provided, and the date the
prescription was filled.
(3) Nursing homes shall itemize
charges for appliances, supplies or
services on the provider’s billhead
stationery and submit them promptly
for processing.
(d) By submitting a bill and/or
accepting payment, the provider
signifies that the service for which
payment is sought was performed as
described and was necessary. In
addition, the provider thereby agrees to
comply with all regulations set forth in
this subpart concerning the rendering of
treatment and/or the process for seeking
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
payment for medical services, including
the limitation imposed on the amount to
be paid for such services.
(e) In summary, bills submitted by
providers must: Be itemized on Form
OWCP–1500 or CMS–1500 (for
physicians), Form OWCP–04 or UB–04
(for hospitals), or an electronic or paperbased bill that includes required data
elements (for pharmacies); contain the
signature or signature stamp of the
provider; and identify the procedures
using HCPCS/CPT codes, RCCs, or NDC
numbers. Otherwise, the bill may be
returned to the provider for correction
and resubmission. The decision of
OWCP whether to pay a provider’s bill
is final when issued and is not subject
to the adjudicatory process described in
subpart D of this part.
pwalker on PROD1PC60 with RULES2
§ 30.702 How should an employee prepare
and submit requests for reimbursement for
medical expenses, transportation costs,
loss of wages, and incidental expenses?
(a) If an employee has paid bills for
medical, surgical or other services,
supplies or appliances provided by a
professional due to an occupational
illness or a covered illness, he or she
must submit a request for
reimbursement on Form OWCP–915,
together with an itemized bill on Form
OWCP–1500 or CMS–1500 prepared by
the provider and a medical report as
provided in § 30.700, for consideration.
(1) The provider of such service shall
state each diagnosed condition and
furnish the applicable ICD–9–CM code
and identify each service performed
using the applicable HCPCS/CPT code,
with a brief narrative description of the
service performed, or, where no code is
applicable, a detailed description of that
service.
(2) The reimbursement request must
be accompanied by evidence that the
provider received payment for the
service from the employee and a
statement of the amount paid.
Acceptable evidence that payment was
received includes, but is not limited to,
a signed statement by the provider, a
mechanical stamp or other device
showing receipt of payment, a copy of
the employee’s canceled check (both
front and back) or a copy of the
employee’s credit card receipt.
(b) If a hospital, pharmacy or nursing
home provided services for which the
employee paid, the employee must also
use Form OWCP–915 to request
reimbursement and should submit the
request in accordance with the
provisions of § 30.701(a). Any such
request for reimbursement must be
accompanied by evidence, as described
in paragraph (a)(2) of this section, that
the provider received payment for the
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
service from the employee and a
statement of the amount paid.
(c) The requirements of paragraphs (a)
and (b) of this section may be waived if
extensive delays in the filing or the
adjudication of a claim make it
unusually difficult for the employee to
obtain the required information.
(d) Copies of bills submitted for
reimbursement will not be accepted
unless they bear the original signature of
the provider and evidence of payment.
Payment for medical and surgical
treatment, appliances or supplies shall
in general be no greater than the
maximum allowable charge for such
service determined by OWCP, as set
forth in § 30.705. The decision of OWCP
whether to reimburse an employee for
out-of-pocket medical expenses, and the
amount of any reimbursement, is final
when issued and is not subject to the
adjudicatory process described in
subpart D of this part.
(e) An employee will be only partially
reimbursed for a medical expense if the
amount he or she paid to a provider for
the service exceeds the maximum
allowable charge set by OWCP’s
schedule. If this happens, the employee
will be advised of the maximum
allowable charge for the service in
question and of his or her responsibility
to ask the provider to refund to the
employee, or credit to the employee’s
account, the amount he or she paid
which exceeds the maximum allowable
charge. The provider that the employee
paid, but not the employee, may request
reconsideration of the fee determination
as set forth in § 30.712.
(f) If the provider fails to make
appropriate refund to the employee, or
to credit the employee’s account, within
60 days after the employee requests a
refund of any excess amount, or the date
of a subsequent reconsideration
decision which continues to disallow all
or a portion of the disputed amount,
OWCP will initiate exclusion
procedures as provided by § 30.715.
(g) If the provider does not refund to
the employee or credit to his or her
account the amount of money paid in
excess of the allowed charge, the
employee should submit documentation
of the attempt to obtain such refund or
credit to OWCP. OWCP may authorize
reasonable reimbursement to the
employee after reviewing the facts and
circumstances of the case.
§ 30.703 What are the time limitations on
OWCP’s payment of bills?
OWCP will pay providers and
reimburse employees promptly for all
bills received on an approved form and
in a timely manner. However, no bill
will be paid for expenses incurred if the
PO 00000
Frm 00043
Fmt 4701
Sfmt 4700
78561
bill is submitted more than one year
beyond the end of the calendar year in
which the expense was incurred or the
service or supply was provided, or more
than one year beyond the end of the
calendar year in which the claim was
first accepted as compensable by OWCP,
whichever is later.
Medical Fee Schedule
§ 30.705 What services are covered by the
OWCP fee schedule?
(a) Payment for medical and other
health services furnished by physicians,
hospitals and other providers for
occupational illnesses or covered
illnesses shall not exceed a maximum
allowable charge for such service as
determined by OWCP, except as
provided in this section.
(b) The schedule of maximum
allowable charges does not apply to
charges for services provided in nursing
homes, but it does apply to charges for
treatment furnished in a nursing home
by a physician or other medical
professional.
(c) The schedule of maximum
allowable charges also does not apply to
charges for appliances, supplies,
services or treatment furnished by
medical facilities of the U.S. Public
Health Service or the Departments of the
Army, Navy, Air Force and Veterans
Affairs.
§ 30.706 How are the maximum fees
defined?
For professional medical services,
OWCP shall maintain a schedule of
maximum allowable fees for procedures
performed in a given locality. The
schedule shall consist of: An assignment
of a value to procedures identified by
HCPCS/CPT code which represents the
relative skill, effort, risk and time
required to perform the procedure, as
compared to other procedures of the
same general class; an index based on a
relative value scale that considers skill,
labor, overhead, malpractice insurance
and other related costs; and a monetary
value assignment (conversion factor) for
one unit of value in each of the
categories of service.
§ 30.707 How are payments for particular
services calculated?
Payment for a procedure identified by
a HCPCS/CPT code shall not exceed the
amount derived by multiplying the
relative values for that procedure by the
geographic indices for services in that
area and by the dollar amount assigned
to one unit in that category of service.
(a) The ‘‘locality’’ which serves as a
basis for the determination of average
cost is defined by the Bureau of Census
Metropolitan Statistical Areas. OWCP
E:\FR\FM\29DER2.SGM
29DER2
78562
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
shall base the determination of the
relative per capita cost of medical care
in a locality using information about
enrollment and medical cost per county,
provided by the Centers for Medicare
and Medicaid Services (CMS).
(b) OWCP shall assign the relative
value units (RVUs) published by CMS to
all services for which CMS has made
assignments, using the most recent
revision. Where there are no RVUs
assigned to a procedure, OWCP may
develop and assign any RVUs
considered appropriate. The geographic
adjustment factor shall be that
designated by Geographic Practice Cost
Indices for Metropolitan Statistical
Areas as devised for CMS and as
updated or revised by CMS from time to
time. OWCP will devise conversion
factors for each category of service, and
in doing so may adapt CMS conversion
factors as appropriate using OWCP’s
processing experience and internal data.
(c) For example, if the unit values for
a particular surgical procedure are 2.48
for physician’s work (W), 3.63 for
practice expense (PE), and 0.48 for
malpractice insurance (M), and the
dollar value assigned to one unit in that
category of service (surgery) is $61.20,
then the maximum allowable charge for
one performance of that procedure is the
product of the three RVUs times the
corresponding geographical indices for
the locality times the conversion factor.
If the geographic indices for the locality
are 0.988(W), 0.948 (PE), and 1.174 (M),
then the maximum payment calculation
is:
[(2.48)(0.988) + (3.63)(0.948) + (0.48)(1.174)]
× $61.20
[2.45 + 3.44 + .56] × $61.20
6.45 × $61.20 = $394.74
§ 30.708 Does the fee schedule apply to
every kind of procedure?
pwalker on PROD1PC60 with RULES2
Where the time, effort and skill
required to perform a particular
procedure vary widely from one
occasion to the next, OWCP may choose
not to assign a relative value to that
procedure. In this case the allowable
charge for the procedure will be set
individually based on consideration of a
detailed medical report and other
evidence. At its discretion, OWCP may
set fees without regard to schedule
limits for specially authorized
consultant examinations, for directed
medical examinations, and for other
specially authorized services.
§ 30.709 How are payments for medicinal
drugs determined?
Payment for medicinal drugs
prescribed by physicians shall not
exceed the amount derived by
multiplying the average wholesale price
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
of the medication by the quantity or
amount provided, plus a dispensing fee.
(a) All prescription medications
identified by NDC number will be
assigned an average wholesale price
representing the product’s nationally
recognized wholesale price as
determined by surveys of manufacturers
and wholesalers. OWCP will establish
the dispensing fee.
(b) The NDC numbers, the average
wholesale prices, and the dispensing fee
shall be reviewed from time to time and
updated as necessary.
§ 30.710 How are payments for inpatient
medical services determined?
(a) OWCP will pay for inpatient
medical services according to predetermined, condition-specific rates
based on the Prospective Payment
System (PPS) devised by CMS (42 CFR
parts 412, 413, 424, 485, and 489). Using
this system, payment is derived by
multiplying the diagnosis-related group
(DRG) weight assigned to the hospital
discharge by the provider-specific
factors.
(1) All hospital discharges will be
classified according to the DRGs
prescribed by CMS in the form of the
DRG Grouper software program. On this
list, each DRG represents the average
resources necessary to provide care in a
case in that DRG relative to the national
average of resources consumed per case.
(2) The provider-specific factors will
be provided by CMS in the form of their
PPS Pricer software program. The
software takes into consideration the
type of facility, census division, actual
geographic location of the hospital, case
mix cost per discharge, number of
hospital beds, intern/beds ratio,
operating cost to charge ratio, and other
factors used by CMS to determine the
specific rate for a hospital discharge
under their PPS. OWCP may devise
price adjustment factors as appropriate
using OWCP’s processing experience
and internal data.
(3) OWCP will base payments to
facilities excluded from CMS’s PPS on
consideration of detailed medical
reports and other evidence.
(4) OWCP shall review the predetermined hospital rates at least once
a year, and may adjust any or all
components when OWCP deems it
necessary or appropriate.
(b) OWCP shall review the schedule
of fees at least once a year, and may
adjust the schedule or any of its
components when OWCP deems it
necessary or appropriate.
§ 30.711
When and how are fees reduced?
(a) OWCP shall accept a provider’s
designation of the code to identify a
PO 00000
Frm 00044
Fmt 4701
Sfmt 4700
billed procedure or service if the code
is consistent with medical reports and
other evidence. Where no code is
supplied, OWCP may determine the
code based on the narrative description
of the procedure on the billing form and
in associated medical reports. OWCP
will pay no more than the maximum
allowable fee for that procedure.
(b) If the charge submitted for a
service supplied to an employee
exceeds the maximum amount
determined to be reasonable according
to the schedule, OWCP shall pay the
amount allowed by the schedule for that
service and shall notify the provider in
writing that payment was reduced for
that service in accordance with the
schedule. OWCP shall also notify the
provider of the method for requesting
reconsideration of the balance of the
charge. The decision of OWCP to pay
less than the charged amount is final
when issued and is not subject to the
adjudicatory process described in
subpart D of this part.
§ 30.712 If OWCP reduces a fee, may a
provider request reconsideration of the
reduction?
(a) A physician or other provider
whose charge for service is only
partially paid because it exceeds a
maximum allowable amount set by
OWCP may, within 30 days, request
reconsideration of the fee
determination.
(1) Any such request will be
considered by the district office with
jurisdiction over the employee’s claim.
The request must be accompanied by
documentary evidence that the
procedure performed was either
incorrectly identified by the original
code, that the presence of a severe or
concomitant medical condition made
treatment especially difficult, or that the
provider possessed unusual
qualifications. In itself, board
certification in a specialty is not
sufficient evidence of unusual
qualifications to justify a charge in
excess of the maximum allowable
amount set by OWCP. These are the
only three circumstances that will
justify reevaluation of the paid amount.
(2) A list of district offices and their
respective areas of jurisdiction is
available upon request from the U.S.
Department of Labor, Office of Workers’
Compensation Programs, Washington,
DC 20210, or on the Internet at https://
www.dol.gov/esa/regs/compliance/
owcp/eeoicp/main.htm. Within 30 days
of receiving the request for
reconsideration, the district office shall
respond in writing stating whether or
not an additional amount will be
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
allowed as reasonable, considering the
evidence submitted.
(b) If the district office issues a
decision that continues to disallow a
contested amount, the provider may
apply to the Regional Director of the
region with jurisdiction over the district
office. The application must be filed
within 30 days of the date of such
decision, and it may be accompanied by
additional evidence. Within 60 days of
receipt of such application, the Regional
Director shall issue a decision in writing
stating whether or not an additional
amount will be allowed as reasonable,
considering the evidence submitted.
§ 30.713 If OWCP reduces a fee, may a
provider bill the employee for the balance?
A provider whose fee for service is
partially paid by OWCP as a result of
the application of its fee schedule or
other tests for reasonableness in
accordance with this part shall not
request payment from the employee for
the unpaid amount of the provider’s
bill.
(a) Where a provider’s fee for a
particular service or procedure is lower
to the general public than as provided
by the schedule of maximum allowable
charges, the provider shall bill at the
lower rate. A fee for a particular service
or procedure which is higher than the
provider’s fee to the general public for
that same service or procedure will be
considered a charge ‘‘substantially in
excess of such provider’s customary
charges’’ for the purposes of § 30.715(d).
(b) A provider whose fee for service
is partially paid by OWCP as the result
of the application of the schedule of
maximum allowable charges and who
collects or attempts to collect from the
employee, either directly or through a
collection agent, any amount in excess
of the charge allowed by OWCP, and
who does not cease such action or make
appropriate refund to the employee
within 60 days of the date of the
decision of OWCP, shall be subject to
the exclusion procedures provided by
§ 30.715(h).
Exclusion of Providers
pwalker on PROD1PC60 with RULES2
§ 30.715 What are the grounds for
excluding a provider from payment under
this part?
A physician, hospital, or provider of
medical services or supplies shall be
excluded from payment under this part
if such physician, hospital or provider
has:
(a) Been convicted under any criminal
statute of fraudulent activities in
connection with any federal or state
program for which payments are made
to providers for similar medical,
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
surgical or hospital services, appliances
or supplies;
(b) Been excluded or suspended, or
has resigned in lieu of exclusion or
suspension, from participation in any
federal or state program referred to in
paragraph (a) of this section;
(c) Knowingly made, or caused to be
made, any false statement or
misrepresentation of a material fact in
connection with a determination of the
right to reimbursement under this part,
or in connection with a request for
payment;
(d) Submitted, or caused to be
submitted, three or more bills or
requests for payment within a 12-month
period under this subpart containing
charges which OWCP finds to be
substantially in excess of such
provider’s customary charges, unless
OWCP finds there is good cause for the
bills or requests containing such
charges;
(e) Knowingly failed to timely
reimburse employees for treatment,
services or supplies furnished under
this subpart and paid for by OWCP;
(f) Failed, neglected or refused on
three or more occasions during a 12month period to submit full and
accurate medical reports, or to respond
to requests by OWCP for additional
reports or information, as required by
§ 30.700 of this part;
(g) Knowingly furnished treatment,
services or supplies which are
substantially in excess of the employee’s
needs, or of a quality which fails to meet
professionally recognized standards; or
(h) Collected or attempted to collect
from the employee, either directly or
through a collection agent, an amount in
excess of the charge allowed by OWCP
for the procedure performed, and has
failed or refused to make appropriate
refund to the employee, or to cease such
collection attempts, within 60 days of
the date of the decision of OWCP.
§ 30.716 What will cause OWCP to
automatically exclude a physician or other
provider of medical services and supplies?
(a) OWCP shall automatically exclude
a physician, hospital, or provider of
medical services or supplies who:
(1) Has been convicted of a crime
described in § 30.715(a); or
(2) Has been excluded or suspended,
or has resigned in lieu of exclusion or
suspension, from participation in any
federal or state program for which
payments are made to providers for
similar medical, surgical or hospital
services, appliances or supplies.
(b) The exclusion applies to
participating in the program and to
seeking payment under this part for
services performed after the date of the
PO 00000
Frm 00045
Fmt 4701
Sfmt 4700
78563
entry of the judgment of conviction or
order of exclusion, suspension or
resignation, as the case may be, by the
court or agency concerned. Proof of the
conviction, exclusion, suspension or
resignation may consist of a copy
thereof authenticated by the seal of the
court or agency concerned.
§ 30.717 When are OWCP’s exclusion
procedures initiated?
Upon receipt of information
indicating that a physician, hospital or
provider of medical services or supplies
(hereinafter the provider) has engaged in
activities enumerated in paragraphs (c)
through (h) of § 30.715, the Regional
Director, after completion of inquiries
he or she deems appropriate, may
initiate procedures to exclude the
provider from participation in the
EEOICPA program. For the purposes of
these procedures, ‘‘Regional Director’’
may include any officer designated to
act on his or her behalf.
§ 30.718 How is a provider notified of
OWCP’s intent to exclude him or her?
The Regional Director shall initiate
the exclusion process by sending the
provider a letter, by certified mail and
with return receipt requested, which
shall contain the following:
(a) A concise statement of the grounds
upon which exclusion shall be based;
(b) A summary of the information,
with supporting documentation, upon
which the Regional Director has relied
in reaching an initial decision that
exclusion proceedings should begin;
(c) An invitation to the provider to:
(1) Resign voluntarily from
participation in the EEOICPA program
without admitting or denying the
allegations presented in the letter; or
(2) Request that the decision on
exclusion be based upon the existing
record and any additional documentary
information the provider may wish to
furnish;
(d) A notice of the provider’s right, in
the event of an adverse ruling by the
Regional Director, to request a formal
hearing before an administrative law
judge;
(e) A notice that should the provider
fail to answer (as described in § 30.719)
the letter of intent within 30 calendar
days of receipt, the Regional Director
may deem the allegations made therein
to be true and may order exclusion of
the provider without conducting any
further proceedings; and
(f) The name and address of the
OWCP representative who shall be
responsible for receiving the answer
from the provider.
E:\FR\FM\29DER2.SGM
29DER2
78564
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
§ 30.719 What requirements must the
provider’s reply and OWCP’s decision
meet?
(a) The provider’s answer shall be in
writing and shall include an answer to
OWCP’s invitation to resign voluntarily.
If the provider does not offer to resign,
he or she shall request that a
determination be made upon the
existing record and any additional
information provided.
(b) Should the provider fail to answer
the letter of intent within 30 calendar
days of receipt, the Regional Director
may deem the allegations made therein
to be true and may order exclusion of
the provider.
(c) By arrangement with the OWCP
representative, the provider may inspect
or request copies of information in the
record at any time prior to the Regional
Director’s decision.
(d) The Regional Director shall issue
his or her decision in writing, and shall
send a copy of the decision to the
provider by certified mail, return receipt
requested. The decision shall advise the
provider of his or her right to request,
within 30 days of the date of the adverse
decision, a formal hearing before an
administrative law judge under the
procedures set forth in § 30.720. The
filing of a request for a hearing within
the time specified shall stay the
effectiveness of the decision to exclude.
issue a Notice of Hearing and Hearing
Schedule for the conduct of the hearing.
A copy of the hearing notice shall be
served on the provider by certified mail,
return receipt requested. The Notice of
Hearing and Hearing Schedule shall
include:
(1) A ruling on each item raised in the
request for hearing;
(2) A schedule for the prompt
disposition of all preliminary matters,
including requests for more definite
statements and for the certification of
questions to advisory bodies; and
(3) A scheduled hearing date not less
than 30 days after the date the schedule
is issued, and not less than 15 days after
the scheduled conclusion of preliminary
matters, provided that the specific time
and place of the hearing may be set on
10 days’ notice.
(b) The purpose of the designation of
issues is to provide for an effective
hearing process. The provider is entitled
to be heard on any matter placed in
issue by his or her response to the
Notice of Intent to Exclude, and may
designate ‘‘all issues’’ for purposes of
hearing. However, a specific designation
of issues is required if the provider
wishes to interpose affirmative defenses
or request the certification of questions
for an advisory opinion.
§ 30.720 How can an excluded provider
request a hearing?
§ 30.722 How are subpoenas or advisory
opinions obtained?
A request for a hearing shall be sent
to the OWCP representative named
pursuant to § 30.718(f) and shall
contain:
(a) A concise notice of the issues on
which the provider desires to give
evidence at the hearing;
(b) Any request for a more definite
statement by OWCP;
(c) Any request for the presentation of
oral argument or evidence; and
(d) Any request for a certification of
questions concerning professional
medical standards, medical ethics or
medical regulation for an advisory
opinion from a competent recognized
professional organization or federal,
state or local regulatory body.
(a) In exclusion proceedings involving
medical services provided under Part B
of the Act only, the provider may apply
to the administrative law judge for the
issuance of subpoenas upon a showing
of good cause therefore.
(b) A certification of a request for an
advisory opinion concerning
professional medical standards, medical
ethics or medical regulation to a
competent recognized or professional
organization or federal, state or local
regulatory agency may be made:
(1) As to an issue properly designated
by the provider, in the sound discretion
of the administrative law judge,
provided that the request will not
unduly delay the proceedings;
(2) By OWCP on its own motion either
before or after the institution of
proceedings, and the results thereof
shall be made available to the provider
at the time that proceedings are
instituted or, if after the proceedings are
instituted, within a reasonable time after
receipt. The opinion, if rendered by the
organization or agency, is advisory only
and not binding on the administrative
law judge.
pwalker on PROD1PC60 with RULES2
§ 30.721 How are hearings assigned and
scheduled?
(a) If the designated OWCP
representative receives a timely request
for hearing, the OWCP representative
shall refer the matter to the Chief
Administrative Law Judge of the
Department of Labor, who shall assign
it for an expedited hearing. The
administrative law judge assigned to the
matter shall consider the request for
hearing, act on all requests therein, and
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
PO 00000
Frm 00046
Fmt 4701
Sfmt 4700
§ 30.723 How will the administrative law
judge conduct the hearing and issue the
recommended decision?
(a) To the extent appropriate,
proceedings before the administrative
law judge shall be governed by 29 CFR
part 18.
(b) The administrative law judge shall
receive such relevant evidence as may
be adduced at the hearing. Evidence
shall be presented under oath, orally or
in the form of written statements. The
administrative law judge shall consider
the Notice and Response, including all
pertinent documents accompanying
them, and may also consider any
evidence which refers to the provider or
to any claim with respect to which the
provider has provided medical services,
hospital services, or medical services
and supplies, and such other evidence
as the administrative law judge may
determine to be necessary or useful in
evaluating the matter.
(c) All hearings shall be recorded and
the original of the complete transcript
shall become a permanent part of the
official record of the proceedings.
(d) In conjunction with the hearing,
the administrative law judge may:
(1) Administer oaths; and
(2) Examine witnesses.
(e) At the conclusion of the hearing,
the administrative law judge shall issue
a written decision and cause it to be
served on all parties to the proceeding,
their representatives and OWCP.
§ 30.724 How can a party request review
by OWCP of the administrative law judge’s
recommended decision?
(a) Any party adversely affected or
aggrieved by the decision of the
administrative law judge may file a
petition for discretionary review with
the Director for Energy Employees
Occupational Illness Compensation
within 30 days after issuance of such
decision. The administrative law judge’s
decision, however, shall be effective on
the date issued and shall not be stayed
except upon order of the Director.
(b) Review by the Director for Energy
Employees Occupational Illness
Compensation shall not be a matter of
right but of the sound discretion of the
Director.
(c) Petitions for discretionary review
shall be filed only upon one or more of
the following grounds:
(1) A finding or conclusion of material
fact is not supported by substantial
evidence;
(2) A necessary legal conclusion is
erroneous;
(3) The decision is contrary to law or
to the duly promulgated rules or
decisions of OWCP;
(4) A substantial question of law,
policy, or discretion is involved; or
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
(5) A prejudicial error of procedure
was committed.
(d) Each issue shall be separately
numbered and plainly and concisely
stated, and shall be supported by
detailed citations to the record when
assignments of error are based on the
record, and by statutes, regulations or
principal authorities relied upon.
Except for good cause shown, no
assignment of error by any party shall
rely on any question of fact or law upon
which the administrative law judge had
not been afforded an opportunity to
pass.
(e) A statement in opposition to the
petition for discretionary review may be
filed, but such filing shall in no way
delay action on the petition.
(f) If a petition is granted, review shall
be limited to the questions raised by the
petition.
(g) A petition not granted within 20
days after receipt of the petition is
deemed denied.
§ 30.725 What are the effects of nonautomatic exclusion?
(a) OWCP shall give notice of the
exclusion of a physician, hospital or
provider of medical services or supplies
to:
(1) All OWCP district offices;
(2) CMS; and
(3) All employees who are known to
have had treatment, services or supplies
from the excluded provider within the
six-month period immediately
preceding the order of exclusion.
(b) Notwithstanding any exclusion of
a physician, hospital, or provider of
medical services or supplies under this
subpart, OWCP shall not refuse an
employee reimbursement for any
otherwise reimbursable medical
treatment, service or supply if:
(1) Such treatment, service or supply
was rendered in an emergency by an
excluded physician; or
(2) The employee could not
reasonably have been expected to know
of such exclusion.
(c) An employee who is notified that
his or her attending physician has been
excluded shall have a new right to select
a qualified physician.
pwalker on PROD1PC60 with RULES2
§ 30.726 How can an excluded provider be
reinstated?
(a) If a physician, hospital, or provider
of medical services or supplies has been
automatically excluded pursuant to
§ 30.716, the provider excluded will
automatically be reinstated upon notice
to OWCP that the conviction or
exclusion which formed the basis of the
automatic exclusion has been reversed
or withdrawn. However, an automatic
reinstatement shall not preclude OWCP
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
from instituting exclusion proceedings
based upon the underlying facts of the
matter.
(b) A physician, hospital, or provider
of medical services or supplies excluded
from participation as a result of an order
issued pursuant to this subpart may
apply for reinstatement one year after
the entry of the order of exclusion,
unless the order expressly provides for
a shorter period. An application for
reinstatement shall be addressed to the
Director for Energy Employees
Occupational Illness Compensation, and
shall contain a concise statement of the
basis for the application. The
application should be accompanied by
supporting documents and affidavits.
(c) A request for reinstatement may be
accompanied by a request for oral
argument. Oral argument will be
allowed only in unusual circumstances
where it will materially aid the decision
process.
(d) The Director for Energy Employees
Occupational Illness Compensation
shall order reinstatement only in
instances where such reinstatement is
clearly consistent with the goal of this
subpart to protect the EEOICPA program
against fraud and abuse. To satisfy this
requirement the provider must provide
reasonable assurances that the basis for
the exclusion will not be repeated.
Subpart I—Wage-Loss Determinations
Under Part E of EEOICPA
General Provisions
§ 30.800 What types of wage-loss are
compensable under Part E of EEOICPA?
Years of wage-loss occurring prior to
normal retirement age that are the result
of a covered illness contracted by a
covered Part E employee through workrelated exposure to a toxic substance at
a Department of Energy facility or a
RECA section 5 facility, as appropriate,
may be compensable under Part E of the
Act. Whether years of wage-loss are
compensable depends on
determinations with respect to:
(a) The average annual wage of the
employee as determined by OWCP in
accordance with § 30.810;
(b) The percentage of his or her
average annual wage that the employee
was able to earn during the calendar
year(s) in question as determined by
OWCP in accordance with § 30.811; and
(c) Whether the employee’s inability
to earn at least as much as his or her
average annual wage was due to a
covered illness as defined in § 30.5(r).
PO 00000
Frm 00047
Fmt 4701
Sfmt 4700
78565
§ 30.801 What special definitions does
OWCP use in connection with Part E wageloss determinations?
For the purposes of paying
compensation based on wage-loss under
Part E of the Act, OWCP will apply the
following definitions:
(a) Average annual wage means four
times the average quarterly wages of a
covered Part E employee for the 12
quarters preceding the quarter during
which he or she first experienced wageloss due to exposure to a toxic substance
at a DOE facility or RECA section 5
facility, excluding any quarters during
which the employee was unemployed.
Because being ‘‘retired’’ is not
equivalent to being ‘‘unemployed,’’
quarters during which an employee had
no wages because he or she was retired
will not be excluded from this
calculation.
(b) Normal retirement age means the
age at which a covered Part E employee
first became eligible for unreduced
retirement benefits under the Old-Age,
Survivors and Disability Insurance
(OASDI) provisions of the Social
Security Act. In general, persons born
during or before 1937 are eligible for
unreduced OASDI retirement benefits at
age 65, and that age increases in
monthly increments until it reaches 67,
which is the age at which persons born
during or after 1960 become eligible for
unreduced OASDI retirement benefits.
(c) Quarter means the three-month
period January through March, April
through June, July through September,
or October through December.
(d) Quarter during which the
employee was unemployed means any
quarter during which the covered Part E
employee had $700 (in constant 2005
dollars) or less in wages unless the
quarter is one during which the
employee was retired.
(e) Year of wage-loss means a calendar
year during which the covered Part E
employee’s earnings were less than his
or her average annual wage, after such
earnings have been adjusted using the
Consumer Price Index for All Urban
Consumers (CPI–U), as produced by the
Bureau of Labor Statistics, to reflect
their value in the year during which the
employee first experienced wage-loss
due to exposure to a toxic substance at
a DOE facility or RECA section 5
facility.
Evidence of Wage-Loss
§ 30.805 What evidence does OWCP use to
determine a covered Part E employee’s
average annual wage and whether he or she
experienced compensable wage-loss under
Part E of EEOICPA?
(a) OWCP may rely on quarterly
wages information reported to the Social
E:\FR\FM\29DER2.SGM
29DER2
78566
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
Security Administration to establish a
covered Part E employee’s presumed
average annual wage (see § 30.810) and
the duration and extent of any years of
wage-loss that are compensable under
Part E of the Act (see § 30.811). OWCP
may also rely on other probative
evidence of a covered Part E employee’s
wages, and may ask the claimant for
additional evidence necessary to make
this determination, if necessary. For the
purposes of making these two types of
determinations, OWCP will consider all
monetary payments that the covered
Part E employee received in a quarter
from employment or services, except for
monetary payments that were not
taxable as income during that quarter
under the Internal Revenue Code, to be
‘‘wages.’’
(b) OWCP also requires the
submission of rationalized medical
evidence of sufficient probative value to
establish that the period of wage-loss at
issue is causally related to the covered
Part E employee’s covered illness.
§ 30.806 May a claimant submit factual
evidence in support of a different
determination of average annual wage and/
or wage-loss than that found by OWCP?
A claimant who disagrees with the
evidence OWCP has obtained under
§ 30.805(a) and alleges a different
average annual wage for the covered
Part E employee, or that there was a
greater duration or extent of wage-loss,
may submit records that were produced
in the ordinary course of business due
to the employee’s employment to rebut
that evidence, to the extent that such
records are determined to be authentic
by OWCP by a preponderance of the
evidence. The average annual wage and/
or wage-loss of the covered Part E
employee will then be determined by
OWCP in the exercise of its discretion.
Determinations of Average Annual
Wage and Percentages of Loss
pwalker on PROD1PC60 with RULES2
§ 30.810 How will OWCP calculate the
average annual wage of a covered Part E
employee?
To calculate the average annual wage
of a covered Part E employee as defined
in § 30.801(a), OWCP will:
(a) Aggregate the wages for the twelve
quarters that preceded the quarter
during which the covered Part E
employee first experienced wage-loss
due to exposure to a toxic substance at
a DOE facility or a RECA section 5
facility, excluding any quarter during
which the employee was unemployed;
(b) Add any additional wages earned
by the employee during those same
quarters as evidenced by records
described in §§ 30.805(a) and 30.806;
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
(c) Divide the sum of paragraphs (a)
and (b) of this section by 12 less the
number of quarters during which the
employee was unemployed; and
(d) Multiply this figure by four to
calculate the covered Part E employee’s
average annual wage.
§ 30.811 How will OWCP calculate the
duration and extent of a covered Part E
employee’s initial period of compensable
wage-loss?
(a) To determine the initial calendar
years of wage-loss, OWCP will use the
evidence it receives under §§ 30.805 and
30.806 to determine the quarter in
which a covered Part E employee first
sustained wage-loss due to exposure to
a toxic substance while engaged in
employment at a DOE facility or a RECA
section 5 facility, as appropriate.
(b) OWCP will then compare the
calendar-year wages for that employee,
as adjusted, with the average annual
wage determined under § 30.810 for
each calendar year beginning with the
calendar year that includes the quarter
in which the wage-loss commenced, and
concluding with the last calendar year
of wage-loss prior to the submission of
the claim or the calendar year in which
the employee reached normal retirement
age (as defined in § 30.801(b)),
whichever occurred first.
(c) OWCP will then aggregate
separately the number of calendar years
of wage-loss in which the employee’s
wages, as adjusted, did not exceed 50
percent of the average annual wage
determined under § 30.810, and the
number of calendar years of wage-loss
in which the employee’s wages, as
adjusted, exceeded 50 percent of such
average annual wage, but did not exceed
75 percent of such average annual wage.
(d) For each calendar year of wageloss determined under paragraph (c) of
this section during which the
employee’s wages did not exceed 50
percent of his or her average annual
wage, OWCP will pay the employee
$15,000 as compensation for wage-loss.
For each calendar year of wage-loss
determined under paragraph (c) of this
section during which the employee’s
calendar-year wages exceeded 50
percent of his or her average annual
wage but did not exceed 75 percent of
such average annual wage, OWCP will
pay the employee $10,000 as
compensation for wage-loss.
§ 30.812 May a covered Part E employee
claim for subsequent periods of
compensable wage-loss?
A covered Part E employee previously
awarded compensation for wage-loss
under § 30.811 may file for additional
compensation for wage-loss suffered by
the employee during periods subsequent
PO 00000
Frm 00048
Fmt 4701
Sfmt 4700
to a period for which a wage-loss claim
for the employee has already been
adjudicated by OWCP. However, no
compensation for wage-loss shall be
awarded for any period following the
year during which the covered Part E
employee attained normal retirement
age for purposes of the Social Security
Act as described in § 30.801(b).
Special Rules for Certain Survivor
Claims Under Part E of EEOICPA
§ 30.815 Are there special rules that OWCP
will use to determine the extent of a
deceased covered Part E employee’s
compensable wage-loss?
(a) For purposes of adjudicating a
claim of a survivor of a deceased
covered Part E employee only, OWCP
will presume that such employee
experienced wage-loss for each calendar
year subsequent to the calendar year of
his or her death through and including
the calendar year in which the
employee would have reached normal
retirement age under the Social Security
Act. During these particular calendar
years, OWCP will also presume that the
deceased covered Part E employee’s
subsequent calendar-year wages did not
exceed 50 percent of his or her average
annual wage as determined under
§ 30.810.
(b) Except as provided in paragraph
(a) of this section, OWCP will calculate
the wage-loss of a deceased covered Part
E employee in conformance with the
provisions of §§ 30.800 through 30.811.
(c) If OWCP determines that a
deceased covered Part E employee had
an aggregate of not less than ten
calendar years of adjusted earnings that
did not exceed 50 percent of his or her
average annual earnings, it will pay the
eligible surviving beneficiary(s)
additional compensation (the basic
survivor award payable under section
7385s–3(a)(1) is $125,000) in the
amount of $25,000 pursuant to section
7385s–3(a)(2) of the Act. In the
alternative, if OWCP determines that the
aggregate number of such years is not
less than 20 years, it will pay the
eligible surviving beneficiary(s)
additional compensation in the amount
of $50,000 pursuant to section 7385s–
3(a)(3).
Subpart J—Impairment Benefits Under
Part E of EEOICPA
General Provisions
§ 30.900 Who can receive impairment
benefits under Part E?
In order to receive impairment
benefits under Part E, the employee
must show that:
(a) He or she is a covered Part E
employee who has been determined to
E:\FR\FM\29DER2.SGM
29DER2
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
have contracted a covered illness
through exposure to a toxic substance at
a DOE facility or a RECA section 5
facility, as appropriate, pursuant to
either §§ 30.210 through 30.215 or
§§ 30.230 through 30.232 of these
regulations; and
(b) He or she has been determined to
have an impairment, pursuant to the
regulations set out in this subpart, that
is the result of the covered illness
referred to in paragraph (a) of this
section.
§ 30.901 How does OWCP determine the
extent of an employee’s impairment that is
due to a covered illness contracted through
exposure to a toxic substance at a DOE
facility or a RECA section 5 facility, as
appropriate?
pwalker on PROD1PC60 with RULES2
(a) OWCP will determine the amount
of impairment benefits to which an
employee is entitled based on one or
more impairment evaluations submitted
by physicians. An impairment
evaluation shall contain the physician’s
opinion on the extent of whole person
impairment of all organs and body
functions of the employee that are
compromised or otherwise affected by
the employee’s covered illness or
illnesses, which shall be referred to as
a ‘‘minimum impairment rating.’’
(b) The minimum impairment rating
shall be determined in accordance with
the current edition of the American
Medical Association’s Guides to the
Evaluation of Permanent Impairment
(AMA’s Guides). In making impairment
benefit determinations, OWCP will only
consider medical reports from
physicians who are certified by the
relevant medical board and who satisfy
any additional criteria determined by
OWCP to be necessary to qualify to
perform impairment evaluations under
Part E, including any specific training in
use of the AMA’s Guides, specific
training and experience related to
particular conditions and other
objective factors.
(c) OWCP will establish criteria based
upon objective factors such as training
and certification that must be met by
physicians preparing impairment
evaluations in order for an impairment
evaluation to be considered in
determining an impairment award. Such
criteria shall be made available to
claimants and the public by OWCP.
§ 30.902 How will OWCP calculate the
amount of the award of impairment benefits
that is payable under Part E?
OWCP will multiply the percentage
points of the minimum impairment
rating by $2,500 to calculate the amount
of the award.
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
Medical Evidence of Impairment
§ 30.905 How may an impairment
evaluation be obtained?
(a) Except as provided in paragraph
(b) of this section, OWCP may request
that an employee undergo an evaluation
of his or her permanent impairment that
specifies the percentage points that are
the result of the employee’s covered
illness or illnesses. To be of any
probative value, such evaluation must
be performed by a physician who meets
the criteria OWCP has identified for
physicians performing impairment
evaluations for the pertinent covered
illness or illnesses in accordance with
the AMA’s Guides.
(b) In lieu of submitting an evaluation
requested by OWCP under paragraph (a)
of this section, an employee may obtain
an impairment evaluation at his own
initiative and submit it to OWCP for
consideration. Such an evaluation will
be deemed to have sufficient probative
value to be considered in the
adjudication of impairment benefits by
OWCP only if:
(1) The evaluation was performed by
a physician who meets the criteria
identified by OWCP for the covered
illness or illnesses in question;
(2) The evaluation was performed no
more than one year before the date that
it was received by OWCP; and
(3) The evaluation conforms to all
applicable requirements set out in this
part.
§ 30.906 Who will pay for an impairment
evaluation?
(a) OWCP will pay for one
impairment evaluation obtained by an
employee if it meets the criteria set out
in § 30.905(b), unless it was performed
by a physician prior to the date that the
claim for Part E benefits is filed, or
obtained for a claim in which OWCP
finds that the employee did not contract
a covered illness. At its discretion,
OWCP may direct that the employee
undergo additional evaluations. OWCP
will pay for any such additional
evaluations and will reimburse the
employee for any reasonable and
necessary costs incident to the
evaluations, as described in §§ 30.404
and 30.412 of this part.
(b) Except for one impairment
evaluation obtained pursuant to
§ 30.905(b) and meeting the criteria set
out in § 30.905(b)(1), (2) and (3), the
employee must pay for any impairment
evaluations not directed by OWCP.
§ 30.907 Can an impairment evaluation
obtained by OWCP be challenged prior to
issuance of the recommended decision?
(a) An employee may submit
arguments challenging an impairment
PO 00000
Frm 00049
Fmt 4701
Sfmt 4700
78567
evaluation, and/or additional medical
evidence of impairment, before the
district office issues a recommended
decision on his or her claim. However,
the district office will not consider an
additional impairment evaluation, even
if it differs from the impairment
evaluation obtained under §§ 30.905 or
30.906, if it does not meet the criteria
listed in § 30.905(b)(1), (2) and (3).
(b) If the district office obtains an
additional impairment evaluation that
differs from the impairment evaluation
obtained under §§ 30.905 or 30.906, the
district office will base its
recommended determinations regarding
impairment upon the evidence it
considers to have the greatest probative
value, after evaluating all relevant
evidence of impairment in the record,
including evidence from directed
impairment evaluations and referee
impairment evaluations, if any, that it
deems necessary pursuant to §§ 30.410
and 30.411 of this part.
§ 30.908 How will the FAB evaluate new
medical evidence submitted to challenge
the impairment determination in the
recommended decision?
(a) If an employee submits an
additional impairment evaluation that
differs from the impairment evaluation
relied upon by the district office, the
FAB will not consider the additional
impairment evaluation if it does not
meet the criteria listed in § 30.905(b)(1),
(2) and (3).
(b) The employee shall bear the
burden of proving that the additional
impairment evaluation submitted is
more probative than the evaluation
relied upon by the district office to
determine the employee’s recommended
minimum impairment rating.
(c) If an employee submits an
additional impairment evaluation that
differs from the impairment evaluation
relied upon by the district office, the
FAB will review all relevant evidence of
impairment in the record, and will base
its determinations regarding impairment
upon the evidence it considers to be
most probative. The FAB will determine
the minimum impairment rating after it
has evaluated all relevant evidence and
argument in the record.
Ratable Impairments
§ 30.910 Will an impairment that cannot be
assigned a numerical percentage using the
AMA’s Guides be included in the
impairment rating?
(a) An impairment of an organ or body
function that cannot be assigned a
numerical impairment percentage using
the AMA’s Guides will not be included
in the employee’s impairment rating.
E:\FR\FM\29DER2.SGM
29DER2
78568
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 / Rules and Regulations
(b) A mental impairment that does not
originate from a documented physical
dysfunction of the nervous system, and
cannot be assigned a numerical
percentage using the AMA’s Guides,
will not be included in the impairment
rating for the employee. Mental
impairments that are due to
documented physical dysfunctions of
the nervous system can be assigned
numerical percentages using the AMA’s
Guides and will be included in the
rating.
§ 30.911 Does maximum medical
improvement always have to be reached for
an impairment to be included in the
impairment rating?
pwalker on PROD1PC60 with RULES2
(a) An impairment that is the result of
a covered illness will be included in the
employee’s impairment rating
determined by OWCP under § 30.901
only if OWCP concludes that the
impairment has reached maximum
medical improvement, which means
VerDate Aug<31>2005
18:28 Dec 28, 2006
Jkt 211001
that it is well-stabilized and unlikely to
improve substantially with or without
medical treatment.
(b) Notwithstanding paragraph (a) of
this section, if OWCP finds that an
employee’s covered illness is in the
terminal stages, based upon probative
medical evidence, an impairment that
results from such covered illness will be
included in the impairment rating for
the employee even if it has not reached
maximum medical improvement.
§ 30.912 Can a covered Part E employee
receive benefits for additional impairment
following an award of such benefits by
OWCP?
A covered Part E employee previously
awarded impairment benefits by OWCP
may file a claim for additional
impairment benefits. Such claim must
be based on an increase in the
impairment rating that is the result of
the covered illness or illnesses from the
impairment rating that formed the basis
PO 00000
Frm 00050
Fmt 4701
Sfmt 4700
for the last award of such benefits by
OWCP. OWCP will only adjudicate
claims for such an increased rating that
are filed at least two years from the date
of the last award of impairment benefits.
However, OWCP will not wait two years
before it will adjudicate a claim for
additional impairment that is based on
an allegation that the employee
sustained a new covered illness.
Signed at Washington, DC, this 15th day of
December, 2006.
Victoria A. Lipnic,
Assistant Secretary of Labor for Employment
Standards.
Signed at Washington, DC, this 15th day of
December, 2006.
Shelby Hallmark,
Director, Office of Workers’ Compensation
Programs, Employment Standards
Administration.
[FR Doc. E6–21839 Filed 12–28–06; 8:45 am]
BILLING CODE 4510–CR–P
E:\FR\FM\29DER2.SGM
29DER2
Agencies
[Federal Register Volume 71, Number 250 (Friday, December 29, 2006)]
[Rules and Regulations]
[Pages 78520-78568]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-21839]
[[Page 78519]]
-----------------------------------------------------------------------
Part II
Department of Labor
-----------------------------------------------------------------------
Office of Workers' Compensation Programs
-----------------------------------------------------------------------
20 CFR Parts 1 and 30
Performance of Functions; Claims for Compensation Under the Energy
Employees Occupational Illness Compensation Program Act of 2000, as
Amended; Final Rule
Federal Register / Vol. 71, No. 250 / Friday, December 29, 2006 /
Rules and Regulations
[[Page 78520]]
-----------------------------------------------------------------------
DEPARTMENT OF LABOR
Office of Workers' Compensation Programs
20 CFR Parts 1 and 30
RIN 1215-AB51
Performance of Functions; Claims for Compensation Under the
Energy Employees Occupational Illness Compensation Program Act of 2000,
as Amended
AGENCY: Office of Workers' Compensation Programs, Employment Standards
Administration, Labor.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: On June 8, 2005, the Department of Labor (DOL) published
interim final regulations that govern its responsibilities under the
Energy Employees Occupational Illness Compensation Program Act of 2000,
as amended (EEOICPA or Act). Part B of the Act provides lump-sum
payments of $150,000 and medical benefits to covered employees and,
where applicable, to survivors of such employees, of the Department of
Energy (DOE), its predecessor agencies and certain of its vendors,
contractors and subcontractors. Part B also provides lump-sum payments
of $50,000 and medical benefits to individuals found eligible by the
Department of Justice (DOJ) for $100,000 under section 5 of the
Radiation Exposure Compensation Act (RECA) and, where applicable, to
their survivors. Part E of the Act provides variable lump-sum payments
(based on a worker's permanent impairment and/or calendar years of
qualifying wage-loss) and medical benefits for covered DOE contractor
employees and, where applicable, provides variable lump-sum payments to
survivors of such employees (based on a worker's death due to a covered
illness and any calendar years of qualifying wage-loss). Part E also
provides these same payments and benefits to uranium miners, millers
and ore transporters covered by section 5 of RECA and, where
applicable, to survivors of such employees.
At the same time the Department published the interim final
regulations, it also invited written comments and advice from
interested parties regarding possible changes to those regulations.
This document amends the interim final regulations based on comments
that the Department received.
DATES: Effective Date: This rule will be effective on February 27,
2007, and will apply to all claims filed on or after that date. This
rule will also apply to any claims that are pending on February 27,
2007.
FOR FURTHER INFORMATION CONTACT: Shelby Hallmark, Director, Office of
Workers' Compensation Programs, Employment Standards Administration,
U.S. Department of Labor, Room S-3524, 200 Constitution Avenue, NW.,
Washington, DC 20210, Telephone: 202-693-0031 (this is not a toll-free
number).
SUPPLEMENTARY INFORMATION: The Department of Labor's interim final
regulations implementing its responsibilities under the Energy
Employees Occupational Illness Compensation Program Act of 2000, as
amended (42 U.S.C. 7384 et seq.), were published in the Federal
Register on June 8, 2005 (70 FR 33590). They took effect immediately
and included a 60-day period for comment. During the comment period,
the Department received 533 timely comments: two joint comments from 39
congressional representatives; two from labor organizations; four from
attorneys; four from advocacy groups; one from a lay representative;
one from DOE; one from a DOE contractor; and 518 from individuals. The
Department also received untimely comments from one physician, one
attorney, one advocacy group, the Coconino County (Arizona) Board of
Supervisors, one labor organization, the Navajo Nation and 23
individuals; all of the points they raised were also raised by the
timely comments. Almost all of the timely comments (521) addressed the
issue of eligibility for survivor benefits under Part E of EEOICPA; 494
of the comments addressed this issue alone. They also addressed a
number of other issues, including the administrative claims process
used to adjudicate claims under EEOICPA, entitlement qualifications,
and the extent of coverage provided under Part E. The Department's
section-by-section analysis of the timely comments it received is set
forth below (see sections I and II).
Some minor changes have been made to the interim final regulations
that did not result from any comments. One such change is the addition
of new language to Sec. 30.112(b) to recognize that pursuant to Sec.
30.106, entities other than DOE may be verifying alleged periods of
employment that claimants have reported to OWCP. A second change is the
addition of language to Sec. 30.301(c) clarifying that OWCP will also
not issue a subpoena for the testimony of employees of the National
Institute for Occupational Safety and Health (NIOSH) or contractors of
either OWCP or NIOSH acting in their official capacities with respect
to the EEOICPA claims adjudication process. In addition, the existing
language of Sec. 30.316(c) has been modified so that a recommended
decision on a claim that is pending for more than one year after the
date it was reopened for issuance of a new final decision will be
considered a final decision on that claim as of that date, and Sec.
30.400(a) has been modified to reflect the current practice of OWCP to
pay for medically necessary treatment of a primary cancer in claims
where the accepted occupational illness or covered illness is a
secondary cancer.
When publishing a final rule following a comment period, it is
customary to publish only the changes that have been made to the rule;
however, in order to be more user-friendly, the Department is
publishing the entire rule, including the parts that have not been
changed. By doing so, only one document containing all of the
regulations and commentary needs to be consulted rather than multiple
documents.
I. Comments on the Interim Final Regulations
The section numbers used in the headings of the following analysis
are those that were used in the interim final regulations. Unless
otherwise stated, the section numbers in the text of the analysis refer
to the numbering used for the final regulations. No comments were
received with respect to part 1.
Section 30.5
One individual suggested that the definition for the statutory term
``Department of Energy facility'' be modified to more clearly identify
the ``list of facilities established by the Department of Energy''
referred to in the interim final regulation. To eliminate any confusion
with respect to this list, and as suggested by the comment, Sec.
30.5(x) has been amended in this final rule to specify which list of
facilities the Department has adopted. Another individual believed that
the five-year latency period requirement for specified cancers listed
in Sec. 30.5(ff)(5) was ``in error'' and suggested that it be deleted.
However, the latency period requirement is contained within section
7384l(17)(A) of the Act and cannot be modified in these regulations.
Therefore, the suggested change was not made. A third individual
suggested that Sec. 30.5(gg) be modified to more clearly describe the
requirements for eligibility of survivors under Part E. Section
30.5(gg) is only intended to inform readers that survivors must be
alive to receive a payment. Because complete descriptions of the
requirements for
[[Page 78521]]
eligibility of survivors under Part B and Part E of EEOICPA already
appear at Sec. 30.500, the suggested change is unnecessary and was not
made.
Sections 30.100, 30.101, 30.102 and 30.103
One attorney pointed out that while employees and survivors can use
Forms EE-1 and EE-2 to file their initial claims with OWCP, there was
no form provided for filing a claim for an alleged consequential
illness or injury. The absence of a specific form for claiming an
alleged consequential illness or injury is intentional since in those
situations, OWCP would already have all of the necessary factual
information that could be requested by a form. Claimants need only
submit written ``words of claim'' to OWCP, together with the type of
supporting medical evidence described in Sec. Sec. 30.207(d), 30.215,
30.222(b), 30.226 or 30.232(c), to file a claim for a consequential
illness or injury. Therefore, no new form has been designed and the
suggested changes to Sec. Sec. 30.100 and 30.101 were not made.
Two individuals disputed the provision in Sec. 30.101(c) that a
survivor must be alive to receive a payment under the Act and noted
that if all of the eligible survivors die before payment can be made,
no payment can be made to any other individual as the heir of a
deceased eligible survivor. However, this result is required under both
Parts B and E of EEOICPA pursuant to sections 7384s(e)(1) and 7385s-
3(c), which require that survivors under both Part B and Part E must be
alive at the time of payment, and cannot be altered by regulation.
Therefore, the requested change to Sec. 30.101(c) was not made.
Three advocacy groups suggested that the provision in Sec. 30.102
that OWCP will only adjudicate a claim for an increased impairment
rating if it is filed at least two years from the date of the last
award of impairment benefits is unreasonable and proposed that the
waiting period to be reduced to either one year or six months. The
claim development process that OWCP uses when it determines a covered
Part E employee's minimum impairment rating is necessarily complex and
usually takes a considerable amount of time to complete. For example,
the medical evidence submitted in support of an alleged rating may not
contain all of the information that OWCP will need to determine an
impairment rating. OWCP would then have to seek that information from
another source, or obtain an impairment evaluation by another physician
before it would be able to determine the extent of the alleged
permanent impairment based on the evidence in the case record. If
claimants were permitted to apply for an increased impairment rating
sooner than two years after their prior award for impairment benefits,
the claims processing system would inevitably become less efficient and
claimants who have not had their initial impairment claims adjudicated
and who have not received benefits for their compensable permanent
impairments would necessarily have to wait even longer to receive a
decision from OWCP. Therefore, in order to maintain an efficient system
of adjudication for all claimants and to best use its limited
resources, OWCP concludes that the two-year waiting period should
remain in place and none of the suggested changes to this section have
been adopted.
One of these same advocacy groups also noted that while Sec.
30.103 requires claimants to use approved forms when filing claims
under Part E of EEOICPA, ``the present forms do not allow for claiming
diseases other than cancer, berylliosis or silicosis.'' On June 20,
2005, the Office of Management and Budget approved new versions of
Forms EE-1 and EE-2 that allow claimants to file for all illnesses
potentially compensable under Part E. As noted in Sec. 30.103(b),
these forms are available on the Internet at https://www.dol.gov/esa/
regs/compliance/owcp/eeoicp/main.htm. Therefore, the suggested change
to Sec. 30.103 is unnecessary and has not been made.
Section 30.106
One individual questioned whether DOE was in possession of
sufficient employment data to enable it to verify alleged periods of
employment for ``most'' claims. OWCP does not dispute that there are a
number of facilities for which DOE does not have access to any
employment data. However, OWCP has developed a number of alternative
methods to be used for verifying alleged employment at those
facilities. In acknowledgement of this situation, Sec. 30.106
describes the various alternative methods by which OWCP may seek to
verify alleged periods of employment at those facilities for which DOE
has no employment data, and no change to this section was made in the
final rule.
Sections 30.111, 30.113 and 30.114
One individual and two labor organizations questioned the
description of the general burden of proof that all claimants must meet
in order to establish their entitlement to any compensation under
either Parts B or E of EEOICPA. Section 30.111(a) describes the general
burden of proof that claimants must meet, ``[e]xcept where otherwise
provided in the Act and these regulations,'' with respect to all of the
required elements involved in a claim. As one of these labor
organizations noted, there are differing burdens of proof between Parts
B and E, as well as between different claimed illnesses within a single
Part of the Act. This fact, however, does not mean that the description
of the general burden of proof in Sec. 30.111(a) is incorrect. OWCP is
committed to helping claimants meet their burden of proof and is aware
that some claimants may have difficulty proving both the presence of
and their exposure to a toxic substance at a particular facility under
Part E. In an effort to remedy this situation, OWCP is currently
developing exposure matrices that will compile information provided by
a variety of sources, including DOE, former worker medical survey
programs, and epidemiological studies. For all of the DOE facilities,
extensive documentation exists covering thousands of toxic materials.
The matrices now being developed will be posted on our Web site and
will be available to claimants and their representatives. While it is
not possible to define precisely in a regulation how these complex
matrices will be used in each case, OWCP's procedural guidance
documents will provide additional clarity in this regard, and those
documents will also be available to the public on our Web site.
Nevertheless, it would not be appropriate to relieve claimants of their
ultimate obligation to prove their claims, which is a standard
requirement of all state and federal workers' compensation programs.
Since Part E was intended to substitute for the state workers'
compensation benefits that claimants could have sought DOE's assistance
in obtaining under former Part D of EEOICPA, OWCP's application of
standard workers' compensation principles is appropriate and no changes
were made to Sec. 30.111(a).
Another individual suggested that OWCP amend Sec. 30.111(c) to
state that an affidavit submitted by a claimant is not, in and of
itself, sufficient to establish a period of alleged employment. Section
30.111(c) currently states that such affidavits ``may be relied on in
determining whether a claim meets the requirements of the Act. * * *''
However, since Sec. 30.112(b)(3) already makes clear that OWCP may
reject a claim when the only evidence of covered employment is a
``self-serving affidavit,'' the suggested change is unnecessary and was
not adopted in the
[[Page 78522]]
final rule. A third individual suggested that language be added to
Sec. 30.111 stating that when OWCP requests a second opinion from a
medical specialist, it will only provide such specialist with copies of
the ``medical'' evidence in the case file to review instead of all
``relevant'' evidence in the file. This suggestion ignores the fact
that factual evidence from a case file may be highly relevant (e.g.,
evidence of exposure levels, environmental assessments, etc.) to the
probative value of the specialist's medical opinion and as a result,
the requested change was not made.
A third individual requested that Sec. 30.113(a) be changed to
indicate that OWCP will accept various types of ``electronic''
submissions in support of claims for compensation under EEOICPA, while
an advocacy group suggested that Sec. 30.113(c) be changed due to its
belief that all statements regarding the substance of lost or destroyed
factual or medical evidence would be ``self-serving'' and therefore not
acceptable. Both of these provisions have been in effect since the
issuance of the first final rule on December 26, 2002, and have not
proved problematic in practice. Therefore, the requested changes were
not made in this final rule.
A fourth individual disagreed with the general requirement in Sec.
30.114 that claims for compensation under EEOICPA be supported with
medical evidence that establishes the existence of the alleged
occupational illness under Part B or covered illness under Part E.
However, these medical requirements are derived from the statutory
requirements in the Act itself and cannot be altered through the
rulemaking process. Therefore, the requested change to Sec. 30.114 was
not made.
Section 30.115
Two individuals asserted that application of the dose
reconstruction process discussed in Sec. 30.115 of the interim final
regulations to Part E cancer claims would be neither just nor fair, and
one advocacy group asked how OWCP planned to adjudicate the claims of
employees with non-specified cancers (those not listed at Sec.
30.5(ff)) at newly designated Special Exposure Cohort worksites. With
respect to the first of these two concerns, the discussion of Sec.
30.213 in the preamble to the interim final rule described the
scientific and administrative reasons why OWCP decided to use the
existing dose reconstruction process from Part B to adjudicate certain
radiogenic cancer claims filed under Part E, and the two commenters
have not presented any arguments challenging the underlying bases for
that decision. As for the comment regarding OWCP's adjudication of non-
specified cancer claims following an administrative addition of a class
of employees to the Special Exposure Cohort, this question involves the
manner in which the Department of Health and Human Services (HHS)
defines the new class of employees and the unique factual basis for its
addition to the Special Exposure Cohort. However, since neither of
these matters are within the jurisdiction of OWCP, they cannot be
addressed in the context of this rulemaking (see Sec. 30.2(b)). For
the above reasons, no changes were made to Sec. 30.115 in the final
rule based on these three comments.
Section 30.213
OWCP received 19 comments regarding the operation of Sec. 30.213
with respect to the 50 percent compensable level of probability of
causation (PoC) it will use to adjudicate claims for radiogenic cancer
under Part E of EEOICPA (three comments were received from advocacy
groups, 11 from individuals, two from congressional representatives,
one from a lay representative, and two from a single labor
organization). These comments requested that OWCP lower the
compensability level below the 50 percent level that is used for Part B
claims, but gave no scientific or other rationale for setting the
compensability level at any particular point below 50 percent. Rather,
the commenters base their arguments on the fact that the statutory
causation standard for Part E uses language that differs from the
language used for Part B. For the reasons set forth below, OWCP has
determined that it is more consistent with congressional intent and
current science to continue to use HHS's regulations in making the
determination required by section 7385s-4(c)(1)(A) of the Act because
those regulations provide the only reasonable factual basis upon which
OWCP can determine if it is ``at least as likely as not'' that exposure
to radiation at a DOE facility or RECA section 5 facility was a
``significant factor in aggravating, contributing to, or causing''
radiogenic cancer for which compensation is claimed under Part E.
It is clear from the scientific literature that it is not possible
to definitively attribute any individual's cancer to any particular
cause, and no commenter identified a method of attribution. As noted in
Science Panel Report No. 6, Use of Probability of Causation by the
Veterans Administration in the Adjudication of Claims of Injury Due to
Ionizing Radiation, issued by the Committee on Interagency Radiation
Research and Policy Coordination of the Office of Science and
Technology Policy, Executive Office of the President (August 1988),
``[a]nalysis of medical findings cannot separate the `radiogenic cases'
from those unrelated to radiation exposure; no `biological markers'
have yet been identified that can unequivocally point to radiogenic
cancers as distinct from non-radiogenic cancers. An excess incidence of
cancer is identifiable in a statistical sense only.''
It is, thus, not surprising that Congress required the use of
statistical probability in the determination whether to compensate an
individual with a claimed cancer under Part B. Under Part B, an
individual will be determined to have sustained ``cancer in the
performance of duty for purposes of the compensation program if, and
only if, the cancer [at issue] was at least as likely as not related to
employment at the facility'' (emphasis added), determined pursuant to
guidelines based upon radiation dose and ``the upper 99 percent
confidence interval of the probability of causation in the
radioepidemiological tables published under section 7(b) of the Orphan
Drug Act (42 U.S.C. 241 note),'' as well as a number of other factors.
The technical documentation prepared by HHS to explain the computer
program used to make this calculation similarly notes that ``it is not
possible to determine, for a given individual, whether his or her
cancer resulted from workplace exposure to ionizing radiation.''
(NIOSH--Interactive RadioEpidemiological Program (IREP) Technical
Documentation, June 18, 2002). Part B, thus, requires that a claimed
cancer be determined to be ``related to'' employment at a covered
facility if the radiation dose and other factors combined indicate that
there is a statistical probability that the cancer would not have
occurred in the absence of work-related exposure to radiation. In other
words, the PoC determination made for purposes of Part B is actually a
determination that there is a 50 percent or better chance that
radiation was a factor, however slight, ``in aggravating, contributing
to, or causing'' a claimed cancer because, in the absence of work-
related exposure to radiation, the cancer would not have occurred at
all.
Because it is impossible to determine the extent to which any
individual factor contributed to the development of cancer, OWCP has
concluded that the only way to comply with the statutory
[[Page 78523]]
mandate in Part E is, in effect, to interpret ``a significant factor''
as including any factor. Accordingly, the determination made pursuant
to HHS regulations issued under Part B whether there is a 50 percent
probability that radiation was a factor in the development of cancer
(i.e., that in the absence of work-related exposure to radiation, the
cancer would not have occurred at all) will be deemed sufficient to
establish that radiation was not only a factor, but was also a
significant factor ``in aggravating, contributing to, or causing'' the
cancer in question.
The position taken by the commenters appears to be based on a
misunderstanding of the test used by Congress in Part B of EEOICPA for
determining coverage for cancer due to exposure to radiation. The
standard used is whether a cancer suffered by a worker is ``related
to'' his or her employment at a covered facility. The commenters
suggest that Part B awards benefits only for cancers caused by exposure
to radiation, while Part E was intended to award benefits where the
cancer was either caused by or contributed to by exposure to radiation.
This misunderstanding may well stem from use of the term ``probability
of causation'' to describe the results of the statistical determination
made by the radioepidemiological tables used in the process. By using
the term ``related to'' in Part B, however, Congress encompassed all
cancers for which there is a statistical probability that exposure to
radiation was a factor in the development of the cancer. Despite the
use of the word ``causation'' in the term ``probability of causation,''
the determination reached is not an individual determination of the
mechanism of cause and effect leading to a particular cancer, which as
explained above is not scientifically possible, but a statistical
prediction of the probability that the cancer would not have occurred
in the absence of exposure to radiation. Thus, the HHS technical
documentation describes PoC as ``the likelihood that an existing cancer
resulted from that [workplace radiation] exposure.'' (NIOSH-IREP
Technical Documentation, June 18, 2002). Scientific analysis does not
distinguish between cancers that are caused or contributed to by
radiation. Since the actual mechanisms of cause (or contribution) for a
given cancer are not known, only probabilistic assertions can be made,
and they address only whether the cancer is more or less likely not to
have occurred absent the exposure. The IREP approach identifies all
conceivable cancers that might have resulted from the radiation
exposure. This probabilistic approach is the only generally accepted
scientific means of assigning responsibility for cancers in relation to
radiation exposure. The Department of Veterans Affairs and the Defense
Department also utilize essentially the same statistical probability
test to adjudicate benefits for potentially radiogenic cancer cases
incurred by veterans exposed to radiation.
Further, it should be noted that the epidemiological method
utilized in this determination is actually far more favorable towards
claimants than merely requiring a determination that radiation exposure
was ``at least as likely as not'' a significant factor. The method
specified by Congress for Part B and adopted by OWCP for Part E
requires that OWCP use the upper 99 percent confidence interval to
determine whether cancers of employees are to be compensable. In
essence, a confidence interval indicates the likelihood that a
statistical sample will reflect actual results and is often
demonstrated in terms of a margin of error (e.g., 5
percentage points in a poll). The precise statistical definition of the
99 percent confidence interval is that if a study or poll were
conducted 100 times, the results would be within the sample's margin of
error 99 times and one time the results would be either higher or
lower. For purposes of the calculations performed under Parts B and/or
E of EEOICPA, an upper 99 percent confidence interval establishes a
significant margin of error in favor of claimants for whether the
exposures that appeared at least as likely as not to cause cancer
actually did. That is, use of this confidence interval means that there
is only a one percent chance that the exposure level has been
underestimated and a 99 percent chance that it has been overestimated.
Because of this extremely claimant-favorable margin of error, we
believe that it is reasonable to conclude that the use of this method
for adjudicating radiogenic cancer claims under Part E will provide
compensation in any case in which it is at least as likely as not that
an employee would not have suffered cancer absent his or her
employment-related exposure to radiation.
This conclusion finds further support in the Report of the NCI-CDC
Working Group to Revise the 1985 NIH Radioepidemiological Tables
(September 2003), which found that the PoC model was a viable method to
adjudicate claims for radiation-related instances of cancer that
appropriately summarized ``the likelihood that prior radiation exposure
might be causally related to cancer occurrence.'' The report described
the Department of Veterans Affairs' use of PoC calculated at the 99
percent credibility limit (the term used in that report for confidence
interval) as ``highly unlikely to exclude persons with meritorious
claims. However it is likely to award many persons whose true [PoC's]
are very much less than 50 percent.'' For example, as noted in that
report, because of the substantial margin for error established by use
of the 99 percent confidence level, a cancer that is actually nine
percent likely to have been caused by the alleged exposure, but for
which data is limited, could yield a PoC of 82 percent under the HHS
PoC guidelines.
OWCP also believes that utilizing the 50 percent PoC process for
Part E is more likely to result in a scientifically valid and
consistent determination process than attempting to reach a
determination based on medical opinions from physicians that inevitably
contain a significant speculative component. Use of the PoC guidelines
for claims under both Part B and Part E allows OWCP to adjudicate the
entitlement of radiogenic cancers that are potentially compensable
under both Part B and Part E in a uniform manner. Any process for
determining coverage of claims for radiogenic cancers that would yield
inconsistent results as to whether that cancer is compensable under
Parts B and E is unlikely to be understood or accepted by claimants and
other stakeholders.
The commenters' argument that eligibility for a radiogenic cancer
under Part E should be based on a lower than 50 percent PoC level
apparently is based on their interpretation of the language of section
7385s-4(c)(1)(A), which requires a determination that it is ``at least
as likely as not that exposure to a toxic substance at a Department of
Energy facility was a significant factor in aggravating, contributing
to, or causing'' the claimed cancer. While Congress utilized different
terminology to establish the test for compensation in Part E and Part
B, the differences reflect the fact that Part B was intended to
establish narrowly drawn tests for specific medical conditions, such as
radiogenic cancer or chronic beryllium disease. Part E, on the other
hand, sets forth a broad test that must be used to determine the
compensability of a virtually unlimited array of illnesses potentially
caused by exposure to the tens of thousands of toxic substances present
at Department of Energy facilities. While there is no way to
distinguish between causation and
[[Page 78524]]
contribution in regard to cancer related to exposure to radiation
(because it is only possible to determine the statistical probability
that, absent work-related exposure to radiation, the employee in
question would not have incurred the cancer or cancers from which he or
she suffered), Part E applies to other types of illnesses for which the
concept of ``contribution'' may be highly relevant. Indeed, unlike the
case of radiogenic cancer, it is possible to determine that toxic
exposure contributed to a number of other illnesses or that other pre-
existing illnesses were aggravated by toxic exposure. Therefore, the
difference in the statutory language between the standard in Part B and
the standard in Part E does not indicate that Part E was intended to
establish a more lenient test, but can be explained by the fact that it
was designed to cover a wide variety of situations and circumstances,
as opposed to the more narrowly drawn Part B radiogenic cancer
standard, where no difference existed between causation and
contribution.
It should also be noted that the regulation specifies that the PoC
model will be determinative under Part E only with respect to claims
where the sole alleged condition is radiogenic cancer. When a claim for
cancer under Part E cannot be accepted based on exposure to radiation
alone because the PoC was determined to be less than 50 percent, the
claimant is provided the opportunity to establish that the cancer was
caused by a combination of exposure to radiation and exposure to one or
more other toxic substances. OWCP will adjudicate those claims for
cancer allegedly due to exposure to radiation combined with exposure to
one or more other toxic substances using the eligibility criteria for
other covered illnesses in Sec. Sec. 30.230 through 30.232. As a
result, no changes were made to Sec. 30.213(c) in the final rule.
Sections 30.230, 30.231 and 30.232
One labor organization suggested that the statutory terms
``aggravated,'' ``contributed to'' and ``caused'' from one portion of
the Part E causation standard appearing in section 7385s-4(c)(1)(A) of
EEOICPA be defined in Sec. 30.230 of the final rule so it will be
``possible to determine how DOL will adjudicate claims.'' However,
these statutory terms have a long and settled history in workers'
compensation law, and OWCP believes any attempt to further define those
terms (which involve matters of administrative discretion and
professional medical opinion) would only lead to increased confusion.
As a result, Sec. 30.230 has not been amended in the final rule.
Two comments from congressional representatives, three from
advocacy groups and one from an individual asserted that it would be
extremely difficult for claimants to satisfy their burden of proof
under Sec. 30.231 to establish both the presence of a toxic substance
and the employee's exposure to the substance without the development of
site exposure assessments of toxic substances. OWCP shares this concern
and is committed to studying all of the available information
pertaining to these sites and making publicly available a listing of
the toxic substances present at such sites. The information compiled
from these studies will be accepted as probative evidence in
determining the eligibility of claimants, barring extraordinary and
unusual circumstances, and Sec. 30.231(b) has been modified to clarify
OWCP's policies regarding this matter. However, the remainder of the
suggested changes to the burden of proof described in Sec. 30.231 have
not been adopted.
One advocacy group objected to the requirement in Sec.
30.232(a)(2) that each claimant under Part E provide a signed medical
release authorizing the release of any diagnosis, medical opinion or
medical records documenting the employee's alleged covered illness and
that it resulted from exposure to a toxic substance. The advocacy group
is concerned that in some cases such documents may no longer exist.
OWCP is aware of this problem and has established procedures in Sec.
30.113 by which a claimant can nevertheless meet this requirement
through the submission of affidavits attesting to medical evidence that
was contained in documents that no longer exist. However, a signed
medical release is needed in all Part E claims so OWCP may thoroughly
investigate the claim. Thus, the suggestion to drop this requirement
was not adopted. The same advocacy group and another advocacy group
suggested that the requirement contained in Sec. 30.232(c) that a
claimant establish that a covered Part E employee suffered an injury,
illness, impairment or disease as a consequence of a covered illness be
deleted. These commenters feel that OWCP claims examiners should have
enough documentation and medical evidence in the case file to made
these determinations without requiring the submission of additional
medical evidence. However, the nature of these consequential conditions
is that they only arise subsequent to the development of an underlying
condition, thus necessitating the submission of more recent medical
evidence establishing their causal relationship to an existing covered
illness. Accordingly, the suggestion was not adopted in the final rule.
Section 30.300
Two comments from individuals, two from congressional
representatives and one from an advocacy group suggested that OWCP use
Physicians Panels to make determinations when there is a dispute with
regard to issues of causation or the degree of impairment. After
considering the use of Physicians Panels in the adjudication of Part E
claims, OWCP decided in the interim final rule to base the formal
adjudicatory and review structure for those claims on the same
successful and streamlined structure that has been used for Part B
claims since 2001. The use of Physicians Panels as deciding bodies for
claims submitted to DOE under former Part D of EEOICPA proved to be
both inefficient and extremely time-consuming. Nevertheless, OWCP will
use a full range of qualified medical specialists to assist in the
development of claims, especially the kind of complex cases these
comments discuss. When a claim involves extreme complexity and multiple
medical disciplines, OWCP may refer the claimant to a panel of
physicians for a medical evaluation. Once a report is received, OWCP's
adjudicatory staff will then consider it when they make a decision on
the claim. OWCP continues to believe that this type of claims
adjudication process provides for a more efficient and expeditious
handling of medical disputes and the application of more uniform
criteria to resolve such disputes. Thus, the suggested changes have not
been adopted.
The same advocacy group suggested that OWCP state in the
regulations the processes it will follow with respect to classified
information that may be pertinent to a claim under EEOICPA, and urged
that in situations where the claimant or his or her representative
lacked the requisite security clearances, OWCP should ask the Ombudsman
to provide a properly cleared lawyer or qualified technical expert to
evaluate the factual evidence and advocate on behalf of the claimant
during the claims adjudication process. OWCP is also concerned about
the impact of using classified information to adjudicate claims under
the Act. However, since it is not the classifying agency with respect
to such information, it cannot allow greater access to the information
than is currently permitted. As for the suggestion that OWCP should ask
the Ombudsman to nominate or otherwise provide a person with the
requisite security clearance to advocate for
[[Page 78525]]
claimants, the Ombudsman is not authorized to perform that function by
either the statute or Secretary's Order 1-2005 (70 FR 33328), which
established the Office of the Ombudsman within the Department. The
Ombudsman does not have any role in the claims adjudication process
administered by OWCP. Thus, the suggestions were not adopted in the
final rule.
Another advocacy group suggested that the claims adjudication
processes described in Sec. 30.300 be altered to include a review by
an ``independent entity'' like an administrative law judge. This same
suggestion was made by several commenters with respect to this section
as it appeared in the first interim final rule governing its
administration of the Act that OWCP published on May 25, 2001 (66 FR
28948). As it noted when it subsequently published the first final rule
governing its administration of EEOICPA on December 26, 2002 (67 FR
78874), OWCP believed that utilizing administrative law judges or
another type of independent review body would unnecessarily complicate
and delay the claims adjudication process to the detriment of
claimants. The commenter did not present any new reason not previously
considered by OWCP when it originally decided to retain the
adjudicatory structure described in Sec. 30.300, or any evidence of
problems with it since its inception in 2001. Therefore, the suggested
change to this section of the regulations was not adopted.
Sections 30.301 and 30.302
One advocacy group suggested that OWCP extend the ability to
request issuance of a subpoena to include Part E claims as well as Part
B claims, and that this ability should be extended to all stages of the
claims adjudication process. Section 30.301 indicates that a claimant
may request that a Final Adjudication Branch (FAB) reviewer issue a
subpoena in connection with a claim under Part B of EEOICPA. The
statutory authority underlying this section is derived from section
7384w, which only applies to claims filed under Part B; Part E does not
contain a similar provision. Therefore, OWCP does not have authority to
extend the ability to request a subpoena to claimants under Part E.
Further, OWCP has found it to be more efficient to limit the use of
subpoenas by claimants to the portion of the claims adjudication
process that includes the right to request an oral hearing, i.e., the
portion before the FAB. OWCP claims examiners regularly assist
claimants in obtaining relevant documents and information in the early
development of claims under EEOICPA, and adding subpoena requests to
this assistance would not appear to be either efficient or productive.
Therefore, the suggested changes to Sec. 30.301 have not been adopted.
One attorney suggested that Sec. 30.302 be modified so that
claimants will be relieved of their obligation to pay the costs
associated with subpoenas they have requested when the subpoenaed
witness submits evidence into the case record that is relevant to the
claimant's case and where the witness failed before the hearing to
provide written evidence after being requested to provide such evidence
by the claimant. OWCP believes that the suggested modification
erroneously presumes that there will likely be situations where a
witness will refuse to provide requested evidence without issuance of a
subpoena by a FAB reviewer. This has not been the experience of OWCP in
other benefit programs it administers, and OWCP does not contemplate
that it will occur in its future administration of Part B. Up to the
present time, OWCP has not encountered significant difficulty obtaining
the factual or medical evidence necessary for it to adjudicate these
claims, and there is no reason to think that these sorts of
difficulties will occur in the future. Therefore, the suggestion to
modify Sec. 30.302 was not adopted in the final rule.
Section 30.303
DOE commented that the 60-day period within which it was required
to respond to a request from OWCP for information or documents relevant
to a claim under Part E of the Act in Sec. 30.303 was unreasonable,
and noted that it would not be able to respond to such a request in a
timely manner if the evidence needed to be reviewed for
declassification purposes. As an alternative, DOE proposed that the
standard for compliance with such a request be ``as soon as possible.''
While it does not dispute the validity of this concern, OWCP believes
that the suggested proposal would effectively remove the time period
for response from Sec. 30.303. However, in order to accommodate DOE's
belief that it requires additional time to comply with these necessary
requests, OWCP has amended Sec. 30.303(a) to provide DOE with 90 days
within which to respond.
Sections 30.307 and 30.316
One attorney suggested that Sec. Sec. 30.307(a) and 30.316(e) be
amended to provide that a copy of the recommended decision and the
final decision be sent to both the claimant and the claimant's
representative. These sections currently provide that the recommended
decision and final decision be sent to the claimant, unless he or she
has a representative. In such a case, the recommended decision and
final decision are to be sent only to the representative. OWCP believes
that these suggestions have merit, and also notes that this has been
the administrative practice of the program for some time. Thus,
Sec. Sec. 30.307(a) and 30.316(e) have been amended in the final rule
to provide that OWCP will send a copy of the recommended decision and
the final decision on a claim to both the claimant and the claimant's
representative, if any.
Section 30.315
One attorney suggested that Sec. 30.315 be amended to permit, at
the discretion of the FAB reviewer, a postponement of a hearing if the
claimant's representative provides reasonable notice that the
representative has a medical reason that prevents his or her attendance
at the claimant's hearing. The interim final rule permits such a
postponement where the claimant is prevented from attending the hearing
for medical reasons, and it is the current practice of OWCP to permit
such postponements for representatives whose attendance is prevented
for the same reasons. Thus, Sec. 30.315(b) has been amended as
suggested by the commenter.
Section 30.320
One attorney suggested that Sec. 30.320(b) be amended to require
the reopening of a final adverse decision on a claim if the claimant
submits new evidence of a medical condition or discovers additional
medical reports. The section currently requires the Director for Energy
Employees Occupational Illness Compensation to a reopen a final
decision on a claim if he concludes that the claimant has submitted new
and material evidence with regard to either covered employment or
exposure to a toxic substance, or identifies either a material change
in the PoC guidelines, a material change in the dose reconstruction
methods or a material addition of a class of employees to the Special
Exposure Cohort. The experience of OWCP with respect to the processing
and adjudicating of claims based on occupational or covered illnesses
is that new medical evidence of a condition is easily obtained and,
upon consideration, rarely sufficient to warrant the reversal of an
earlier determination regarding a claimed condition. To permit an
automatic reopening of a final decision based on such evidence would
inevitably lead to
[[Page 78526]]
numerous frivolous reopenings and the attendant administrative
inefficiencies would deprive claimants with meritorious claims of the
opportunity to have those claims adjudicated in a timely manner. It
should be noted, however, that claims may be reopened on the basis of
new medical evidence by the Director under Sec. 30.320(a), which
permits the Director, at his discretion, to reopen a final decision at
any time. For these reasons, the suggestion regarding Sec. 30.320(b)
has not been adopted.
Sections 30.400, 30.403, 30.404 and 30.405
OWCP received three comments from advocacy groups, one from an
attorney and two from congressional representatives objecting to the
wording in Sec. Sec. 30.400, 30.403, 30.404 and 30.405 that suggested
that there was no way for a claimant to administratively challenge a
denial of a particular medical benefit. The wording in question was
intended to describe the process that OWCP's medical billing contractor
uses to inform claimants of decisions on medical bills that are
submitted for payment. However, this wording incorrectly suggested that
there was no administrative method by which a claimant could challenge
an adverse medical billing determination by OWCP's contractor. To
rectify this situation, and as suggested by the commenters, Sec. Sec.
30.400, 30.403, 30.404 and 30.405 have been changed to indicate that a
claimant may administratively challenge an adverse medical billing
determination by utilizing the internal adjudicatory processes
described in subpart D of the regulations.
Sections 30.410 and 30.411
One advocacy group asked that OWCP clarify the provisions in
Sec. Sec. 30.410(b) and 30.411(c) regarding disruptions of directed
medical examinations. The provisions in question are intended to remind
employees and their representatives that these medical examinations are
under the control of medical professionals and are not, therefore, a
proper forum for disputing aspects of individual claim adjudications.
These physicians have been asked to conduct an examination at the
request of OWCP in order to further clarify aspects of an employee's
alleged medical condition, not to treat the employee, and therefore
they do not have the type of ethical obligations regarding the employee
that would otherwise naturally arise with a normal ``doctor-patient''
relationship. Since any attempt to interfere with a directed
examination would disrupt the purpose of the examination, Sec.
30.410(b) and Sec. 30.411(c) set out the consequences of taking such
actions, and have not been altered in the final rule.
This same advocacy group disagreed with Sec. 30.411(b), which
states that when OWCP finds that a conflict in the medical evidence
exists, OWCP will select a third physician to conduct a referee
examination that resolves such conflict. This process has been in place
since the inception of OWCP's administration of Part B, and was not
altered in any way with the promulgation of the interim final rule.
Further, this same process has been used successfully in other benefit
programs administered by OWCP. Accordingly, Sec. 30.411(b) was not
modified in the final rule.
The same advocacy group and another advocacy group criticized the
absence of any ``conflict of interest'' provisions with respect to
physicians in the interim final rule. These comments asserted that it
was important that OWCP indicate that physicians involved in the claims
adjudication process who submitted medical evidence upon which OWCP
claims examiners would make determinations on claims would be subject
to some sort of constraints regarding such matters as prior involvement
with a claimant, former work for a claimant's employer, etc. OWCP
agrees with the general thrust of these comments, and has added
provisions to Sec. Sec. 30.410 and 30.411 that indicate that
physicians who perform directed medical examinations at the request of
OWCP in connection with the claims adjudication process will be subject
to ``conflict of interest'' standards devised by OWCP to ensure their
compliance with ethical standards of professional conduct.
Sections 30.500 and 30.501
A total of 521 comments objecting to the definitions of ``covered''
child and ``surviving spouse'' for the purposes of Part E in Sec.
30.500(a) were received from 502 individuals and one lay representative
(several individual commenters submitted multiple comments on this
issue). While the definition of a ``surviving spouse'' is the same one
that applies to Part B claims, a ``covered'' child under Part E must
meet the same definition of a ``child'' used in Part B and, as of the
date of the covered Part E employee's death, be either under the age of
18, under the age of 23 and a full-time student who was continuously
enrolled in one or more educational institutions since attaining the
age of 18 years, or any age and incapable of self-support. These
definitions merely follow, as they must, the definitions for these two
terms that appear in section 7385s-3(d). Since these terms cannot be
altered through the rulemaking process, the suggestions were not
adopted and no changes were made to Sec. 30.500(a).
The same lay representative and two of the same individuals also
objected to the order of precedence for survivors under Part E that is
set out in Sec. 30.501(b) and argued that a surviving spouse should
not be required to share an award with children of a deceased Part E
employee under any circumstances. This section states that if there is
a surviving spouse and at least one ``covered'' child of a deceased
covered Part E employee who is living at the time of payment and who is
not a recognized natural child or adopted child of such surviving
spouse, half of the payment is made to the surviving spouse and the
other half is shared equally among all ``covered'' children of the
employee who are living at the time of payment. As was the case with
the survivor definitions discussed in the preceding paragraph, the
regulatory order of precedence for survivors under Part E of the Act
merely tracks the statutory order of precedence contained in section
7385s-3(c)(3) of EEOICPA. Since the order of precedence for survivors
under Part E cannot be modified by regulation, the suggestion was not
adopted.
Section 30.505
Two advocacy groups suggested that the unified benefit payment
processes for both Parts B and E described in Sec. 30.505(a) be
amended to require OWCP to issue a ``partial'' award of $12,500 to
covered Part E employees at the time it determines that they have
contracted a covered illness, and to determine the balance of any
compensation due them within another six months. Unlike Part B of
EEOICPA, which compensates individuals upon a finding that a covered
Part B employee contracted an occupational illness, Part E monetary
compensation can only be awarded if OWCP further determines that a
covered Part E employee's wage-loss, impairment or death was due to his
or her covered illness. Thus, this suggestion would result in the
issuance of a monetary award to a claimant before OWCP has determined
that the statutory entitlement criteria established by Part E have been
met, and that a payment is due after any required offsets have been
calculated. Shortening the monetary benefit payment processes for Part
E as suggested by these two commenters would violate the explicit terms
of EEOICPA, and therefore the
[[Page 78527]]
suggestions to change Sec. 30.505(a) have not been adopted.
One labor organization suggested that Sec. 30.505(d) be amended to
permit a claimant to receive up to the $250,000 maximum aggregate
compensation payable under Part E for both wage-loss and impairment,
for each of his or her covered illnesses. As OWCP noted in the preamble
discussion of this provision of the interim final rule, 42 U.S.C.
7385s-12 ``limits the aggregate compensation (other than medical
benefits) that OWCP may pay under Part E to all claimants for each
individual whose illness or death serves as a basis for compensation or
benefits under Part E to a total of $250,000. This is the only reading
of the statutory language that is consistent with the statutory
requirement that the computation of both impairment benefits and wage-
loss benefits under [section] 7385s-2 be based upon impairment or wage-
loss that is 'the result of any covered illness.' This reading is also
consistent with congressional intent, as reflected in the Conference
Report for Public Law 108-375, which states that the `maximum aggregate
benefit available under [Part] E of EEOICPA is $250,000.' See H.R.
Conf. Rep. No. 108-767, at 894 (2004).'' Thus, the suggested changes
have not been adopted.
Section 30.509
Two advocacy groups asked why Sec. 30.509(c) indicates that OWCP
will only make an impairment determination for a deceased Part E
employee if an eligible survivor makes an election to receive the
compensation of the employee as permitted by section 7385s-1(2)(B) of
EEOICPA, when the Conference Report states that survivors under Part E
are to receive a minimum lump-sum payment of $125,000. These comments
are based on a misunderstanding of the operation of Sec. 30.509, which
describes the very limited universe of survivors who are eligible to
make the election described in section 7385s-1(2)(B), and the fact that
the only survivors entitled to utilize this election provision would
not be entitled to survivor benefits because the election is only
available to survivors of a covered Part E employee who died ``from a
cause other than the covered illness of the employee.'' Survivors who
make this election will therefore not be eligible to receive any other
compensation (such as the $125,000 lump-sum payment) under the terms of
section 7385s-3. Accordingly, the provision discussed in Sec.
30.509(c) is correct, and no changes were made to this section in the
final rule.
Sections 30.513 Through 30.517
One lay representative suggested that in Sec. 30.517, OWCP should
more specifically describe the circumstances under which it would
decide to waive its statutory right to recover an overpayment pursuant
to section 7385j-2 of EEOICPA. While Sec. 30.513 of the interim final
regulations notes the general authority of OWCP to waive recovery of an
overpayment of EEOICPA benefits, Sec. Sec. 30.514 through 30.517
elaborate on that authority with a substantial amount of detail. In
light of the variety of factual circumstances and fairness
considerations that may apply in any specific case, it is not possible
to identify particular circumstances rather than general principles
concerning how this authority is to be exercised. Therefore, since
Sec. Sec. 30.513 through 30.517 in the interim final regulations
adequately identify the standards that OWCP will use to make these
determinations without depriving OWCP of sufficient flexibility to
administer this aspect of the program, the suggested changes have not
been adopted.
Section 30.600
One individual suggested that Sec. 30.600(b) make it clearer that
a claimant can grant a person a ``power of attorney'' to act on his or
her behalf, and that such person can then designate a representative to
pursue the claim under EEOICPA. OWCP believes there is merit in this
suggestion. Thus, additional language was added to Sec. 30.600(b) to
clarify that a person who has been granted a power of attorney by a
claimant under EEOICPA may designate a representative to pursue that
claim before OWCP. Also, one attorney suggested that OWCP change Sec.
30.600(c)(2) to allow an attorney or representative to complete, but
not sign, a Form EN-20. OWCP believes that this suggestion has merit,
and Sec. 30.600(c)(2) has been amended as requested.
Section 30.603
One attorney suggested that the 10 percent limit for attorney fees
for filing objections to a recommended decision should apply to the
amount of the lump-sum awarded in the final decision. The interim final
rule currently applies this limit to the amount by which the lump-sum
award is increased as a result of the objections, and is consistent
with the mandate in section 7385s-9 to limit such fees in Part E cases
in the same manner as Part B cases. Since Part B claimants either
receive a full lump-sum award or no award at all, successful objections
to a recommended decision provide a claimant with an ``increased''
lump-sum award equal to the entire amount payable under Part B. Section
30.603(b)(2) in the interim final rule merely applies this same
principle to Part E cases as required by the explicit terms of the Act.
Since lump-sum awards to covered Part E employees may vary according to
their level of impairment and the extent of their wage-loss, there may
be instances where an objection to a recommended decision proposing to
award benefits under Part E may result in a final decision awarding
greater benefits. In such a case, the gain to the covered Part E
employee from the filing of the objection will not be the entire lump-
sum award; the gain will the difference between the lump-sum payment
and the amount proposed in the recommended decision. To be consistent
with Part B, as required by the statute, the attorney fees under Part E
have to be limited to the difference in lump-sum amounts. Thus, the
suggested change has not been adopted.
This attorney and two other attorneys also objected to the
provision in Sec. 30.603(b)(1) that does not permit a representative
to charge a two percent fee unless he or she was retained prior to the
initial filing of the claim. This provision, however, is based on the
limitation contained in 42 U.S.C. 7385g(b)(1), which states that a
representative may only charge a two percent fee ``for the filing of an
initial claim for payment of lump-sum compensation. * * *'' OWCP
believes that it would violate the statute to permit a representative
to charge a fee of two percent of the lump-sum award if the
representative was retained after the claim was filed. One of these two
other attorneys also suggested that the term ``initial claim'' be
defined to include the filing of amended claim forms, the submission of
additional documents or data, or the reopening of the claim following
the issuance of a final decision by the FAB; in the alternative, he
also suggested that the limitations described in the interim final rule
not apply to claims that were filed prior to the effective date of that
rule, i.e., June 8, 2005. OWCP believes that an expansive definition of
the term ``initial claim'' would be inconsistent with the plain meaning
of the statute, which has not changed in this regard since section
7385g was amended on December 28, 2001. For this same reason, OWCP also
believes that there would be no justification for applying the fee
limitations described in Sec. 30.603 only to claims filed on or after
June 8,
[[Page 78528]]
2005. Thus, none of these suggested changes were adopted in the final
rule.
Section 30.609
Two advocacy groups disagreed with the requirement in Sec. 30.609
that claimants must report (for offset purposes) any payments that they
receive due to medical malpractice resulting from treatment of their
occupational illness or covered illness. Such medical malpractice
payments have as their genesis exposures for which compensation is
payable under Part B or Part E of EEOICPA. Under section 7385 of
EEOICPA, benefits payable under Part B or Part E must be offset to
reflect these types of payments. Thus, OWCP must be informed of these
types of payments so it can perform the statutorily mandated offset of
EEOICPA benefits, and the suggestion to eliminate this section has not
been adopted in the final rule.
Section 30.626
One lay representative and five individuals objected to Sec.
30.626, which describes the required coordination of payments under
Part E of EEOICPA with benefits from state workers' compensation
programs for the same covered illness or illnesses. However, OWCP is
required to coordinate Part E benefits in this manner by section 7385s-
11 of the Act. Thus, the suggestion to eliminate this section has not
been adopted.
Sections 30.801, 30.805, 30.806 and 30.815
One individual suggested that Sec. 30.801 indicate that
compensation will be provided to employees who have suffered occasional
days of lost pay due to their covered illnesses. However, Part E is not
a program that provides compensation for any wage-loss, regardless of
amount, that a covered Part E employee may experience due to his or her
covered illness. Instead, Part E only provides compensation under a
specific formula in section 7385s-2(a)(2)(A) based on a qualifying
amount of wage-loss sustained in a given calendar year, and this
formula cannot be altered in this final rule. Thus, the suggestion has
not been adopted.
One labor organization asserted that it is more difficult for
employees who worked intermittently at DOE facilities to establish
their average annual wage and their alleged calendar years of wage-loss
through reliance on wage data received from the Social Security
Administration, and that this will result in employees having to use
the methods of Sec. 30.806 to convince OWCP to determine a different
average annual wage and/or the extent of compensable calendar years of
wage-loss than it determined using Sec. 30.805. However, the labor
organization did not put forward any discernable proposal to address
the purported problem it raised in its comment. While it is possible
that some employees may incur difficulties in securing the type of
records described as acceptable to OWCP in Sec. 30.806, these
difficulties alone should not relieve them of their burden to produce
records that show a level of wage-loss sufficient to make them eligible
for an award. OWCP claims examiners are instructed to accept tax
returns, pay stubs, union records and pension records as evidence of
earnings. In addition, claims examiners can request earning records
from employers. Therefore, no change has been made to Sec. 30.806 in
the final rule. However, because of these concerns, Sec. 30.805 has
been amended in the final rule to more precisely define the term
``wages.'' Another labor organization asserted that some occupations
are more likely to be affected by the business cycle than others, and
asked that the wages of employees in these occupations be determined by
looking to the average wages of their ``peer group'' rather than to
their own individual wages. OWCP does not believe that adjustments for
fluctuations in demand for labor in certain occupations can be made
fairly or efficiently, nor does it believe that it has the authority to
make this type of change to the statutory formulae